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Abstract 
 
Stereoselective organocatalyzed transformations involving rotationally restricted systems 
 
Stereoselective organocatalyzed reactions are powerful synthetic tools complementary to 
transition metal-catalyzed transformations that allow access to a large variety of chiral 
scaffolds with stereogenic centers, axes or planes. Due to their low toxicity and ready 
availability, small molecule catalysts represent thus a more sustainable alternative for the 
synthesis of complex structures.  
 
Herein we investigated an enantiospecific electrophilic substitution catalyzed by ortho-
substituted anilines through the formation of atropisomeric enamine intermediates. Using an 
enantiopure a-fluorinated aldehyde as a substrate, several anilines bearing bulky ortho- 
substituents were tested to selectively catalyze the addition of an electrophile to form a 
quaternary stereocenter with retention or inversion of configuration. 
 
 
 
Multi-axis systems with rotationally restricted bonds are topologically well-defined motifs 
and valuable chiral scaffolds with diverse applications from catalysis to medicinal chemistry. 
However, synthetic pathways to these compounds as well as studies about their rotational 
behavior remain scarce. Therefore, we reported the enantioselective synthesis of rotationally 
restricted aromatic amides displaying three stereogenic axes. Catalyzed by a chiral tetrazole 
derived proline, the anilides were obtained with an e.r. up to 87:13 and a cis/trans ratio of 
1:3. An exhaustive study was conducted to identify the 3D structures of the major compounds 
and to deepen our understanding regarding their rotational behavior
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Due to their peculiar handle-shaped structure imparting them a stereogenic plane, 
cyclophanes have always been a fascination for chemists around the world. Widely spread 
among natural products and bioactive compounds, they also find application in 
nanotechnologies and material sciences. If multiple synthetic strategy to access such 
macrocycles have already been described, the development of organocatalyzed 
transformation to obtain enantiopure cyclophanes is severely limited. Hence, we explored 
the use of the enantioselective arene forming aldol condensation developed in our group to 
achieve the synthesis of enantiopure paracyclophanes with an anthracene core and fifteen 
methylene groups on the side chain. 
 
 
 
 
Synthesis of acridinium salts and their application in photoredox catalysis 
 
The continuous development of photocatalytic methods motivates the design of organic 
catalysts towards a more sustainable approach, in order to complement the frequently used 
and precious polypyridyl transition metal complexes. However, this rational design is often 
hampered by the mechanistic complexity and low modularity of the catalyst structure. 
Herein, a scalable synthesis of symmetric acridinium dyes was reported. Optimized reaction 
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conditions and purification methods allowed to prepare these catalysts on multi-gram scale, 
using a double halogen-metal exchanged as a key step.  
 
 
 
A thorough photophysical study of a diverging photocatalytic pathway drove the design and 
fully modular synthesis of asymmetric acridinium catalysts. A combination of halogen-metal 
exchange with directed ortho-metalation allowed to generate a wide panel of dyes with fine-
tuned photophysical and photochemical properties. 
 
 
 
Given the high degradation observed for several dyes during a photocatalytic reaction, the 
design of a new generation of photostable acridinium salts was tackled. Symmetric 
photocatalyst with carbazole moieties and asymmetric ones with a methoxy group on one 
side and a diphenylamino group on the other side of the core were thus synthesized
N
Me
R2
Br
R1 R1N
MeBr
R1
R2
OMeOBr
R1
N
MeM
R1
M
R1
Mg
THF, 60 °C
M = MgBr
up to 3.9 g
up to 84% yield
N+
R
R’
N
BrR
n-BuLi
65 °C
hexane/Et2O
NMe2
MeO
R = Me, Ph
N
Li LiR
NMe2
MeO
OMeO
R’
Br–
OMe
NMe2
THF, 12 h
then HBr
 
 
VI	
 
 
Finally, application in photoredox deuterations and trans-stilbene isomerization were 
described. The symmetric acridinium catalysts, prepared on multi-gram scale, allowed the 
deuteration of a pharmaceutically relevant scaffold in high yield and selectivity. The 
asymmetric ones gave 84% of cis-stilbene through a TTET (triplet-triplet energy transfer). 
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1	
 INTRODUCTION 
 
1.1 ROTATIONALLY RESTRICTED SYSTEMS 
 
 Enantiospecific reactions through the formation of rotationally restricted 
enolates 
 
Enantiospecific reactions are powerful tools for the stereoselective synthesis of drugs[1] and 
natural products.[2] Throughout these transformations, an enantiopure starting material is 
controlling the absolute configuration of the product as exemplified by the SN2 reaction. 
Starting from an enantiopure compound, the attack of a nucleophile leads to a Walden 
inversion in an absolute stereocontrol (Scheme 1, top). However, in regard to SN1 reactions, 
enantiopure starting materials with sp3-hybridized stereogenic centers get trigonalized during 
the transformation which is known to lead to racemic mixtures. Therefore, SN1 
reactions represent a challenging enantiospecific reaction to perform (Scheme 1, bottom).[3], 
[4]  
 
 
Scheme 1: Enantiospecific SN2 with Walden inversion (top) and general mechanism for a-addition (bottom). 
 
In 1981, Seebach and Wasmuth took serendipitously a first step into solving this question 
with an interesting discovery while investigating the b-alkylation of diethyl malate (Scheme 
2, top).[5],[3] They reasoned that upon addition of the electrophile following the dilithiation of 
the substrate, the b-alkylated product would be formed (Scheme 2, top). However, after 
X Nu + X
Nu
SN2
Walden inversion
- X + Y
+
enantiopure substrate trigonal intermediate racemic product
X X
X
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deprotonation with lithium diethylamide of the substrate and alkylation with iodomethane, 
they observed two distinct products. The desired b-alkylated compound was received in 
moderate yield (55%) but an unexpected side product generated by the a-alkylation could 
also be isolated in 15% yield with 60% ee (Scheme 2, bottom). This discovery led to different 
hypothesis regarding the mechanism behind this outcome. The side product could be the 
result of mixed aggregate of the intermediates. Or, the stereogenic axis arising from a non-
co-planar orientation of the enolate and imine moieties (along the Calpha–N bond) could direct 
the absolute configuration of the side product. Even though the first hypothesis was 
confirmed later, this discovery set the path to a new concept for enantiospecific SN1 type 
reactions: rotationally restricted enolates.[6] 
 
Scheme 2: b-alkylation of diethyl malate (top) and discovery of enantiospecific a-alkylation through the 
formation of rotationally restricted enolates. 
 
Therefore, Seebach and coworkers designed an innovative approach to achieve this idea 
(Scheme 3).[6] Starting from a chiral compound with two functional groups but only one 
stereogenic center, the reaction with an aldehyde auxiliary would form an acetal, creating 
thus a second stereocenter. After the trigonalization of the original stereocenter, the 
temporary one would control diastereoselectively the addition step. Finally, a cleavage of the 
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acetal would lead to the enantiopure product either with inversion or retention of 
configuration.  
 
 
Scheme 3: Mechanistic hypothesis for the enantiospecific SN1 type reactions. 
 
This strategy was then widely applied for the synthesis of a-alkylated amino-acids and more 
specifically proline (Scheme 4, top).[7] Pivaldehyde was chosen as a cleavable auxiliary for its 
high diastereoselectivity and efficiency for acetalization without side product formation 
during the alkylation step (due to the bulkiness and inertia of the t-Bu group). Moreover, this 
reagent has a low boiling point (74°C) which makes it easily removable after cleavage. The 
addition of the pivaldehyde to L-proline thus led to the formation of a bicyclic acetal as a 
single diastereomer. Upon deprotonation with LDA, the intermediate with a newly created 
stereocenter directs the subsequent addition of allyl bromide which generates, after cleavage 
of the auxiliary, (S)-a-allylproline with retention of configuration in good yields (87%). 
Thereafter, this method was frequently applied in the total synthesis of natural products 
(Scheme 4, bottom).[8], [4]  
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Scheme 4: a-allylation of L-proline through enantiopure enolate intermediate(top) and natural products 
synthesized using this method (bottom). 
 
Ten years later, Fuji and Kawabata took a step further by designing enantiopure ketones 
which upon deprotonation generate a rotationally restricted enolate.[9] The stereogenic axis 
is then the element which is controlling the absolute configuration during the alkylation step 
compared to the previously designed stereogenic center control (Scheme 5). This approach 
allowed to avoid the use of an auxiliary and could provide the a-alkylated product in 
moderate yield (48%) and good ee (66%). Better results were achieved when moving on to 
amides which through an intermediate with a hindered rotation about the C-N bond (t1/2 = 
22h at -78°C) led to the product in excellent yield (91%) and selectivity (81%).[10], [11] 
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Scheme 5: Enantiospecific methylation through rotationally restricted enolates. 
 
Kawabata could also extend this method to intermediates with rotationally restricted C-O 
bond to perform an enantiospecific five-membered cyclization of alkyl aryl ethers (Scheme 
6).[12] The bulkiness of the ortho substituent is crucial in this transformation to maintain a 
rotational barrier of the enolate around 11-12 kcal.mol-1. Although the intermediate is short-
lived, an efficient induction of enantioselectivity (84–99%) could be achieve with retention of 
absolute configuration in moderate to good yields (20–82%). 
 
 
Scheme 6: Enantiospecific cyclization through rotationally restricted enolate. 
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Broadening this concept, Penso, Lupi and coworkers reported an elegant enantiospecific 
intramolecular a-arylation through the formation of a rotationally restricted enolate  
(Scheme 7).[13] Starting from an alanine derivative, the deprotonation leads to a conformer 
where the t-Bu group and the sulfonyl group are remote from each other giving rise to a 
rotationally restricted enolate. A subsequent intramolecular nucleophilic attack of the 
enolate on the aromatic ring generates a spiro-Meisenheimer intermediate which upon 
elimination of sulfur dioxide delivers the product. 
 
 
Scheme 7: Synthesis of a-quaternary a-amino acids derivatives through rotationally restricted enolates (top) 
and proposed mechanism (bottom). 
 
Carlier and coworkers even applied this method to enantiospecific electrophilic addition on 
Benzodiazepines (Scheme 8).[14] Upon deprotonation, the starting material of (S) 
configuration known to adopt preferentially a (M) conformation (confirmed by X-Ray) leads 
to an enolate intermediate with a restricted C-N bond (barrier for racemization around 20 
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kcalmol-1). The addition then occurs then on the concave face which places the electrophile 
in the pseudo-axial position and gives the product with retention of configuration. Even 
though this spatial arrangement seems sterically hindered, the addition on the concave face 
decreases torsional strains and increases imine and amide resonance.  
 
 
Scheme 8: Enantiospecific electrophilic addition on Benzodiazepines through rotationally restricted enolate. 
 
In light of these examples, it appears that rotationally restricted enolate intermediates are a 
powerful tool to induce enantiospecific SN1 type reactions. This method was broadly 
applicable to various starting material from amino-acids to more complex structures and even 
drug-like molecules. The extension of this concept to rotationally restricted enamines will be 
discussed later in this thesis. 
 
 Stereoselective synthesis of atropisomers and multi-axis systems 
 
Even though plethora of methods have been developed and reported for the synthesis of 
enantioenriched compounds with stereocenters, the area remains to be explored when it 
comes to molecules with one or multiple stereogenic axis. First experimentally discovered by 
Christie and Kenner in 1922 [15] and further labeled by Kuhn in 1933,[16] atropisomers (from 
the Greek “a” = not and “tropos” = turn) are stereoisomers arising from a hindered rotation 
about a single bond (Scheme 9). Their valuable chiral scaffolds provide a broad range of 
topologies with various application from catalyst design to medicinal chemistry.[17–21]  
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Scheme 9: Configuration of atropisomers. 
 
Traditionally prepared by cross coupling followed by kinetic resolution, several synthetic 
approaches such as de novo construction of arenes, conversion of a stereodynamic system, 
desymmetrization and many others have been since developed to access those structurally-
well defined motifs.[22–31]  
Pioneered by Bringmann, the use of a lactone bridge was one of the first innovative 
stereoselective functionalization of racemic biaryls (Scheme 10, top).[32] After esterification 
to attach the two aromatic moieties, the cyclization through aryl coupling leads to the 
formation of the ester bridge. This lactone plays a key role in decreasing the rotational barrier 
to ensure a racemic mixture of configurationally unstable compounds. Finally, the 
enantioselective cleavage with chiral nucleophiles allow the formation of enantioenriched 
atropisomeric biaryls. This dynamic kinetic resolution (DKR) strategy granted access to the 
synthesis of a large variety of natural products with a stereogenic axis (Scheme 10, 
bottom).[33] 
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Scheme 10: “Lactone concept” for the synthesis of atropisomeric biaryls (top) and natural products (bottom). 
 
Following a biomimetic approach, atroposelective oxidative couplings catalyzed by enzymes 
or small molecules were also often used as a method to obtain enantioenriched natural 
products with a stereogenic axis.[34–38] For instance, Shaw and coworkers employed a t-
leucine-BINOL derived vanadium complex for a related coupling of two naphthylpyranone 
units in the total synthesis of (−)-virditoxin.[39] This efficient reaction led to the tetra-ortho 
substituted biaryl intermediate with excellent diastereoselectivity (95:5) (Scheme 11). 
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Scheme 11: Total synthesis of (–)-Viridotoxin. 
 
Although this strategy can be very effective, the attachment of two identical moieties severely 
limits its application. To circumvent this issue and access a broader scope of molecular 
scaffolds, atroposelective cross-couplings were further developed as reported by Buchwald 
in a pioneering study about the synthesis of atropisomeric phosphonates.[40–43] In a similar 
process involving a bidentate ferrocenyl aminophosphine ligand, Gu and coworkers achieved 
an atropisomeric Suzuki cross-coupling of 2-iodo-2,3-unsaturated enones with trisubstituted 
aromatic boronic acids or boronic esters to obtain configurationally stable precursors of  
2,2ʹ-biphenol motifs (Scheme 12, top).[44] In an interesting approach disclosed by Suginome 
and co-workers, a Suzuki cross-coupling of arylboronic acids with  
1-bromo-2-naphthylphosphonates catalyzed by a chiral polymeric  
quinoxaline biarylphosphine (PQXphos) delivered a panel of atropisomeric biaryl 
phosphonates (Scheme 12, bottom).[45] Noticeably, the selectivity can be inverted by heating 
the catalyst which triggers a switch of configuration regarding the helicity. 
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Scheme 12: Atroposelective Suzuki cross-coupling for the synthesis of arylcyclohexanones (top) and biaryl 
phosphonates (bottom). 
 
As an alternative to cross-coupling, the conversion of a stereodynamic system is a powerful 
tool to generate atropisomers in high selectivity. Illustrated by Bressy, Bugaut, and Rodriguez, 
an elegant Hantzsch-type reaction allowed the atroposelective synthesis of 4-arylpyridines 
(Scheme 13).[46] The enantioselective Michael addition catalyzed by a chiral thiourea 
derivative was followed by the condensation with an ammonium acetate salt, giving rise to 
1,4-dihydropyridines. By transferring central-to-axial stereogenic information during the 
MnO2 oxidation, a variety of atropisomeric 4-arylpyridine derivatives were obtained, a 
general scaffold comprising members with antitumor and antiviral properties. 
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Scheme 13: Atroposelective Hantzsch-type synthesis of 4- arylpyridines. 
 
For scaffolds with restricted rotation about a C−N bond, Bencivenni studied a new class of 
succinimides, a type of compounds well-known for their antiseizure properties (Scheme 
14).[47] An atroposelective Diels−Alder reaction catalyzed by a chiral primary amine allowed 
the successful desymmetrization of N-arylmaleimides, giving rise to a large range of 
heteroaryls displaying three stereocenters as well as a stereogenic axis. Notably, the sterically 
demanding t-butyl substituent in the ortho position is fundamental for sufficiently restricting 
the rotation about the C−N axis. 
 
 
Scheme 14: Stereoselective desymmetrization of N-arylmaleimides. 
 
In order to achieve more versatility for the preparation of biaryls and non-biaryls compounds, 
the de novo construction of a rotationally restricted system was widely investigated. In a 
seminal atroposelective [2+2+2]-cycloaddition catalyzed by a rhodium/H8−BINAP complex, 
Tanaka described a highly efficient synthesis of QUINAP-type phosphine oxides (Scheme 15, 
top).[48] Turning to gold catalysis, Gong explored the atroposelective synthesis of boron-based 
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heteroaryls, a relevant scaffold in drug discovery (Scheme 15, bottom).[49] A 
cycloisomerization-amination cascade reaction allowed the stereoselective construction of a 
variety of heteroaryls. The protecting groups on the diazene are thus responsible for the 
restricted rotation about the C−N bond of the corresponding hydrazide. The postulated 
mechanism involves an initial coordination of the Au(I) complex to the alkyne to form a 
vinylgold intermediate. The latter is added to the diazene, itself coordinated to a chiral gold 
complex, giving rise to a configurationally stable compound with a stereogenic axis.  
 
 
Scheme 15: De novo synthesis of substituted QUINAPs (top) and gold-catalyzed atroposelective synthesis of 
amino-oxaborininol dervivatives (bottom). 
 
By using an earth-abundant metal combined with an organocatalyst, Tan developed an 
atroposelective synthesis of arylpyrroles, a motif largely found among natural products 
(Scheme 16).[50] A Paal−Knorr reaction catalyzed by a chiral phosphoric acid, with iron(III) 
triflate as a Lewis acid, led to a diversity of arylpyrroles with stereogenic axes. After the 
formation of a key enamine intermediate, the chiral phosphoric acid catalyzes the 
dehydrative cyclization resulting in the formation of the atropisomer. The rotation about the 
C−N bond was sufficiently suppressed by the ortho substituents on the pyrrole moiety and 
the aryl ring. 
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Scheme 16: Atroposelective Paal−Knorr for the synthesis of arylpyrrole derivatives. 
 
Towards a more biomimetic approach inspired by the biosynthesis of aromatic polyketides, 
our group developed a stereoselective arene-forming aldol condensation of ketoaldehydes 
catalyzed by a pyrrolidinyl tetrazole. This method allowed for the atropisomeric synthesis of 
biaryls as well as rotationally restricted aromatic amides in high yields and selectivity, under 
mild conditions (Scheme 17). [51,52]  
 
 
 
 
Scheme 17: Atroposelective arene forming aldol condensation for the synthesis of biaryl (top) rotationally 
restricted aromatic amides (bottom). 
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In light of its high efficiency, the atroposelective aldol condensation was extended to the 
synthesis of multi-axis systems. An iterative sequence of building block addition, oxidation of 
the diol to the corresponding ketoaldehyde, and a catalyst- or substrate-controlled 
stereoselective aldol condensation delivered configurationally stable oligo-1,2-naphthylenes 
with multiple stereogenic axes in high enantioselectivity (Scheme 18, top).[53] This study was 
further used as a platform for the investigation of a catalyst-controlled atropodivergent 
synthesis of oligo-1,2-naphthylenes with up to four stereogenic axes (Scheme 18, bottom).[54] 
 
 
Scheme 18: stereoselective synthesis of oligo-1,2-naphtylenes (top) and stereodivergent synthesis of an 
atropisomeric four-axis system (bottom). 
 
OH
CHO
n
Chiral catalyst
OHC
n
up to 90% ee
Br
CHO
*
*
*
(Sa,Sa,Sa)
(Ra,Sa,Sa,Sa)
Br
CHO*
*
*
*
Br
OHC
(Sa,Sa,Sa,Sa)
*
* *
*
*
* *
substrate-controlled
catalyst-controlled
ROTATIONALLY	RESTRICTED	SYSTEMS	
	 16	
Achieving the synthesis of one of the largest multi-axis systems, Tsubaki reported the 
preparation of dotriacontanaphtalenes (Scheme 19, top).[55] These optically active rod-
shaped oligo-1,4-naphtalenes were assembled by sequential oxidative couplings catalyzed by 
Cu(II) to reach an impressive maximum of 32 units. Studying a different type of oligomers, 
Clayden and coworkers disclosed an investigation of the conformational behavior in solution 
of oligo-m-benzanilides and oligo-p-benzanilides involving three different set of stereogenic 
axis (Ar-CO, N-CO, Ar-N).[56] Although a conformational control was achieved on short dimers 
and trimers, a mixture of conformers was obtained when extending the oligomers (Scheme 
19, bottom). 
 
 
Scheme 19: Atroposelective synthesis of oligo-1,4-napthalenes (top) and conformational study of oligo-
benzanilides (bottom). 
 
Exploring a two-axis system of benzamide-like scaffolds, Miller and coworkers accomplished 
an elegant atropisomeric peptide-catalyzed tribromination of rotationally restricted amides 
(Scheme 20).[57] This transformation produced thus four stereoisomer in an interesting partial 
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without a loss of the overall enantiomeric excess. Although the enantiomeric ratios are 
fluctuating, each enantiomeric pair was produced under the influence of the catalyst. 
 
 
Scheme 20: Catalytic atropisomeric bromination of a two-axis benzamide. 
 
In conclusion, various conceptually distinct methods for the stereoselective synthesis of 
atropisomers are emerging although the pathway to multi-axis systems remains challenging 
and scarce. Elegant strategies that allow the transfer of stereochemical information from 
substrates or readily available catalysts into important atropisomeric structures have been 
elaborated. With methods becoming available for their synthesis, the various types of 
atropisomers and multi-axis systems will find widespread applications in several research 
fields. 
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 Cyclophanes 
 
Cyclophanes are macrocycles constituted by one or several aromatic units connected with an 
aliphatic chain forming a bridge (Scheme 21). First discovered by Lüttringhaus in 1942 who 
baptized them “ansa-compounds” (“ansa” = handle in Latin) regarding their peculiar shape, 
they were referred to as “di-p-xylylene” by Brown and Farthing.[58,59] Finally, the Nobel prize 
winner Cram suggested the name “paracyclophane” to characterize this class of 
compounds.[60] Nowadays, the nomenclature of those scaffolds is influenced by two factors: 
the mancude ring system (maximum number of noncumulative double bonds) and the 
connectivity of the interlinked chain (saturated or not).[61] Furthermore, these molecules are 
optically active as a result of the restricted rotation about the side chain. The stereogenic 
plane is formed by the position of the spacer regarding the aromatic ring. Therefore, the 
length and rigidity of the handle as well as the size of the substituents on the ring affect 
directly their rotational barrier.[62] 
 
 
Scheme 21: Evolution of the nomenclature of cyclophanes. 
 
Due to their unique structure and properties, cyclophanes have known applications in 
multiple fields. With the presence of phosphine groups on the aromatic core, they are 
valuable ligands for asymmetric catalysis (Scheme 22, top right).[63,64] Moreover, their optical 
and electronical features are widely explored in nanotechnologies and material sciences 
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(Scheme 22, top left).[65,66] Finally, they are broadly spread among natural products (Scheme 
22, bottom).[67–69] 
 
 
Scheme 22: Applications of cyclophanes in material sciences (top left), asymmetric catalysis (top right), and 
natural products (bottom). 
 
The synthesis of cyclophanes follow mainly two strategies to close the macrocyle.[69] The de 
novo construction of the aromatic ring can be achieved primarily through cycloaddition (Diels 
Alder, [2+2+2]) or rearrangement. On the other hand, the junction of the alkyl chain offers 
more synthetic options such as metathesis, olefination, esterification, cross coupling, 
aromatic substitution, addition, rearrangement and many more.[70–73]  
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containing an oxazole moiety starting from an a-formylketoxime dimethyl acetal (Scheme 23, 
bottom).[75] 
 
  
Scheme 23: Preparation of cyclophanes through Favorskii (top) and Beckman rearrangement (bottom). 
 
The de novo construction of the aromatic moiety was also carried out through various 
cycloaddition reactions as illustrated by Wulff and coworkers who achieved the synthesis of 
cyclophanes via a Dötz benzannulation (Scheme 24, top).[76] Involving a Fischer carbene 
complex, the [3+2+1] cycloaddition generated two regioisomers in 40% and 21% yield. A 
famous type of cycloaddition often used is the [4+2] as described by Cossy and Meyer who 
reported a diastereoselective sequential Diels-Alder/retro Diels-Alder strategy for the 
synthesis of functionalized [n]paracyclophanes (Scheme 24, bottom).[77] 
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Scheme 24: Preparation of cyclophanes through de novo construction of the aromatic ring through 
benzannulation (top) and Diels-Alder (bottom). 
 
Towards an enantioselective approach, Tanaka and coworkers applied a [2+2+2] 
cycloaddition to access strained dioxa[7]paracyclophanes (Scheme 25, top).[78] Catalyzed by a 
Rhodium-BINAP complex, the product was obtained in moderate yield with up to 75% ee. 
Starting from branched triynes, Shibata and coworkers successfully achieved the synthesis of 
diverse cyclophanes in high yields and enantioselectivity, using a Rhodium-DUPHOS complex 
(Scheme 25, bottom).[79] 
 
 
Scheme 25: Preparation of cyclophanes through enantioselective rhodium catalyzed [2+2+2] cycloaddition. 
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For the synthesis of a natural product, Kondo and Miyake described an original Hantzsch 
pyridine strategy to obtain a normuscopyridine analogue (Scheme 26).[80] An oxymercuration-
oxidation sequence followed by a condensation with hydroxylamine hydrochloride delivered 
[11](2,6)-pyridinophane. 
 
 
Scheme 26: Synthesis of a normuscopyridine analogue through Hantzsch synthesis. 
 
Addition reactions are also widely used to close the macrocycle via the alkyl chain as 
illustrated by Erker and coworkers who used an intramolecular Mannich-type condensation 
to synthesize amino-substituted [3]ferrocenophane (Scheme 27, top).[81] With a cascade 
reaction involving a Michael addition, Reißig and coworkers reported an elegant route 
towards benzannulated cyclodecanone derivatives (Scheme 27, middle).[82] Taking advantage 
of carbonyl chemistry, Shinmyozu and coworkers described an efficient aldol condensation 
strategy to access hyperconjugated multibridged [3n]cyclophanes with significant π-donating 
properties in almost quantitative yields (Scheme 28, bottom).[83] 
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Scheme 27: Preparation of cyclophanes through mannich condensation (top), Michael addition (middle) and 
aldol condensation (bottom). 
 
The extensive development of metathesis reactions opened up the synthetic strategies to the 
preparation of cyclophanes with higher chains and more complex structures with a larger 
functional group tolerance. Starting from a sugar-containing macrocycle, Murphy and Jarikote 
disclosed an alkyne metathesis catalyzed by Mo(CO)6 to obtain a glycophane (Scheme 28, 
top).[70] For natural product synthesis, the ring closing metathesis (RCM) has been a method 
of choice for many years.  Smith and coworkers illustrated this approach by completing the 
total synthesis of (−)-cylindrocyclophane A, an antitumoral agent originally isolated from a 
blue-green alga (Scheme 28, middle).[83] The use of Schrock’s catalyst delivered in high yield 
(78%) the dialkene intermediate which was converted to the product after reduction and 
deprotection. Towards the use of Ruthenium based catalysts, Kotha and Shirbhate reported 
a pathway to the longithorone scaffold involving a RCM catalyzed by Grubbs II (Scheme 28, 
bottom).[71] 
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Scheme 28: Macrocylization through alkyne metathesis (top) and ring closing metathesis (middle and bottom). 
 
Although metathesis reactions are powerful tools to close macrocycles, coupling reactions 
remain one of the most widely spread methods for the synthesis of a large panel of 
cyclophanes. Among them, Glaser couplings are often used as a key step to ensure the 
junction of two terminal alkynes.[73,84–86]  As illustrated by Kotha and Waghule, a Glaser-
Eglinton coupling catalyzed by Cu(II) delivered a macrocyclic bisacetylene derivative which 
was converted to the desired cyclophane after reduction (Scheme 29, top).[87] Cross couplings 
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Colobert disclosed an atroposelective Heck coupling for the synthesis of enantiopure 
isoplagiochin D, a macrocyclic bioactive compound with a rotationally restricted axis (Scheme 
29, bottom).[93] With an enantiopure sulfinyl auxiliary, a complete control over the 
diastereoselectivity of the transformation could be achieved in good yield (98% ee for the 
(aS)-atropisomer). Finally, the sulfinyl intermediate was cleaved and converted to the natural 
product without erosion of selectivity. 
 
 
Scheme 29: Glaser coupling (top) and atroposelective Heck coupling (bottom) for the synthesis of cyclophanes. 
 
Towards a catalyst-controlled approach, Cai and coworkers developed an enantioselective 
synthesis of (–)-pterocarine and (–)-galeon, two natural products from woody plants with 
bioactive properties (Scheme 30).[67] Using a chiral phase transfer catalyst, an efficient SNAr 
cyclization led to the formation of a key diarylether intermediate in high enantioselectivity 
and good yield (91:9 e.r. then 99:1 after recrystallization) which was then converted to the 
corresponding natural products without erosion of ee. 
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Scheme 30: Enantioselective synthesis of (–)-pterocarine and (–)-galeon. 
 
In conclusion, a plethora of strategies can be used to construct cyclophane scaffolds as 
previously discussed. Several other strategies including C-H arylation,[94] Friedel and 
Crafts,[95,96] esterification,[97] olefination,[98] radical mechanism,[99] alkylation,[100] 
elimination[101] and many more are known synthetic methods for the obtention of these 
macrocycles. However, stereoselective approaches to achieve the synthesis of enantiopure 
cyclophanes remain scarce. Later in this thesis, a strategy to access enantiopure cyclophanes 
will be examined. 
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1.2 ACRIDINIUM SALTS IN PHOTOREDOX CATALYSIS 
 
Polypyridyl transition metal systems have been transformative for the field of photoredox 
catalysis with ruthenium and iridium catalysts representing particularly versatile scaffolds 
(Scheme 31).[102–105] The wide range of properties due to the tunability of their ligands make 
them exceptionally valuable catalysts for photochemical transformations. With the 
development of fully organic alternatives, the area opened up towards potentially sustainable 
processes.[106–108] Among them, acridinium salts pioneered by Fukuzumi[109,110] are known to 
have remarkable photophysical properties, complementary to those of polypyridyl transition 
metal structures. Their high reduction potential in the excited state (often E1/2 [P*/P–] > 2 V 
vs. SCE) and their robustness, pH independence, and high solubility in a variety of solvents, 
render them valuable photocatalysts for a wide range of preparative transformations. 
 
 
Scheme 31: Commonly used photoredox catalysts. 
 
 Synthetic strategies for the formation of acridinium salts 
 
The design of acridinium dyes initially evolved towards an increased chemical stability. First, 
Fukuzumi integrated a bulky mesityl group at the C9 position to prevent nucleophilic addition 
that results in photobleaching.[109] Moreover, the introduction of electron donating groups 
favours charge transfer by the stabilizing mesityl moiety.[111] As a consequence, the MesMe-
Acr+ displays unique oxidizing properties (E1/2 [P*/P–] = +2.08 V vs. SCE), with a suitable lifetime 
of the singlet and triplet excited state, which renders it a valuable catalyst for numerous 
photochemical reactions[112–115] To further overcome competitive dealkylation processes, 
Nicewicz developed N-arylated acridinium salts with higher chemical stability and an 
extended range of redox properties (E 1/2 [P*/P–] = 1.62–2.08 V vs. SCE, Scheme 32).[116]  
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Scheme 32: Representative photocatalysts reported by Nicewicz and coworkers. 
 
A series of symmetrically substituted acridinium salts were prepared, with alkyl or methoxy 
substituents attached to the acridinium core. A one step synthesis featuring a triarylamine 
precursor in a Friedel–Crafts reaction with a benzoyl chloride derivative delivered the desired 
acridinium salt with a tetrasubstituted core in good yields (71–81%, Scheme 33). Recently, 
Nicewicz and co-workers designed an efficient synthesis of acridinium photocatalysts starting 
from xanthylium salts.[117] The rapid assembly of a xanthylium dye was thereby combined with 
a condensation reaction with an aniline to give the corresponding acridinium salt.  
 
 
Scheme 33: Synthetic strategies for acridinium salts. 
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Furthermore, an elegant strategy consisting of an oxidative Ugi-type reaction for the synthesis 
of a novel class of imideacridinium salts has been developed by Mancheño and Alemán 
(Scheme 34).[118] Starting from N-substituted acridanes, a coppercatalysed oxidation takes 
place at the C9 position to give a cationic intermediate that reacts with the isocyanide. After 
addition of the in situ formed benzoate, the intermediate is concomitantly rearranged in an 
Ugi-type fashion to produce C9-substituted imide-acridanes. A subsequent aromatization by 
hydride abstraction carried out by tritylperchlorate delivered the desired acridinium salt. 
Photophysical and photoredox studies of these catalysts have been conducted.[119] Direct 
applications in photoredox catalysis were subsequently demonstrated with a suitable activity 
in several benchmarking transformation including anti-Markovnikov hydrofunctionalization 
of alkenes and a dehydrogenative lactonization. 
 
 
Scheme 34: Ugi reaction for the synthesis of acridinium salts and their application. 
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The evolution of the synthesis of acridinium salts towards more modular approaches allowed 
the diversification of their scaffold in order to tune their photophysical properties. In order to 
access this range of acridinium salts, individual strategies were employed for a modular 
synthetic preparation. For the synthesis of symmetrical acridinium salts, such as diamino 
derivatives, a 1,5-bifunctional organomagnesium reagent was added to a variety of carboxylic 
acid esters to provide a broad range of acridinium derivatives (Scheme 35, top).[120] The 
synthesis of 1,8-dimethoxy substituted acridinium dyes was achieved through a double 
directed ortho-metalation (DoM) to generate the 1,5-organodilithium reagent that was 
engaged in a direct ester to heterocycle transformation with variation of the carboxylic acid 
esters (Scheme 35, middle).[121] This approach also enabled the synthesis of atropisomeric 
acridinium salts with a 1,8-dimethoxy-peri-substitution and 9-naphthyl moiety (Scheme 35, 
bottom).[122] After reduction of the racemic acridinium, the enantiomers of the leuco-form 
with a diastereomeric ratio of 97 : 3 were separated by HPLC and reoxidized by chloranil to 
give the two atropisomerically pure compounds. These compounds display a remarkable 
configurational stability with bond-rotational barriers of DG‡298K = 124 kJ.mol–1 and DG‡298K = 
127 kJ.mol–1 respectively.  
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Scheme 35: 1,5-bifunctional organomagnesium reagent for the synthesis of unfunctionalized and diamino 
acridinium dyes (top), double directed ortho-metalation (dDoM) for the synthesis of 1,8-dimethoxy substituted 
acridinium salts (middle) and synthesis of atropisomeric acridinium salts (bottom). 
 
 Acridinium salts as organophotoredox catalysts 
 
A rapidly growing number of chemical transformations employs acridinium salts as 
catalysts.[123–126] Photooxidations, polar radical crossover cycloaddition reactions, C–H 
functionalization, crosscoupling and cross-dehydrogenative reactions, are merely selected 
recent examples of the use of acridinium salts in photoredox catalysis.[127–133] For instance, an 
acyl radical generation for the synthesis of asymmetric ketones was described by Fagnoni and 
co-workers (Scheme 36, top).[134] Starting from readily prepared acylsilanes, the oxidation to 
the corresponding radical cation by Fukuzumi’s catalyst led to the aliphatic acyl radical after 
loss of the TMS group. The addition to a Michael acceptor followed by reduction and 
protonation delivered a variety of asymmetric ketones. Recently, Glorius and co-workers 
disclosed a carbonyl olefin cross-metathesis catalysed by an acridinium salt derived from 
Nicewicz’s 3,6-di-tert-butyl acridinium catalyst (Scheme 36, bottom).[135] 1,3-Diols are thereby 
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generated from aldehydes and alkenes upon visible-light irradiation that subsequently 
undergo acid-promoted Grob-type fragmentations. After the elimination of acetone, the 
cross-metathesis product is thereby formed.  
 
 
Scheme 36: Photocatalyzed acylation of Michael acceptors (top) and carbonyl olefin cross metathesis for the 
synthesis of disubstituted trans alkenes (bottom). 
 
Using a cascade of C–H and C–C bond cleavage steps, the group of Leonori achieved an 
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Acr-Me+ catalyst (Scheme 37).[136] The key step of this transformation lies in the formation of 
an iminyl radical arising from the SET oxidation and deprotonation of a carboxylic acid 
containing cyclic oxime. For instance, a stepwise sequence of an abnormal Beckmann 
fragmentation and a fluorination gives access to a broad range of distal fluorinated nitriles. 
This strategy could also be applied to the synthesis of g-fluorinated and chlorinated ketones. 
After SET oxidation of a linear oxime, a 1,5-hydrogen abstraction provides a nucleophilic 
radical that reacts with N-chlorosuccinimide or selectfluor to deliver the targeted compounds.  
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Scheme 37: Remote fluorination via iminyl radicals. 
 
A photocatalyzed three-component carbofluorination for the synthesis of a-fluoro-a-amino 
acid derivatives has been developed by Molander and co-workers (Scheme 38, top).[137] Upon 
irradiation of the Mes-Acr-Me+ catalyst, an alkyltrifluoroborate reagent is oxidized to give an 
alkyl radical that adds to the dehydroalanine to generate an a-amino radical intermediate, 
which reacts with selectfluor to provide the a-fluoro-a-amino acids. The Nicewicz group 
furthermore investigated an organophotoredox catalysed C–H fluorination of arenes with 18F 
(Scheme 38, bottom).[138] Using the 9-mesityl-3,6-di-t-butyl-10-phenylacridinium salt as a 
photooxidant, TEMPO as a redox co-mediator and caesium fluoride combined with 
tetrabutylammonium bisulfate to generate TBAF in situ, the 18F-fluorination of a wide range 
of arenes, heterocycles and even bioactive compounds was enabled. Their approach was 
expanded to radiofluorinations for PET imaging applications in diagnosis and pharmacological 
studies.  
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Scheme 38: Photocatalyzed synthesis of a-fluoro a-amino acids (top) and direct 18F-fluorination of arenes 
(bottom).  
 
Several direct photoredox catalysed C(sp2 )–H functionalization reactions induced by a dual 
catalytic cobalt/Mes-Acr-Me+ combination were explored by the group of Lei.[139,140] Among 
them an oxidative phosphonylation of arenes for the synthesis of valuable molecular scaffold 
is described (Scheme 39, top).[141] The key step of this reaction is the SET oxidation of the 
arene to give a radical cation that reacts with the trialkylated phosphite. The resulting 
intermediate is then oxidized to a cationic intermediate which is subsequently deprotonated. 
By loss of an alkyl moiety, a wide range of aryl phosphonate products were obtained, even 
allowing the late stage functionalization of druglike compounds. Extending the application of 
their dual catalytic cobalt/ acridinium salt process, the same group also performed a 
photooxidative [4+2] annulation between aromatic ketimine derivatives and styrenes 
(Scheme 39, bottom).[142,143] The SET oxidation of the alkene substrate by the excited Mes-
Acr-Me+ catalyst thereby produces a radical cation that reacts with the nucleophilic aromatic 
ketimine to give a stable benzylic radical intermediate. A subsequent sequence consisting of 
a cyclization, oxidation and deprotonation allows to obtain highly substituted 3,4-
dihydroisoquinolines with excellent trans diastereoselectivity.  
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Scheme 39: Photooxidative phosphonylation of arenes (top) and photooxidative [4+2] annulation for the 
synthesis of 3,4-dihydroisoquinoline derivatives. 
 
The group of Kanai investigated a different type of dual catalytic palladium/acridinium 
systems for the catalytic dehydrogenation of N-heterocycles under visible light irradiation at 
ambient temperature (Scheme 40).[144] For tetrahydronaphthalenes, a thiophosphoric imide 
organocatalyst was added as a third component, allowing in this catalytic process the 
formation of hydrogen gas under mild conditions.  
 
 
Scheme 40: Catalytic dehydrogenation of N-heterocycles (top) and tetrahydronaphthalene derivatives (bottom). 
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Exploiting the properties of the Mes-Acr-Me+ , Rueping and co-workers reported a cross-
coupling of allylic C(sp3 )–H bonds with aryl- and vinylbromides, using a combination of nickel 
and an acridinium photocatalyst (Scheme 41, top). [120][145] After the oxidative addition of aryl- 
or vinylbromide to the nickel, a triplet–triplet energy transfer was proposed to take place 
between the excited acridinium salt and the nickel species. Cleavage of the halogen-metal-
bond then generates the radical bromide, which abstracts a hydrogen from the alkene to form 
an allylic radical compound. The reaction with the Ni intermediate then undergoes a reductive 
elimination to release the allylarene or corresponding 1,4-dienes. Acridinium salts are not 
limited to visible light-induced catalysis but can also be used as organocatalyst based on their 
ground state redox properties. Taking advantage of those properties, Ooi and co-workers 
designed an interesting acridinium betaine catalyst that enables PCET (proton-coupled 
electron transfer) and applied it to the oxidative dimerization of oxindoles under air (Scheme 
41, bottom).[146] The 9-mesityl acridinium moiety acts as the redox active unit whereas the 
phenoxide represents the substrate activation site. Using this catalyst, a successful 
homodimerization of 3-aryl oxindoles could be achieved. 
 
 
Scheme 41: Ni-dual catalytic cross coupling for allylic arylation (top) and dimerization of 3-aryloxindoles 
catalyzed by an acridinium betaine (bottom). 
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In conclusion, a growing library of acridinium catalysts has been developed and utilized for 
various visible-light photocatalytic processes. If several strategies were disclosed for the 
design and synthesis of highly oxidative acridinium salts, only a few allowed to reach lower 
excited states redox potentials similar to those of polypyridyl transition metal systems. A 
more modular approach providing tuneable redox properties is thus needed to achieve a 
suitable range of photosynthetic applications and will be discussed later in this thesis.  
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 RESULTS AND DISCUSSION 
 
2.1 STEREOSELECTIVE ORGANOCATALYZED TRANSFORMATIONS 
INVOLVING ROTATIONALLY RESTRICTED SYSTEMS 
 
 Enantiospecific electrophilic substitution through the formation of 
atropisomeric enamines 
 
Enantiospecific reactions are powerful tools to generate quaternary centers, pioneered by 
Seebach in 1981[147].  Starting from an enantiopure compound, an auxiliary (generally an 
aldehyde) is added to form an acetal as a single diastereomer. A subsequent deprotonation 
at the original stereocenter generates an enantiopure intermediate which can be used to 
direct the electrophilic addition to selectively form a new quaternary center. Finally, the 
cleavage of the auxiliary releases the product with either retention or inversion of 
configuration (Scheme 42, top). Following this concept, Kawabata used innovative 
rotationally restricted enolates as intermediates to direct selectively the electrophilic 
addition. This strategy successfully led to the synthesis of various chiral compounds including 
cyclic amino-acids and ether derivatives (Scheme 42, bottom).[12,148–152] Therefore, we 
reasoned that such a process might be applicable to a wider range of substrates by using an 
organocatalyst which would give an intermediate possessing a stereogenic axis.  
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Scheme 42: Principle of enantiospecific electrophilic addition (top) and enantiospecific synthesis of bicyclic 
compounds with a quaternary stereocenter (bottom). 
 
Inspired by the use of anilines as organocatalysts in epoxidation reactions reported by Pikho 
and coworkers (Scheme 43, top), [153] we envisioned an organocatalyzed process based on the 
formation of an enamine intermediate with a stereogenic axis (Scheme 43, bottom). Starting 
from an enantiopure fluorinated aldehyde, the double ortho-substituted aniline would 
undergo a condensation with the substrate to give a rotationally restricted enamine 
intermediate, which would direct the electrophilic addition. Finally, hydrolysis of this 
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compound would generate a product with a quaternary stereocenter with either retention or 
inversion of configuration 
 
 
Scheme 43: Pikho’s epoxidation (top) and enantiospecific synthesis of quaternary stereocenter through 
rotationally restricted enamines (bottom). 
 
We started our studies with the enantioselective synthesis of (S)-2-fluoro-3-phenylpropan-1-
ol reported by Jørgensen and coworkers (Scheme 44, top).[154] For the analysis of this reaction 
by chiral HPLC, an acetylation step was required prior to the measurements. An excellent e.r. 
of 98:2 of the derivatized product was determined, which is in high agreement with the 
literature data (93 % ee reported).[154] We then proceeded to test the robustness of this 
selectivity by submitting the alcohol to a sequence of subsequent oxidation, reduction and 
finally acetylation in order to verify the influence of these reactions on the enantiomeric ratio 
(Scheme 44, bottom). To our satisfaction, the selectivity remained unscathed with an e.r. of 
99:1.  
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Scheme 44: Enantioselective synthesis of S)-2-fluoro-3-phenylpropan-1-ol and its acetyl derivative (top) and 
oxidation/reduction/acetylation (bottom).  
 
Following this first experiment, we were curious to investigate the impact of adding anilines 
to the reaction, forming the hypothesized chiral enamine prior to reduction. To do so, aliquots 
of oxidized 2 were taken and stirred with either o-t-Bu-N-methyl-aniline or N-methylaniline 
respectively at RT for 24 hours (Scheme 45). The results were subsequently analyzed to the 
reduction/acetylation sequence. Given a significantly decreased enantioenrichement when 
using the N-methylaniline (e.r. = 78:22) compared to the o-t-Bu-N-methyl-aniline (e.r. = 93:7), 
the formation of an enamine intermediate influencing the selectivity was considered. 
 
 
Scheme 45: Influence of anilines on the enantiospecific protonation of the enamine with stereogenic axis. 
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reaction mixture by either water or acetic acid. A reduction using NaBH4 was then performed 
to study the amine derivative however, after purification the compound could not be 
obtained. With the o-t-Bu-N-methyl-aniline, only starting material was observed regardless 
of the addition of acetic acid (Scheme 46). 
 
 
Scheme 46: Enamine synthesis. 
 
We continued our investigations by screening suitable electrophiles to perform an 
enantiospecific substitution (Scheme 47). A variety of electrophilic compounds was 
investigated using the conditions described in scheme 45. However, only NBS and NCS yielded 
the desired product with 50% and 100% conversion respectively after 24 h.  
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[a] Reaction performed with 100 µmol of 2; [b] Conversion determined by NMR. 
Scheme 47: Screening of electrophiles for the enantiospecific addition to the enamine with stereogenic axis. 
 
Selecting NCS as the electrophile, we decided to pursue our inquiry by measuring the 
enantiomeric ratio using the reduction/acetylation sequence. However, following the 
reduction the compound could not be isolated. We therefore investigated other strategies. A 
first approach involving the derivatization of the aldehyde was envisaged. An aliquot of the 
reaction mixture was added to a solution of Brady’s reagent (2,4-dinitrophenylhydrazine). 
However, the hydrazine adduct could not be purified for analysis. Another pathway utilizing 
a Pinnick-Lindgren oxidation followed by an esterification was then selected. This method 
allowed us to measure an e.r. of 48:52 for the desired compound (Scheme 48). 
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Scheme 48: Derivatization of the aldehyde. 
 
Having the conditions in hand to analyze the enantiomeric ratio, we then proceeded to screen 
different substituted anilines as organocatalysts for the a-chlorination of enantiopure 
aldehydes. A trend became apparent, indicating that only the anilines with an EDG were able 
to convert the aldehyde (Table 1). In the presence of anilines bearing an EWG the reaction 
did not yield any product (Scheme 49). Moreover, longer reaction times and lower conversion 
were observed among the di-ortho-substituted anilines compared to their mono substituted 
analogues (see cat 33 and 38). Finally, all the anilines tested led to a racemic product. 
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Cat* Conversion e.r. Cat* Conversion e.r. 
26 Quant. (12 h) 48 : 52 35 9% 48 : 52 
27 17% 48 : 52 36 55% 51 : 49 
28 9% 49 : 51 37 17% 52 : 48 
29 9% 50 : 50 38 78% 51 : 49 
30 29% 50 : 50 39 Quant. (15 h) 50 : 50 
31 Quant. (3 h) 48 : 52 40 Quant. (15 h) 50 : 50 
32 41% 51 : 49 41 Quant. (15 h) 51 : 49 
33 9% 51 : 49 42 17% 52 : 48 
34 33% 48 : 52    
[a] Reaction performed with 100 µmol of 2; [b] Conversion determined by NMR; [c] The e. r. was determined by HPLC on a chiral stationary 
phase. 
Table 1: Screening of anilines with EDG. 
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Scheme 49: Screening of anilines with EWG. 
 
In light of these results, we considered shielding one side of the enamine intermediate 
through the use of secondary anilines. Accordingly, we selected the catalysts which gave the 
best conversion in the chlorination and prepared their corresponding benzylated derivatives. 
Applying the conditions of Murphy and coworkers[155] using ZnCl2 and NaCNBH3, several 
secondary anilines were synthesized for investigation in further screening (Scheme 50). 
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[a] Reaction performed with 5.33 mmol of substrate; [b] Isolated yields.  
Scheme 50: Benzylation of primary anilines. 
 
In addition to the newly synthesized anilines, three indolines were also screened (Table 2). 
TFA (40 mol%) was added to the reaction mixture to activate the aldehyde and to increase 
the conversion of the more sterically hindered catalysts. A blank reaction using catalytic 
amount of TFA showed as expected only starting material after 16 h. The results 
demonstrated that benzylated anilines with the addition of TFA generate overall a good 
conversion however the use of indolines did not yield any product. Interestingly, an ee of 10% 
was reached when using catalyst 61 despite the conversion being one of the lowest. 
 
NH2 Benzaldehyde, ZnCl2, NaCNBH3
MeOH, 70°C, 2 ha, b
HN
R R
NH NH NH NH
61
13% yield
62
84% yield
63
81% yield
64
80% yield
OMe
MeO
t-Bu
NHNH
65
74% yield
66
58% yield
Cl
Bn Bn Bn Bn
Me
MeBn
Me
Bn
NH NH NH
67
94% yield
68
23% yield
69
54% yield
Cl NOMe
Bn Bn Bn
OEt
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Cat* Conversion e.r. Cat* Conversion e.r. 
61 36% 55 : 45 67 78% 51 : 49 
62 59% 52 : 48 68 N.C. - 
63 93% 50 : 50 69 92% 51 : 49 
64 71% 51 : 49 70 N.C. - 
65 92% 50 : 50 71 N.C. - 
66 93% 51 : 49 72 N.C. - 
[a] Reaction performed with 100 µmol of 2; [b] Conversion determined by NMR; [c] The e. r. was determined by HPLC on a chiral stationary 
phase. 
Table 2: Screening of secondary anilines. 
 
Encouraged by the success of catalyst 61, we moved to more attentively examine the role of 
solvents and chlorinating agents (Table 3). Catalyst 69, which gave excellent conversion with 
NCS, was used with reagents 73–76. However, these reactions resulted in very low conversion 
or did not yield any product. Catalyst 61, which produced the best result in terms of 
enantioselectivity (10% ee), was further investigated in different solvents. While the 
conversion was significantly enhanced while using Et2O (Table 3, entry 9), the use of any other 
solvent produced a racemic compound. 
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Entry Reagent Catalyst Solvent Conversion e.r. 
1 73 69 CDCl3 9% - 
2 74 69 CDCl3 2% - 
3 75 69 CDCl3 N. C. - 
4 76 69 CDCl3 12% - 
5 NCS 61 CH3CN 52% 50 : 50 
6 NCS 61 MTBE 9% - 
7 NCS 61 CH2Cl2 43% 50 : 50 
8 NCS 61 EtOAc 63% 49 : 51 
9 NCS 61 Et2O 77% 50 : 50 
10 NCS 61 THF 50% 50 : 50 
11 NCS 66 CH3CN 83% 48 : 52 
12 NCS 66 MTBE Quant. 48 : 52 
13 NCS 66 CH2Cl2 77% 51 : 49 
14 NCS 66 EtOAc 77% 51 : 49 
[a] Reaction performed with 100 µmol of 2; [b] Conversion determined by NMR; [c] The e. r. was determined by HPLC on a chiral stationary 
phase. 
Table 3: Screening of solvents and chlorinating agents. 
 
The absence of selectivity drove us to envisage an increase of the enamine intermediate’s 
rotational barrier by placing a bulkier substituent in the ortho-position. Inspired by the 
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scaffold of the Jørgensen catalyst, [154] a synthetic route to a new ortho-substituted aniline 
was designed. Starting from methyl anthranilate, a benzyl group was first installed to convert 
the primary aniline using the method described above. [155] An excess of phenylmagnesium 
bromide in THF allowed for introduction of the two phenyl groups. Finally, the protection of 
the alcohol with TMSOTf delivered the desired catalyst 79 (Scheme 51). This newly 
synthesized aniline was immediately tested in the chlorination reaction using the conditions 
described in Scheme 45. The results show a conversion lower than 10% despite the use of 
TFA, likely due to the bulkiness of the substituents in ortho-position. However, only racemic 
compound was observed. 
 
 
[a] Reaction performed with 100 µmol of 2; [b] Conversion determined by NMR; [c] The e. r. was determined by HPLC on a chiral stationary 
phase. 
Scheme 51: Design of a new ortho-substituted aniline 52 for organocatalysis. 
 
Considering this outcome, we turned to another class of substrates to resume our 
investigations. Amino alcohol derivatives were our first choice because of their abundance as 
enantiopure material. Thus, we started our study with L-glycinol and L-phenylalaninol which 
were first protected using (Boc)2O in good yields (respectively 59 and 88%). With the 
substrate in hand, we carried on with the investigation of a suitable electrophile for our 
desired transformation (Scheme 52). Surprisingly, only the chlorinating agent 75 led to full 
conversion. NFSI (N-fluorobenzenesulfonimide) showed a partial conversion of 50% while the 
other electrophiles tested did not yield any product. Following the chlorination, the reduction 
of the aldehyde was performed in order to measure the e. r. after acetylation. However, the 
alcohol decomposed during purification. 
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[a] Reaction performed with 100 µmol of 80; [b] Conversion determined by NMR 
Scheme 52: Screening of electrophiles. 
 
In conclusion, we attempted to design an enantiospecific electrophilic addition involving 
rotationally restricted enamine intermediates by using ortho-substituted anilines as 
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organocatalysts. Chlorination reactions proved to be the most effective using NCS or 
compound 75. Anilines bearing EDG appeared to be suitable catalysts for this transformation. 
Despite our efforts to increase the rotational barrier of the enamine intermediate (going from 
primary to secondary anilines, installing bulkier substituents in ortho-position), we did not 
achieve any significant selectivity (10% ee).  
 
 Enantioselective synthesis of multi-axis systems: atropisomeric aromatic 
amides 
 
With their structurally well-defined scaffolds, multiaxis systems have always been a 
fascination for the study of rotational behaviors.[55,156,157] However, due to their molecular 
complexity, only a few catalyst-controlled stereoselective methods to prepare them have 
been developed.[54,57] Taking a strong interest in non biaryl systems and more particularly 
atropisomeric anilines, a challenging synthesis of a three-axis aromatic amide system was 
tackled. This topic has been previously explored by our group with the synthesis of oligo-1,2-
naphthylenes. Using a strategic and iterative sequence of oxidation and building block 
addition followed by the stereoselective arene-forming aldol condensation developed earlier 
in our group,[51] the synthesis of configurationally stable oligo-1,2-naphthylenes was achieved 
(Scheme 53, top).[53] Based on the highly effective atropisomeric synthesis of rotationally 
restricted amides (Scheme 53, middle),[52] we envisioned a study of more complex systems 
involving multiple stereogenic axes. We envisaged to investigate configurationally stable 
aromatic amides, bearing bulky substituents, ultimately leading to restricted rotations about 
the Ar-C(O), C(O)-N and Ar-N bonds (Scheme 53, bottom). 
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Scheme 53: Rotationally restricted systems. 
 
Given the presence of three stereogenic axes involved in the arene forming aldol 
condensation, eight stereoisomers are expected. Moreover, the rotational barriers of similar 
scaffolds described in literature (∆G‡ > 100 kJ.mol-1) support the hypothesis of eight 
configurationally stable stereoisomers (Scheme 54).[158–161] 
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Scheme 54: Possible stereoisomers (top) and reported rotational barriers of aromatic amides (bottom). 
 
Based on the retrosynthetic strategy previously described to obtain mono-axis atropisomeric 
aromatic amides,[52] a similar approach was designed (Scheme 55). Therefore, compound 84 
could be obtained after a semi-hydrogenation/oxidation/aldol condensation sequence from 
compound 85. Furthermore, compound 85 would originate from a triflation followed by a 
Sonogashira cross-coupling of 86. Finally, the latter could be accessed from the opening of 
lactone 88 by 2-t-Bu-aniline (Scheme 55). 
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Scheme 55: Retrosynthetic strategy for the synthesis of secondary amide substrate. 
 
The substrate synthesis of our first multiaxis system started then from the addition of the  
2-t-Bu-aniline to synthon 88 at 50 °C.1 This reaction proceeded with full conversion without 
the need of an additional base (Scheme 56). The crude mixture was then engaged in a 
triflation reaction that gave compound 89 after 30 min with an overall yield of 83% over two 
steps. After a Sonogashira cross-coupling with 3-butynol (44% yield), intermediate 85 was 
selectively semi-hydrogenated to its corresponding (Z)-alkene using H2 and Pd/C. The 
subsequent oxidation with DMP led to the desired aldehyde which then reacted with KHCO3 
and the racemic tetrazole catalyst to the aldol condensation product. The final addition of 
NaBH4 in EtOH did not successfully reduce the alcohol therefore we tried to isolate aldehyde 
91 to test other reaction conditions. Despite the purification issues due to the low stability of 
the compound, we managed to explore the reduction of 91 by LiBH4 in THF and DIBAL-H in 
toluene.[162] The former reduction did not yield any product, whereas the latter led to 
decomposition. 
 
 
1 Synthon 88 was graciously supplied by Dr. Vincent C. Fäseke. 
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Scheme 56: Retrosynthetic strategy and synthesis of a primary amide substrate. 
 
Considering the beforementioned issues with the reduction of 91, we decided to move on to 
a more stable substrate by introducing a methyl group on the nitrogen. Applying the 
conditions of Sivaguru and coworkers, 2-tert-butylaniline and 2-phenylaniline were converted 
to their N-Methyl analogues in a two-step procedure.[163] Related to an Eschweiler-Clarke 
methylation, the first step consists of condensation of the aniline and the succinimide with 
formaldehyde in EtOH (Scheme 57). The resulting adduct was then isolated as a white 
crystalline powder and reduced by NaBH4 in DMSO to obtain the desired product in good 
yields (72% for 92a and 84% for 92b). 
With our two newly synthesized starting materials in hand, we carried on with the substrate 
synthesis (Scheme 57). Lactone opening followed by the triflation proceeded smoothly for 
both 2-tert-butylaniline and 2-pehnylaniline in good yields (74% for 93a and 60% for 93b). 
Interestingly, a 2D TLC revealed the presence of cis and trans stereoisomers confirmed by 
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NMR with a ratio of 1:2. The subsequent Sonogashira cross-coupling with 3-butynol 
successfully produced the alkyne intermediates 94a and 94b with 79% and 69% yield, with a 
cis/trans ratio of 1:5. However, the partial reduction to the (Z)-alkene 95 was only achieved 
with the tert-butyl amide intermediate 94a.  
 
 
Scheme 57: Methylation by reductive amination (top) and substrate synthesis of secondary amides (bottom). 
 
Although several reaction conditions for the semi-hydrogenation of 94b were explored, the 
selective reduction remained unsuccessful (Table 4).  
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Entrya, b Catalyst Solvent Observations 
1 Pd/C (5-10 mol%) Pyridine No conversion after 15 h 
2 NiB2 + EDA EtOH No conversion after 15 h 
3 Pd/C (5 mol%) EtOH No conversion after 15 h 
4 Pd(CaCO3) MeOH Over reduction after 2 h 
5 Pd(CaCO3) Pyridine No conversion after 1 h 
6 Pd(CaCO3) MeOH/Pyridine Over reduction after 2 h 
7 Pd(CaCO3) MeOH/Pyridine Over reduction after 2 h 
8 Lindlar + quinoline EtOH No conversion after 15 h 
[a] Reaction performed with 100 µmol of 94b; [b] Conversion determined by NMR. 
Table 4: Reaction conditions for the semi-hydrogenation of substrate 94b. 
 
Nevertheless, the synthesis proceeded with tert-butyl amide 95a going through an oxidation 
with DMP followed by an aldol condensation catalyzed by  
(S)-(–)-5-(2-Pyrrolidinyl)-1H-tetrazole. After the oxidation, an aliquot was reacted with the 
racemic version of the proline tetrazole catalyst to identify the enantiomers by HPLC. Finally, 
the reduction delivered compound 96 with 33% overall yield over four steps. Only one 
diastereomer could be isolated by column chromatography. However, the NMR of the crude 
mixture showed a cis/trans ratio of 1:3. After extensive analysis of the spectra by NMR, 2 we 
could identify the topology of the newly synthesized rotationally restricted amide 96 (Scheme 
58). 
 
2  NMR measurement together with PD Dr. Daniel Häussinger. 
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NO Me
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Scheme 58: NOE correlation for the identification of compound 96. 
 
A strong NOE correlating the t-Bu group and the CH2OH was observed as well as another 
correlation between C5H and C6’H, indicating that the major product isolated is the aS (Ar-
C(O))–trans (N-C(O))–aR (Ar-N). An HPLC analysis was also conducted on the crude mixture 
providing further information into the configuration of this amide. Surprisingly, the results 
revealed the presence of four different enantiomers instead of the eight expected. The 
cis/trans ratio of 3:1 was confirmed by HPLC and interestingly, an e.r. of 87:13 was detected 
for the trans against an e.r. of 75:25 for the cis. This outcome implies that a substantial 
stereocontrol was achieved over one of the three axes which would most likely be the  
Ar-C(O) bond. However, considering the rotational barriers described in literature for a similar 
type of anilides (Scheme 54),[23] the absence of the two other pairs of enantiomers was 
perceived as quite peculiar. Particularly as the rotation about the Ar-N bond is not restricted 
enough to be visible by NMR nor HPLC. 
In order to further study the stability of compound 96, the crude mixture was heated up in 
CDCl3 at 46 °C for 72 h (Table 5 and 6). Over time, the population of the trans-isomer was 
enhanced at the expense of the cis-isomer to reach a trans/cis ratio of 93:8. These results 
were confirmed both by NMR spectroscopy and HPLC. According to Curran and co-
workers,[164] electronic factors overtake the steric hindrance in the case of N-methylanilides. 
The electrostatic repulsion between the π-electrons of the aniline moiety and the lone pairs 
of the oxygen would explain the observed conformation of the major product. Moreover, 
considering the aromatic nature of the phenanthrene moiety, a π-π stacking with the aniline 
system could also be another factor that stabilizes the conformational outcome of the 
reaction.  
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Time 
(h) 
Trans 
(%) 
Cis 
(%) 
e.r. cis 
(%) 
e.r. trans 
(%) 
Time 
Trans 
(%) 
Cis 
(%) 
e.r. cis 
(%) 
e.r. trans 
(%) 
0 66 34 75 87 18 74 26 73 87 
1 71 29 76 87 24 82 18 72 87 
2 87 13 85 87 48 87 13 62 87 
4 76 24 80 82 72 89 11 52 84 
Table 5: HPLC analysis of compound 6 in CDCl3 at 46 °C. 
 
Time 
(h) 
Trans 
(%) 
Cis 
(%) 
Time 
(h) 
Trans 
(%) 
Cis 
(%) 
0 76 24 18 89 11 
1 84 16 24 89 11 
2 85 15 48 88 12 
4 86 14 72 87 13 
Table 6: NMR analysis of compound 6 in CDCl3 at 46 °C. 
 
Excited about these first results, we were curious to further examine the influence of the 
substituents in key positions over the topology of these anilides. Although we could not reach 
the derivative with a phenyl group instead of the t-Bu on the aniline moiety to explore the 
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effect of the ortho-substituents, a more dynamic system with a naphthalene core replacing 
the phenanthrene was envisaged. Without a peri-substituent, the rotational barrier about the 
Ar-C(O) bond would significantly decrease resulting in the Ar-N bond being the only element 
with possible stereocontrol. Enlightened by this hypothesis, we began the synthesis of the 
naphthalene derivative (Scheme 59).  
Following the previous strategy, we first prepared the corresponding lactone 97 using a 
Friedel-Crafts reaction with oxalyl chloride and phenol. The crude mixture of 97 was then 
directly submitted to undergoe a nucleophilic ring openeing by the 2-tert-butyl-aniline 
followed by a triflation to give intermediate 98. This first sequence was achieved smoothly 
with an overall yield of 53% (three steps). The Sonogashira cross-coupling with 3-butynol 
using the conditions previously employed did not yield any product. However, by using a 
combination of triethylamine instead of diisopropylamine and adding an excess of TBAI, the 
corresponding alkyne derivative 99 was obtained in good yield (79%). Palladium on charcoal 
in pyridine did not yield any conversion to the corresponding alkene. While in-situ generated 
Borohydride-Nickel (Ni-P2) was used, which allowed the successful semi-hydrogenation to 
the (E)-isomer. Finally, the oxidation/aldol-condensation/reduction sequence delivered 
compound 101 in 12% overall yield (four steps), with a cis/trans ratio of 2:3. The low yield is 
attributed to the slow and partial oxidation of the alcohol with DMP. 
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Scheme 59: Substrate synthesis of the naphthalene system. 
 
Following purification, the cis and trans compounds could not be separated however we were 
able to determine their molecular arrangement by NMR analysis (Scheme 60).3  
 
 
Scheme 60: NOE correlation for the identification of compound 101. 
 
 
3 NMR measurement together with PD Dr. Daniel Häussinger. 
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A significant correlation between the CH2OH group and C6’H on one side and the methyl 
group on the other indicates clearly a trans configuration. This result is substantiated by a 
strong NOE between the t-Bu group and C5H. For the cis product, an intense correlation 
between C5H and the methyl group is observed. Moreover, a strong NOE is also detected 
between the CH2OH group and t-Bu group. 
Confirming our hypothesis of a more dynamic system, the HPLC analysis of the crude mixture 
of 101 conducted with the enantiopure catalyst displays an identical chromatogram to the 
racemic one, with a ratio of cis/trans 2:3 consistent with the NMR data. This result 
corroborates the importance of a substituent in peri-position of the naphthalene ring in order 
to increase the rotational barrier about the Ar-CO bond and induce selectivity. However, once 
again, only four stereoisomers were detected which would indicate a free rotation about the 
Ar-N bond. 
 
In order to increase the rotational barrier of the Ar-N bond to obtain the missing pair of 
enantiomers and to observe the effect on the cis/trans ratio, we decided to replace the 
methyl group with an i-Pr group on the nitrogen. With the conditions described in a 
patent,[165] the synthesis of compound 102 using NaBH(OAc)3 with acetone in acetic acid was 
achieved in good yields (89%). Despite the use of triethylamine and increased temperatures, 
the low nucleophilicity due the steric hindrance of aniline 102 led to traces amounts of the a-
ketoamide product. However, the latter proved to be unreactive under triflation conditions 
(Scheme 61). Accordingly, the synthesis of this substrate was not pursued any further. 
 
 
Scheme 61: Substrate synthesis attempt with N-isopropyl group. 
 
In conclusion, we successfully achieved the synthesis and the study of a rotationally restricted 
multi-axis phenanthrene system with substantial selectivity (cis/trans ratio of 1:3 and  
OTf
O
O N
t-Bu
1) Coumarandione, 
Toluene, NEt3, 50 °C, 5 h
87
103
2) Tf2O, NEt3, CH2Cl2, 
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acetic acid,
NH2
t-Bu
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89% yield
NH
t-Bu
Me
Me
Me
Me1,2-dichloroethane, 60 °C, 20 h
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e.r. trans = 87:13 and e.r. cis = 75:25). An efficient synthetic sequence with fine-tuned conditions 
including a Sonogashira cross coupling and a selective semi-hydrogenation allowed us to 
prepare a more dynamic naphthalene system to pursue our investigations. Surprisingly, both 
systems indicated a restricted rotation about the Ar-C(O) and N-C(O) bonds however, the 
absence in both systems of a third pair of enantiomers suggested that the Ar-N bond is 
rotating freely. Further research involving the synthesis of an alternative route to obtain the 
isopropyl derivative, with an installation at a later stage using the route previously described 
for the secondary amide, could be explored. 
 
 Enantioselective arene forming aldol condensation towards the 
formation of paracyclophanes 
 
Since their discovery by Lüttringhaus in 1941,[58] cyclophanes have always been a fascination 
for scientists as a result of their peculiar “handle-shaped” structure. Originally called ansa-
compound for this reason (ansa = handle in latin), their chirality arises from the positioning 
of the alkyl chain extending out of the aromatic ring plane. Thus, the rotational barrier of 
these compounds is mainly influenced by two factors: first, the length and rigidity of the 
handle on one side and second, the bulkiness of the substituents on the aryl ring on the other 
(Scheme 62, top).[166] Considering our previous experience with rotationally restricted multi-
axis systems, we decided to take a step further in exploring stereogenic planes. Relying on 
the enantioselective arene forming aldol condensation well-established in our group, we 
envisioned the synthesis of an enantiopure paracyclophane with a phenanthrene core and an 
alkyl chain of 15 methylene units (Scheme 62, bottom). 
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Scheme 62: Paracyclophanes and their rotational barrier (top) and synthesis of enantiopure paracyclophanes 
(bottom). 
 
A synthetic strategy which relies on the initial formation of the cyclophane prior to the 
functionalization of the aromatic core was embraced (Scheme 63). Consequently, the  
b,g-unsaturated aldehyde 105 could be obtained from the dibromo-naphthalene 
intermediate 106 via a mono-Sonogashira cross-coupling followed by a semi-hydrogenation. 
A subsequent functional group conversion of the bromine into the corresponding aldehyde 
would then take place. The naphthalene moiety can be installed via the formation of a 
benzyne on the tetrabromophenylcyclophane 107 which would undergo a Diels-Alder 
cycloaddition with furane followed by a deoxygenation. Finally, intermediate 107 could be 
achieved by full bromination of the phenylparacyclophane 108, the synthesis of which is 
extensively described by Yamamoto and coworkers.[167] 
 
R
[X]n
Br
O
O
[CH2]9
Br
HN
HN
[CH2]9
O
O
∆G‡ = 133 kJ.mol-1 ∆G‡ = 122 kJ.mol-1
[CH2]15
CHO
[CH2]15
O
OH
N
H HN N
N
N
(5.0 mol%)
KHCO3, CDCl3, RT then NaBH4 , EtOH
[CH2]10
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Scheme 63: Retrosynthetic strategy for the preparation of enantiopure paracyclophanes. 
 
The synthesis started with the elimination of water from the tertiary propargylic alcohol 111 
under acidic conditions, as reported by Tabacchi et al. (Scheme 64).[168] An in-situ distillation 
from the reaction mixture allowed to obtain the desired 2-methyl-1-buten-3-yne 110. The 
reaction of dilithiated 110 with commercially available 1,12-dibromododecane led to the 
efficient formation of bis-enyne 112 (95% yield). Subsequently, a palladium-catalyzed 
cyclisation using a hyper dilution method to avoid the formation of polymers allowed to 
obtain compound 113. In order to remove the exomethylene group, ozonolysis followed by a 
double reduction with H2 and Pd/C was performed. However, the low yield and long reaction 
time drove us to consider another method described by Arimoto and coworkers involving the 
use of Zn and TMSCl to fully reduce the double bond.[169] This strategy led to our key 
intermediate 108 with good yield (66%). 
 
Br Br12
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CHO
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Scheme 64: Substrate synthesis of paraphenylcyclophane. 
 
With the phenyl paracyclophane 108 in hand, we proceeded to examine several reaction 
conditions for its fourfold bromination (Table 7). The conditions described by Hart and 
coworkers (Table 7, entry 1) led to decomposition.[170] When using catalytic amount of iodine 
(Table 7, entry 2) at lower temperature as described by Watson et al., only partial conversion 
was achieved with undesired bromination on the alkyl chain.[171] Replacement of I2 with sub-
stochiometric amounts of elemental Fe (Table 7, entry 3) as reported by Caster and coworkers 
produced selective bromination of the phenyl ring. However, a mixture of compounds was 
obtained.[172] Finally, a good conversion was achieved when using a mixture of iodine and iron 
(Table 7, entry 4) with 44% yield. Despite our efforts to optimize the reaction conditions, the 
isolated yield did not exceed 50% by using sub-stochiometric amounts of AlBr3 however, the 
reaction time could be significantly decreased (Table 7, entry 9). 
 
 
Pd(PPh3)4, toluene, 100 °C
high dilution, 15 min
[CH2]14
Me
109, n-BuLi, KOtBu,
LiBr, THF
OH
Me
Me
Ac2O, H2SO4, 
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26% yield
(over two steps)
H2, Pd/C (10 mol%),
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Entrya 
Br2  
(number of eq.) 
Catalyst Solvent Temperature Observations 
1 6 - CCl4 reflux decomposition 
2 10 I2 (10 mol%) CCl4 0 °C 
SM + bromination on 
the alkyl chain 
3 19 Fe (50 mol%) CCl4 0 °C 
Mixture of mono, di, 
tribrominated 
compound 
4 19 Fe (1 eq) CCl4 
0 °C 
(dark) 
Mixture of mono, di, 
tribrominated 
compound 
5 10 
I2 (20 mol%) 
Fe (50 mol%) 
- 
0 °C, 6 h 
(dark) 
44% yield 
6 10 
I2 (20 mol%) 
Fe (50 mol%) 
- 
0 °C, overnight 
(dark) 
Product formation but 
major purification 
issues 
7 10 AlBr3 (2 eq) - 
0 °C 30 min 
(dark) 
Major purification 
issues 
8 10 AlBr3 (2 eq) - 
0 °C 30 min 
(dark) 
Major purification 
issues 
9 10 AlBr3 (50 mol%) - 
0 °C 30 min 
(dark) 
50% yield 
10 10 AlBr3 (40 mol%) - 
0° C 30 min 
(dark) 
17% yield 
[a] Reaction performed with 100 µmol of 109; [b] Isolated yield. 
Table 7: Reaction conditions for full bromination. 
 
Nevertheless, we pursued the synthesis of 106 with a Diels-Alder reaction between furane 
and the in-situ formed benzyne from precursor 107 (Scheme 65). The obtained bridged 
intermediate was immediately deoxygenated by TiCl4 to afford compound 106 in 33% yield 
over two steps.[173] Using n-BuLi and DMF, we were aiming to selectively transform one 
bromine to the corresponding aldehyde 115. However, after purification, we could only 
isolate the dehalogenated compound 116.  
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Scheme 65: Synthesis of naphtaldehyde derivative 116. 
 
To gather more information about the rotational behavior of 116, several HPLC analysis were 
conducted. The results show two peaks with a small plateau at RT which indicates that the 
two enantiomers are interconverting during elution (see Experimental section).[174] As 
expected, increasing the temperature (40 °C) rose the height of the plateau indicating a faster 
interconversion. On the contrary, at 0 °C, we observed distinctly two peaks of the two 
enantiomers with a 50:50 ratio. 
In order to avoid dehalogenation, we decided to install the b,g-unsaturated alcohol chain 
starting first with the Sonogashira cross-coupling with 3-butynol. Unfortunately, despite 
several attempts with various reaction conditions, the bromine position remained unreactive 
(Table 8). The outcome of the reaction was unchanged when using the 
tetrabromoparacyclophane 107 as the starting material under the same reaction conditions. 
 
[CH2]15
Br
Br
Br
Br
1) n-BuLi, furane, 
toluene, RT
2) TiCl4, Zn, 
THF, reflux
 n-BuLi, DMF, 
THF/Et2O, 
– 98 °C to RT[CH2]15
Br
Br
[CH2]15
OHC
Br
 n-BuLi, DMF, 
THF/Et2O, 
– 98 °C to RT
[CH2]15
OHC
H
107 106
33% yield 115
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24% yield
STEREOSELECTIVE	 ORGANOCATALYZED	 TRANSFORMATIONS	 INVOLVING	 ROTATIONALLY	RESTRICTED	SYSTEMS	
	 70	
 
 
Entrya, b Base  Catalyst Solvent Temperature Observation 
1 NEt3 
Pd(PPh3)2Cl2 (5 mol%) 
CuI (3 mol%)  
- 90 °C Glaser coupling 
2 NEt3 
Pd(PPh3)2Cl2 (5 mol%) 
CuI (1 mol%)  
- 90 °C Glaser coupling 
3 i-Pr2NH  
Pd(CN)2Cl2 (5 mol%) 
CuI (1 mol%) 
XPhos (10 mol%)  
1,4-Dioxane  90 °C No product formation 
4 i-Pr2NH  
Pd(PPh3)4 (6 mol%) 
CuI (6 mol%)  
- 90 °C No product formation 
5 NEt3 
Pd(OAc)2 (0.1 mol%) 
FeCl3 (5 mol%) 
SPhos (3 mol%)  
MeMgCl (0.1 eq) 
THF/Surfactant RT-50°C No product formation 
6 - 
Pd2(dba)3 (5 mol%) 
Bu4NOAc(1.5 eq) 
DMF  90 °C No product formation 
[a] Reaction performed with 100 µmol of 106 and 107; [b] NMR analysis. 
Table 8: Sonogashira cross-coupling reaction conditions. 
 
To overcome the low reactivity of the brominated compounds 106 and 107, a Finkelstein 
reaction[175] was performed to turn the bromine into a more reactive iodine intermediate. 
However, once more, only starting material was observed (Scheme 66). 
Br
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STEREOSELECTIVE	 ORGANOCATALYZED	 TRANSFORMATIONS	 INVOLVING	 ROTATIONALLY	RESTRICTED	SYSTEMS	
	 71	
 
 
Scheme 66: Finkelstein attempt. 
 
Focusing on the obtained aldehyde 116, an aldol condensation reaction as well as various 
nucleophilic additions were investigated to study further the stereodynamic of these 
products (Table 9). Nonetheless, the aldehyde remained unreactive in all cases. 
 
 
Entrya, b Nucleophile Conditions Observation 
1 PhMgBr THF, RT No product formation 
2 PhLi THF, – 15 °C No product formation 
3 PhBr 
i-PrMgCl-LiCl, THF, – 15 °C  
No product formation 
n-BuLi, THF, – 78 °C to RT 
4 NaphtBr Mg, THF, reflux No product formation 
5 BB nBu2Mg, THF, then n-BuLi, 0 °C No product formation 
[a] Reaction performed with 100 µmol of 116; [b] NMR analysis. 
Table 9: Reaction conditions for nucleophilic addition to the aldehyde 116. 
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Because of the lack of reactivity of the aldehyde, a step back in the synthesis was taken. 
Dibromo naphthaldehyde 106 was used after halogen metal exchange as a nucleophile with 
benzaldehyde (Table 10). However, despite various reaction conditions tested, no conversion 
to the desired product was obtained. 
 
 
Entrya, b Conditions Observation 
1 n-BuLi, Et2O/THF, – 98 °C to RT No conversion 
2 n-BuLi, i-PrMgCl (0.2 eq), Et2O, – 98 °C to RT No conversion 
3 Mg, Et2O, 50 °C No conversion 
4 i-PrMgCl.LiCl, THF, – 15 °C No conversion 
[a] Reaction performed with 100 µmol of 107; [b] NMR analysis. 
Table 10: Reaction conditions for the nucleophilic addition of 17 to benzaldehyde. 
 
Following the previous strategy to form the naphthalene ring, a Diels-Alder reaction with the 
in-situ formed benzyne did not yield any product with Danishefsky’s diene nor methyl  
3-methyl-2-furoate (Scheme 67).  
 
[CH2]15
Br
Br
[CH2]15
OH
Benzaldehyde, Conditions*
106 121
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Scheme 67: Diels-Alder reaction with compound 106. 
 
In conclusion, we achieved the synthesis of paracyclophane 116 which presents interesting 
stereolabile properties. An efficient synthetic strategy relying on the initial formation of the 
handle followed by a functionalization coupled with optimized reaction conditions allowed 
the construction of several derivatives with a naphthalene core. The analysis of compound 
116 revealed an interconversion of the two enantiomers at RT which already suggests a slight 
hindrance of the handle. This result implies that further catalytic reaction to selectively form 
one of the enantiomers would perform through a dynamic kinetic resolution mechanism. 
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2.2 SYNTHESIS OF ACRIDINIUM SALTS FOR PHOTOREDOX CATALYSIS 
 
 Large scale optimization of the first generation of acridinium salts4 
 
2.2.1.1 Synthesis of acridinium salts with unsubstituted core5 
 
Acridinium salts are important members of the organic photoredox catalyst toolbox and are 
known for their powerful oxidative properties in the singlet excited state.[106,176] Pioneered by 
Fukuzumi, and further developed by Nicewicz, their synthesis remains somewhat rigid (see 
chapter 1.2.1).[116,177] Using a method involving the addition of 1,5-bifunctional 
organometallic reagents to carboxylic acid esters developed in our group, we undertook the 
synthesis of 9,10-substituted acridinium salts (Scheme 68).[173,178] 
 
 
 
4 Together with Christian Fischer. 
5 Reactions performed by Lukas Schneider as part of his student’s project. 
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Scheme 68: Synthetic strategies for the synthesis of acridinium salts: Fukuzumi (top), Nicewicz (middle), our 
approach (bottom). 
 
Pursuing the strategy previously developed to obtain 3,6-disubstituted acridinium salts,[120] 
we started our synthesis with a Buchwald-Hartwig cross-coupling between 2-bromoaniline 
124 and 2-bromoiodobenzene 125 which gave the corresponding secondary aniline 126 in 
74% yield (Scheme 69). After methylation with iodomethane and sodium hydride in THF, we 
received intermediate 127 in very good yield (81%). Upon addition of elemental magnesium, 
127 was transformed into a 1,5-bifunctional Grignard reagent that reacted with different 
carboxylic acid esters. A final dehydration with HBr yielded compounds 128a and 128b in 
moderate to good yields (63% and 78%, respectively).  
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SYNTHESIS	OF	ACRIDINIUM	SALTS	FOR	PHOTOREDOX	CATALYSIS	
	 76	
 
Scheme 69: Synthesis of 9,10-substituted acridinium salts. 
 
Excited that our method could also apply to acridinium salts with an unsubstituted core, we 
initiated the study of the photophysical properties of 128a an 128b. As expected, both 
compounds showed strong oxidizing properties due to the lack of substituent on the acridine 
moiety. Interestingly, catalyst 128a exhibited a higher excited state reduction potential (Table 
11, E1/2 [P*/P–] = +2.32 V vs SCE) compared to the Fukuzumi catalyst  
(E1/2 [P*/P–] = +2.18 V vs SCE). On the other hand, 128b displayed a similar excited state 
reduction potential (E1/2 [P*/P–] = +2.21 V vs SCE), indicating the influence of electron density 
at the phenyl moiety. 
 
Dye 
labs 
[nm]a 
lem 
[nm]a 
E0,0 
[eV]a 
E1/2(P/P–) 
[V]b 
E1/2(P*/P–) 
[V] 
128a 426 512 2.83 –0.51 +2.32 
128b 438 499 2.77 –0.56 +2.21 
[a]Measured in MeCN (15 μmolL–1); [b] Measured in 0.1 molL–1 n Bu4N×PF6 in dry, degassed MeCN against SCE. 
Table 11: Photophysical properties of compounds 128a and 128b. 
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2.2.1.2 Large scale synthesis of the first generation of acridinium salts 
 
Due to their interesting redox properties and their many applications in photoredox catalysis, 
the scalable synthesis of acridinium salts represents a major challenge for the development 
of sustainable alternatives to precious metal complexes in industry. A recent approach 
published by Nicewicz et al. involving a late stage nucleophilic substitution of xanthylium dyes 
allowed them to achieve the synthesis of various acridinium salts in multi-gram scale (Scheme 
70).[117] Considering the remarkable performance of acridinium salt 129a in dual 
Ni/photoredox catalysis, we tackled its large-scale synthesis. As shown by Benniston and 
coworkers,[179] oxidation of the methyl group on the para-position of the mesityl moiety could 
influence the stability of the dye. For this reason, the multi-gram synthesis of the acridinium 
salt 129b with m-xylyl moiety was also envisaged. 
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Scheme 70: Large-scale synthesis of acridinium salts conducted by Nicewicz (top), photostability studies 
reported by Benniston (middle), overview of the multi-gram synthesis of compounds 129a and 129b (bottom). 
 
Starting with the conditions previously described, we initiated our investigations on 20 g (100 
mmol) of compound 130 (Scheme 71). The nitration gave full conversion to the desired 
regioisomer and the pure compound was obtained after precipitation in water. The following 
reduction with SnCl2•H2O led to the corresponding aniline 131 in 58% yield (over two steps).  
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Scheme 71: Initial conditions for the nitration and reduction of compound 130. 
 
Encouraged by these results, we moved on to a larger scale nitration (100 g, 500 mmol). 
Unfortunately, after several attempts, only a mixture of regioisomers was obtained with 
varying ratios. This is likely due to a partial protonation of the dimethyl amino group despite 
the use of a large excess of sulfuric acid. To overcome this issue, we decided to split the 
nitration into two steps (Scheme 72). To ensure full protonation, 130 was stirred with 
stoichiometric amount of aq. HNO3 in a 1:1 mixture of MTBE and THF in order to precipitate 
the corresponding nitric salt in the first step. Afterwards, in the second step, the addition of 
sulfuric acid formed the nitronium ion for the aromatic electrophilic substitution that led to 
the desired product 132 in good yield (52%). Without any further purification, compound 132 
was reduced to aniline 131 using Fe and NH4Cl. This method avoids the handling of tin chloride 
and led to the desired compound through a more fluid work up, without a tedious purification 
step.   
 
 
Scheme 72: Final conditions for the nitration and reduction of compound 130. 
 
In the following step of the large-scale synthesis of 129, the iodination of compound 131 using 
a Sandmeyer reaction proved to be extremely challenging (Table 12). Unreproducible results 
with different ratios of the desired compound coupled with tremendous purification issues 
led us to consider alternative pathways to compound 133. 
Br
NMe2
1) conc. H2SO4, aq HNO3
2) SnCl2•H2O, aq HCl
Br
NMe2
130
20 g (100 mmol)
131
58% yield
(over two steps)
12.5 g (58 mmol)
NH2
Br
NMe2
Br
NMe2
130
50 g (250 mmol)
132
52% yield
32 g (133 mmol)
Fe, NH4Cl, MeOH/H2O
NO2
Br
NMe2
NH2
131
87%
28 g (115 mmol)
Aq. HNO3(68%), MTBE/THF
then H2SO4 CH2Cl2
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Entrya Scale Work up Purification Obeservations 
1 20 mmol (4.3 g) - - No conversion 
2 2 mmol (430 mg) - - Conversion to a side product 
3 58 mmol (12.5 g) Na2SO3/CH2Cl2 
Column 
Chromatography 
100 mg of pure isolated 
compound 
4 58 mmol (12.5 g) Et2O/NH4OH/CH2Cl2 - < 1 g of isolated compound 
5 5 mmol (1.08 g) Et2O/NH4OH/CH2Cl2 - 1:4 P/SP 
6 20 mmol (4.3 g) - - Conversion to a side product 
7 10 mmol (2.15 g) a Filtration through Alox - 607 mg of impure compound 
8 10 mmol (2.15 g) a Filtration through Alox - 2 g of impure compound 
[a] The starting material was the corresponding HCl salt of 131. 
Table 12: Sandmeyer reaction attempts for the formation of 133. 
 
An alternative route had been previously described, consisting in a reductive 
amination/Finkelstein reaction/Bromination sequence. This strategy allowed us to 
successfully obtain compound 133 (Scheme 73).[120] The reductive amination using aq. HCHO 
and NaBH4 fully converted compound 134 to its dimethyl derivative which was engaged 
without further purification in a Finkelstein reaction to deliver 135 with an excellent yield 
(97%). The selective bromination led to the desired intermediate 133 after a recrystallization 
in n-hexane/EtOAc 4:1.  
 
 
Scheme 73: Reductive amination/Finkelstein/bromination sequence. 
 
Br
NMe2
131
aq HCl, NaNO2, then KI
NH2
Br
NMe2
I
133
NH2 NMe2
134
24 g (140 mmol)
135
31 g (127 mmol)
Br2, CH2Cl2
I
Br
NMe2
I
133
24 g (72 mmol)
1) aq. HCHO (37%), H2SO4, 
THF, NaBH4 (94% yield)
Br
2) NaI, CuI (cat), 1,4-dioxane 
(97% yield)
(57% yield)
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The Buchwald-Hartwig cross-coupling between intermediate 131 and 133 proceeded swiftly 
to yield the corresponding coupling product 136 (70%). However, despite our efforts to 
optimize the purification, a column chromatography was inevitable in this case. 
With this intermediate in hand, several alternatives were examined for the methylation step 
(Table 13). Unfortunately, all of these options failed. 
 
 
Entrya, b Conditions Observations 
1 (CHO)n (10 eq), NaBH3CN (4 eq), Acetic acid, 15 h, RT Decomposition 
2 Trioxane, Et3SiH, TFA, CH2Cl2, 24 h, RT No conversion  
3 (CHO)n (2 eq), NaBCNH3 (1.2 eq), ZnCl2 (1.2 eq), MeOH, 12 h, 70 °C No conversion 
4 HCHO (2 eq), HCO2H (4 eq), EtOH/DMSO, 2 h, 80 °C Decomposition 
5 HCHO (1.1 eq), succinimide (1.1 eq), NaBH4 (1.1 eq), EtOH/DMSO, 4 h, 80 °C No conversion 
[a] Reaction performed on 1 mmol scale; [b] Analysis with NMR. 
Table 13: Conditions for methylation. 
 
Turning back to the original conditions using CH3I and NaH, we could achieve the synthesis of 
our key intermediate 137 in good yield (71%) to give a significant amount (35 g) after a 
recrystallization in n-hexane/EtOAc 4:1 (Scheme 75). The formation of the 1,5-bifunctional 
organomagnesium reagent was easily completed after 3 h and the direct ester to acridinium 
transformation finally delivered almost 4 g of compounds 129a and 129b in very good yields 
(82% and 84% respectively). 
 
Br
NMe2
NH2
131
37 g (170 mmol)
Br
NMe2
I
133
55 g (170 mmol)
+
H
N
Br Br
NMe2 NMe2
136
70% yield
49 g (119 mmol)
Pd2(dba)3 (2.5 mol%), dppf (5 
mol%), NaOt-Bu, toluene Conditions*
N
Br Br
NMe2 NMe2
137
Me
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Scheme 75: Methylation and direct ester to acridinium transformation. 
 
Having synthesized a new acridinium salt, we moved on to measure its photophysical 
properties (Table 14). As anticipated the photophysical profile of 129b is extremely similar to 
129a with identical excited and ground state reduction potentials (Table 14,  
E1/2 [P*/P–] = +1.25 V vs SCE). For this reason, we believe that organocatalyst 129b could offer 
comparable performances in photoredox reaction with a slightly improved photostability. 
 
Dye 
labs 
[nm]a 
lem 
[nm]a 
E0,0 
[eV]a 
E1/2(P/P–) 
[V]b 
E1/2(P*/P–) 
[V] 
129a 503 530 2.40 –1.15 +1.25 
129b 504 533 2.40 –1.15 +1.25 
[a]Measured in MeCN (15 μmolL–1); [b]Measured in 0.1 molL–1 n Bu4N×PF6 in dry, degassed MeCN against SCE. 
Table 14: Photophysical properties of compounds 129a and 129b. 
 
In summary, we successfully completed a sustainable large-scale synthesis of compound 129a 
and 129b with optimized reaction conditions and purification procedures (Scheme 76). All 
products were obtained in good to excellent yields, primarily using the crude mixture or a 
recrystallized intermediate directly. Finally, the photophysical properties of 129b showed 
promising results for potential photoredox activities. 
 
N
Br Br
NMe2 NMe2
5) Mg, THF, 60 °C
then 
THF, 60 °C
Me
NaH, THF, 
then MeI
129a : R = Me (82%; 3.9 g)
129b : R = H (84%; 3.9 g)
N
MeMe
R
NMe2
Me Br
137 
71% yield
35 g (82 mmol)
Me2N
 then HBr
MeMe
R
CO2Me
H
N
Br Br
NMe2 NMe2
136
48 g (117 mmol)
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Scheme 76: Final large-scale synthesis of 129a and 129b. 
 
2.2.1.3 In depth study of the photophysical and photochemical properties of a peculiar 
acridinium photocatalyst6 
 
With an excited state reduction potential approaching those of transition metal systems  
(E1/2 [P*/P–] = +1.25 V vs SCE), 129a displayed a peculiar activity in the Ni-dual catalytic cross-
coupling reaction (Scheme 77).[120] When compared to a wide variety of commonly used 
photoredox organocatalysts such as eosin Y, only 129a followed the decarboxylative 
mechanism A, all the others led to the C-O cross-coupling product.[108,180–182] Therefore, these 
results drove us to further investigate the mechanism behind this divergent pathway  
  
 
6 Performed by Dr. Christoph Kerzig in the group of Prof. Dr. Oliver Wenger, University of Basel. 
Br
NMe2 N
Br Br
NMe2 NMe2Br
NMe2
I
Br
NMe2
NH2
+
3) Pd2(dba)3 (2.5 mol%), dppf (5 
mol%), NaOt-Bu, toluene (70%)
1) aq. HNO3(68%), 
MTBE/THF
then H2SO4 CH2Cl2 (52%)
5) Mg, THF, 60 °C
then
Me
4) NaH, THF, then MeI (71%)
NH2
Br a) aq. HCHO (37%), H2SO4,
THF, NaBH4 (94%)
129a : R = Me (82%; 3.9 g)
129b : R = H (84%; 3.9 g)
N
MeMe
R
NMe2
Me Br
134
130
133
131
137 (35 g)
Me2N
2) NH4Cl, Fe, 
MeOH/H2O (87%)
b) NaI, CuI (cat), 
1,4-dioxane (97%)
c) Br2, CH2Cl2 (57%)
MeMe
R
CO2Me
THF, 60 °C
then HBr
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Scheme 77: Divergent pathway for the Ni-dual catalytic cross-coupling reaction. 
 
According to MacMillan’s described mechanism,[183,184] 129a undergoes a single electron 
transfer (SET) to oxidize the deprotonated proline derivative which after decarboxylation 
leads to the radical intermediate (Scheme 78, pathway A). A second catalytic cycle involving 
Ni(0) starts with the oxidative addition of the aryl halide to give a Ni(II) species which reacts 
with the radical forming  a Ni(III) intermediate. Finally, the reductive elimination delivers the 
product and a last SET from the photocatalyst reduces Ni(I) to Ni(0) to complete the cycle. 
Contrarily, the other photocatalysts operate through a triplet-triplet energy transfer (TTET) 
to excite the aryl Ni(II) carboxylate in order to favor the reductive elimination leading to the 
O-aryl ester (Scheme 78, pathway B). Noticeably, the photocatalysts with high oxidative 
excited state reduction potentials such as the Fukuzumi catalyst led to either low conversion 
with a mixture of compounds or no product at all. 
 
N
Boc
NiCl2 glyme, 
2,2'-bipy or dtbbpy
Cs2CO3 or K2CO3, DMF, 
LED light (λmax: 464 nm)
N
Boc CO2Me
O
OH
CO2Me
+
N
Boc
O
O
CO2Me
N+
Me
Me2N NMe2
Mes
A   86%
B   96%
1[PC]*
3[PC]*
ONaO O
CO2Na
Br
BrBr
Br
eosin Y
129a
Br–
I
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Scheme 78: General mechanism of the Ni-dual catalytic cross-coupling. 
 
To gain insight into this singular reactivity, our investigations started with comparative DFT 
calculations between 129a and the Fukuzumi catalyst.[109] The results show a clear contrast in 
the nature of the lowest energetic electronic transitions (Figure 1). While a distinct CT (charge 
transfer) is observed between the mesityl moiety of the HOMO and the acridine core of the 
PC*
PC
SET
R O
O
– CO2
LnNiI-X LnNi0
Ar-I
LnNiII-Ar
I
PC
LnNiIII-R
I
Ar
R
R
PC*
hυ
hυ TTET
Ni0
N DMF
N DMF
NiII
N X
N Ar
Ar-I
NiII
N
N Ar
R O
O
Ar–R
+ RCO2– , – X–
NiII
N
N Ar
R O
O
*
RCO2–Ar
Pathway A
Pathway B
SET
OHN NH
CO2Et
MeMe
O
N N Me
Me
Me
Me
Michler’s Ketone
59%
N
N
N
NHMe
Me
O
O
OH
HO OH
OH
Riboflavine
54%
NMe2N NMe2
Acridine Orange
78%
N
SMe2N NMe2
Methylene Blue Hydrate
81%
Cl • xH2O
O
S
9H- Thioxanthene-9-one
93%
MeMe
Cl
Rhodamine 6G
61%
N+
Me ClO4–
MeMe
Me
Fukuzumi
N.C.
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LUMO for the Fukuzumi catalyst, the dimethyl amino groups of 129a introduce a change to a 
π–π* character. For this reason, the less energetic state of 129a allows Ni-dual catalysis and 
multicomponent reactions whereas the Fukuzumi catalyst, as a highly oxidizing and reactive 
agent is not well-suited for such transformations.   
 
 
Figure 1: DFT calculations (B3LYP/6-31+G(d,p), IEFPCM solvation with MeCN) of 129a and the Fukuzumi catalyst. 
 
We next examined the quantum states of 129a and eosin Y. The singlet excited state 
reduction potentials of both catalysts are very similar (+1.25 V for 129a against +1.23 V for 
eosin Y) therefore, they could both theoretically oxidize the carboxylate 
derivative.[108,120,184,185] Moreover, the calculated triplet energy of 129a ET = 1.89 eV is 
identical to the one of eosin Y, both higher than the triplet energy of the aryl Ni(II) carboxylate 
(ET = 1.85 eV).[108,120,184,185] For this reason, both catalysts would thermodynamically be able 
to favor the formation of the O-aryl ester.  
To understand the difference in the kinetics of these quantum states, laser flash photolysis 
(LFP) studies were conducted (Figure 2).[186] The transient absorption (TA) spectrum of 129a 
(in Ar-saturated acetonitrile upon 532 nm excitation with green laser) shows a long-lived 
species (t = 330 µs). In order to identify this long-lived intermediate, a study of the reactivity 
towards aromatic hydrocarbons and more particularly anthracene was performed. A 
diffusion-controlled quenching and the formation of the anthracene triplet with its 
characteristic spectrum (Figure 2, upper inset) was observed. This result indicates clearly that 
–5.80 eV –2.80 eV
N+
Me
Me2N NMe2
Me Me
129a
Me
N+
Me
Me Me
Me
Fukuzumi
catalyst
–6.91 eV –3.57 eV
HOMO LUMO
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a triplet-triplet energy transfer (TTET) occurred via a Dexter mechanism between the triplet 
state of 129a (donor) and the anthracene (acceptor). Further analysis helped determine that 
the triplet quantum yield of 129a was about 7% with an estimated triplet energy of about 
1.91 eV. These experimental results corroborates the DFT-calculated approximation  
(ET = 1.89 eV).  
 
 
Figure 2: Nanosecond laser flash photolysis (LFP) investigations of the triplet state of 129a (20 μM in 
deoxygenated MeCN) using 532 nm laser pulses of ∼10 ns duration (pulse energy, 16 mJ). Main plot, transient 
absorption spectrum 500 ns after the laser pulse and time-integrated over 200 ns. Lower inset, kinetic transient 
absorption trace-monitored at 615 nm. Upper inset, transient absorption spectrum in the presence of 
anthracene (0.4 mM) recorded with a time delay of 3 µs. 
 
Considering that the triplet quantum yield of eosin Y is about 80%,[187] this quantum state is 
believed to be the photoactive species.[108] However, with a quantum yield of only 7% and 
according to Nicewicz studies on redox properties of acridinium photocatalysts,[188] 129a is 
more likely to react via its more populated singlet excited state. However, in light of the long-
lived triplet state (t = 330 µs) and the high triplet energy (ET = 1.91 eV) displayed by 129a, we 
were curious to test its reactivity. A triplet sensitized trans-to-cis photoisomerization of 
stilbene assay was thus conducted (Scheme 79). The results showed that the triplet state of 
129a can still remain active yielding 71% of the cis-stilbene (for thermodynamic reasons, the 
SYNTHESIS	OF	ACRIDINIUM	SALTS	FOR	PHOTOREDOX	CATALYSIS	
	 88	
cis-stilbene triplet state cannot be generated with 129a as a triplet energy donor). Therefore, 
in absence of a competitive reaction pathway, 129a can operate photochemical 
transformation through its triplet excited state. 
 
 
Scheme 79: Stilbene photoisomerization essay. 
 
Pursuing our analysis, we then focused on the study of the singlet excited state reactivity of  
eosin Y and 129a through fluorescence quenching experiments with Boc-proline derived Cs- 
and K-carboxylates as substrates (Figure 3). Surprisingly, a longer natural lifetime of singlet 
excited state was observed for eosin Y (t = 5.29 ns) compared to 129a (t = 2.23 ns). However, 
according to the Stern-Volmer plot, the quenching by the Cs salt of Boc-Proline was 50 times 
slower in the case of eosin Y than 129a. This observation substantiates that only the singlet 
excited state of 129a is able to perform an efficient quenching. This difference of kinetic 
reactivities is due to Coulomb interactions that have a significant influence on the quenching 
rate constants and could explain the diverging pathways of the two photocatalysts. 
 
N+
Me
Me2N NMe2
Mes
129a
Br–
Photocatalyst 129a (1mol%)
CD3CN
green light (0.3 W, 2h)
71% cis-stilbene
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Figure 3: Fluorescence quenching studies of 129a and eosin Y in deoxygenated DMF upon 473 nm excitation. 
Main plot, response function of the TCSPC instrument (IRF) and unquenched lifetimes of both emitters. Inset, 
Stern−Volmer plots using either K+- or Cs+-salt of Boc-L proline as quencher. 
 
2.2.1.4 Modular synthesis of acridinium photocatalysts 
 
The field of photoredox catalysis have been dominated by polypyridyl transition metal 
systems, especially Ir and Ru based complexes, because of their powerful and flexible 
properties.[103,104,189,190] The high tunability of their ligands offers a great modularity of their 
photophysical features. The development of complementary organic photocatalysts opened 
up the area towards more sustainable alternatives.[106–108] Among them, acridinium salts 
pioneered by Fukuzumi and later refined by Nicewicz are well-established photocatalysts with 
powerful oxidative properties.[109,110,116] However, their synthetic modularity is limited by 
their traditional assembly. This observation associated with the photochemical findings about 
compound 129a (see chapter above) guided us to design a modular approach for the 
synthesis of a variety of acridinium salts with a wide range of photophysical properties. The 
crucial step of this synthesis lies in the combination of a directed ortho-metalation (doM) with 
a halogen-metal exchange delivering a 1,5-bifunctional organolithiated reagent.[120,121] 
Finally, this key intermediate reacts with diverse carboxylic acid esters to deliver the desired 
asymmetric acridinium salts (Scheme 80). 
 
129a (540 nm) 
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Scheme 80: Modular synthesis of acridinium salts. 
 
Encouraged by the efficiency of the substrate synthesis previously developed, a similar 
strategy was envisaged using anisole derivatives to introduce the methoxy group essential for 
the upcoming doM (Scheme 81).7 m-Anisidine 138 was thus coupled to ortho-
bromoiodobenzene 125 to deliver, upon methylation, intermediate 139a in almost 
quantitative yields and significant amount (4 g). The coupling of aniline with m-iodoanisole 
was scaled-up and gave 35 g of the key intermediate 141 in very good yield (91%). This 
secondary aniline intermediate was then engaged in coupling reactions with ortho-
bromoiodebenzene on one side and compound 141 on the other side to deliver precursors 
139b and 139c in significant amounts (7 g and 27 g). Compound 139d was obtained in good 
yield (93%) after the coupling of 138 and 133 but was not scaled-up similar to its analogues 
(Scheme 81 in grey). Finally, an iodination reaction allowed us to obtain 62 g of compound 
143 which after coupling with 141 yielded precursor 139e in 45% yield. 
 
7 Large-scale reactions performed together with Markus Jakobi and Romaric Corsi as part of his internship. 
N+
R
R’
N
BrR
n BuLi
65 °C
hexane/Et2O
NMe2
MeO
R = Me, Ph
N
Li LiR
NMe2
MeO
OMeO
R’
Br–
OMe
NMe2
THF, 12h
then HBr
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Scheme 81: Synthesis of the bi- and tri-arylamine precursors. 
 
With our bi- and tri-arylamine precursors in hand, we pursued our synthesis with the mixed 
metalation using n-BuLi at 65°C. A rapid halogen-metal exchange followed by a slower 
directed ortho-metalation (doM) supported by the methoxy group delivered the 1,5-
NH2
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+
Br
I
1) Pd2(dba)3, dppf,  NaOt-Bu,
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bifunctionnal organolithiated reagents. The in-situ reaction with a variety of carboxylic acid 
esters finally provided a large scope of asymmetric acridinium salts, some of which on a gram-
scale with an optimized purification avoiding column chromatography (Scheme 82). 
Noticeably, the reaction with methyl benzoate delivered the corresponding acridinium dyes 
144g, 144h, 144j, 144l in very good to excellent yields (86% – 98%), probably due to the lack 
of steric bulk. This would explain the lower yields obtained with the double ortho-substituted 
methyl 2,4,6-trimetyl benzoate and methyl 2,6-dimethyl benzoate on a larger scale (29% – 
57%), although the reported yields for 100 µmol reaction were significantly higher (71%).[191] 
Finally, 1-methyl naphthoate could be easily converted to racemic acridinium salts 144c, 
144d, and 144k in moderate to excellent yield (49% – 91%).  
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Scheme 82: Synthesis of asymmetric acridinium salts (compounds not scaled-up in grey). 
 
Following the success of acridinium salts 144-l, we then moved on to study the photophysical 
properties of these newly synthesized dyes (Table 15).8 After investigating the emission 
 
8 Performed together with Dr. Christoph Kerzig in the group of Prof. Dr. Oliver Wenger. 
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lifetimes of compounds 144a–l, we were pleased to observe an average t of about 1 ns which 
makes them all suitable for photocatalysis. Moreover, a broad range of excited state redox 
potential was achieved from E1/2(P*/P−) = +1.19 V (144d) or + 1.23 V (144i) akin to  
Ir[dF(CF3)-ppy]2(dtbbpy)+ (E1/2(P*/P−) = +1.21 V) to E1/2(P*/P−) = +1.81 V (144h),  including  
E1/2(P*/P−) = +1.40 V (144b, 144c, 144j) analogous to Ru(bpz)3. Noticeably, the presence of a 
dimethyl amino or methoxy group on the acridine core significantly contributes to the 
decrease of the excited state redox potential by around 0.3 to 0.4 V and 0.1 to 0.2 V, 
respectively. Finally, organocatalysts 144a–l mostly display π–π* electronic transitions 
sometimes combined with charge transfer (CT). Only 144k showed a pure charge transfer (CT) 
similarly to the Fukuzumi catalyst. 
 
Dye 
E0,0 a 
[eV] 
ET b 
[eV] 
E1/2(P/P–) 
[V] c 
E1/2(P*/P–) 
[V]  
t a 
 
[ns] 
HOMO-LUMO 
transition b 
144a 2.25 1.75 –0.56 +1.69 1.2, 3.3, 16.8 mixed 
144b 2.29 1.91 –0.89 +1.40 1.1, 6.8 p-p* 
144c 2.27 1.88 –0.87 +1.40 1.0, 6.2 mixed 
144d 1.87 1.14 –0.68 +1.19 0.9, 5.0 p-p* 
144e 2.29 1.91 –0.90 +1.39 1.1, 7.2 p-p* 
144f 2.25 1.76 –0.57 +1.68 1.4, 12.1 mixed 
144g 2.23 1.75 –0.54 +1.69 1.0, 9.9 p-p* 
144h 2.29 1.76 –0.48 +1.81 1.0, 3.0, 17.3 p-p* 
144i 1.94 1.17 –0.71 +1.23 1.5, 5.3 p-p* 
144j 2.29 1.90 –0.89 +1.40 1.0, 6.9 p-p* 
144k 2.26 1.74 –0.53 +1.73 1.0, 4.5 CT 
144l 2.30 1.91 –0.83 +1.47 0.9, 4.4 p-p* 
[a]Measured in MeCN (15 μmolL–1); [b] DFT calculation; [c] Measured in 0.1 μmolL–1 n-Bu4NPF6 in degassed, dry MeCN against SCE. 
Table 15: Photophysical properties of compounds 144a–l. 
 
To complete our inquiry, photostability studies were performed on catalysts 129a and 144a, 
144f, 144g, 144l (see experimental part). Highly diluted and degassed solutions of these six 
acridinium dyes (~10 to ~30 µM) were thus irradiated and the UV/Vis absorption spectra were 
monitored over 1 h. The results show a complete decomposition of 129a and an ongoing 
photodegradation for 144l. Whereas 144a, 144f, 144g exhibit an identical spectrum to those 
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of freshly prepared solutions. Moreover, no color change of the solution is observed for 
compounds 144a, 144f, 144g which prompts us to conclude that they are completely stable 
under these irradiation conditions. We next compared our results to the well-known 
photocatalyst complex [Ru(bpy)3](PF6)2 under the same irradiation conditions. The outcome 
indicates an even faster photodegradation than our least stable acridinium salt 129a, with a 
full decomposition after only 30 min. We can therefore assume that the presence of a 
dimethyl amino group on the acridine core leads to a lower stability of the organocatalyst. An 
1H-NMR analysis of several degradation products showed a disappearance of the -NMe2 signal 
and the formation of new entities that would indicate a demethylation process. This 
hypothesis is also supported by several LC-MS measurements revealing m/z signals of 
demethylated acridinium salts. Surprisingly, according to the 1H-NMR spectrum, the mesityl 
moiety remained intact although the oxidation of the p-CH3 group was described by 
Benniston and coworkers for the Fukuzumi catalyst.[179] 
Thus, the variety of photophysical and electrochemical properties of these newly synthesized 
dyes confirmed successfully the modularity of our design. Furthermore, their performance in 
several benchmark reactions such as fluorination and [3+3] cycloaddition was demonstrated 
(Scheme 83).[191–194] Therefore, their efficiency combined to their inherent photostability 
proved their ability to complement polypyridyl transition metal complexes. 
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Scheme 83: Benchmark reactions: [3+2] cycloaddition (top) and decarboxylative fluorination (bottom).  
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 Synthesis of a new generation of acridinium salts 9 
 
Our previous success with the modular synthesis of asymmetric acridinium dyes and the 
proven performance of organophotocatalyst 129a inspired us to design the next generation 
of acridinium salts. Given the results of the photostability assay and the fast decomposition 
of 129a through a demethylation process, we envisaged the synthesis of more photostable 
organocatalysts. A study on organic light-emitting diodes (OLEDs) published by Adachi and 
coworkers showed a high photoluminescence potency as well as an efficient thermally 
activated delayed fluorescence (TADF) of a series of carbazolyl dicyanobenzene (CDCBs) 
derivatives with carbazolyl donor moieties and cyanobenzene acceptor groups.[195] Interested 
by the electronic donating properties of the carbazole and the possibility of a unique 
electronic transition due to its distorted geometry from the plane, we envisioned to introduce 
carbazolyl units to replace the dimethyl amino groups.[196] Moreover, the high selectivity of 
4CzIPN for the C-C cross-coupling product in the Ni-dual catalytic reaction previously 
described (see 2.2.1) coupled with good photostability (58% residual catalyst), as reported by 
Zhang and coworkers, strengthened our belief in designing a synthesis of acridinium salts with 
carbazolyl motifs (Scheme 84).[183,196] 
 
 
9 Together with Markus Jakobi. 
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Scheme 84: Design of a new generation of acridinium photocatalyst. 
 
A retrosynthetic strategy in three steps was envisaged to access the desired product 152 
through a direct ester to acridinium formation from intermediated 153 (Scheme 85). The 
latter could be achieved via a double Buchwald-Hartwig C-N cross-coupling between aniline 
and building block 154. Finally, a nucleophilic aromatic substitution of tri-halogenated 
compound 156 using carbazole as the nucleophile would lead to 154.  
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Scheme 85: Retrosynthetic strategy for the synthesis of photostable acridinium salt 152. 
 
Starting with the nucleophilic aromatic substitution, the standard conditions described by Dai 
and coworkers allowed us to obtain compound 154 in 28% yield. Despite several optimization 
attempts (Table 16), the yield could not be further improved. 
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Entrya, b Base Solvent Temperature Time Observation 
1 Cs2CO3 DMF 150 °C 24 h 28%c 
2 Cs2CO3 - 200 °C 48 h No conversion 
3 Cs2CO3 DMSO 180 °C 48 h < 5% conversion 
4 K2CO3 DMF 150 °C 48 h < 5% conversion 
5 NaH THF 75 °C 3 h decomposition 
[a] Reaction performed on 1 mmol scale; [b] Conversion determined by NMR; [c] Isolated yield. 
Table 16: Reaction conditions for the nucleophilic substitution. 
 
Nevertheless, with building block 154 in hand we moved on to test the double C-N cross-
coupling with aniline (Table 17). Several reaction conditions were thus investigated starting 
from a standard palladium catalyzed Buchwald-Hartwig cross-coupling using dppf as a ligand 
(Table 17, entry 1). Receiving only the mono-addition product 153a, we replaced dppf by 
RuPhos to facilitate the second addition. To our satisfaction, some conversion to the desired 
product 153 was obtained with a ratio of 0.8 : 1 regarding the mono-addition product 153a 
(Table 17, entry 2).  In order to explore further reactions to achieve a higher conversion and 
better yields, we turned to Ullman couplings catalyzed by Cu (Table 17, entry 3–8). However, 
in all cases, we only observed the formation of the mono-addition product 153a. 
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Entry
a, b, c 
Catalyst 
Ligand/ 
Additive 
Base Solvent Temparature Product 
1 Pd2(dba)3 dppf t-BuONa toluene 110 °C 153a (94%) d 
2 Pd2(dba)3 RuPhos t-BuONa toluene 110 °C 
153a/153 
(1:0.8) 
3 CuCl Phenanthroline KOH toluene 110 °C 153a 
4 
Cu 
(powder) 
18-crown-6 K2CO3 dichlorobenzene 180 °C 153a 
5 Cu and CuI - K2CO3 diphenylether 190 °C 153a 
6 CuI DMEDA K2CO3 DMF 110 °C e,f 153a 
7 CuI DMEDA K2CO3 DMF 150 °C e,f 153a 
8 CuI DMEDA K2CO3 DMF 190 °C f 
< 5 % 
conversion to 
153 
[a] Reaction performed on a 100 µmol scale; [b] Conversion determined by NMR; [c] Reaction time of 12 h unless stated otherwise;  
[d] Isolated yield; [e] µwave; [f] Reaction time of 5 h. 
Table 17: Reaction conditions for double C-N cross coupling. 
 
Coming back to our most successful attempt using Buchwald Hartwig cross-coupling 
conditions, we decided to screen ligands starting with the mono-addition product 153a 
(Scheme 86). CataXCium® A achieved a slightly better conversion than RuPhos with 56% 
while CyJohnPhos and DavePhos led to conversion of 23 and 37% respectively. Every other 
tested catalyst did not yield any conversion. 
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[a] Reaction performed on a 100 µmol scale; [b] Conversion determined by NMR. 
Scheme 86: Ligand Screening. 
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Encouraged by those results, we chose inexpensive RuPhos in order to test other reaction 
parameters. PEPPSI and [(π-allyl)PdCl]2 were thus investigated as alternative palladium 
sources. However, PEPPSI did not yield any product and [(π-allyl)PdCl]2 gave a similar 
conversion to Pd2(dba)3 (approximately 40%). Moreover, the use of pre-ligated RuPhos Pd G2 
and G3 did not improve the conversion. Replacing Nat-BuO by Kt-BuO also did not have any 
further effect. Nevertheless, by using the standard conditions with RuPhos, we could obtain 
our key intermediate 153 in 33 % yield (Scheme 87). The formation of the Grignard reagent 
next took place in a mixture of THF/Me-THF/toluene because of the very low solubility of 
substrate 153. The exchange was complete after 3 h and our 1,5-bifunctional 
organomagnesium reagent could successfully react with the mesityl methyl ester into the 
desired product 152 (Scheme 87).  
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Scheme 87: Completed synthesis of the new generation of acridinium salts. 
 
Naturally, we were curious to examine the photophysical properties of 152 and to compare 
them with the dimethyl amino derivative 129a (Table 18). 152 showed a bathochromic shift 
compared to 129a with absorption and emission wavelengths of 543 nm and 566 nm 
respectively, which would have interesting application with green light. This fact can also be 
observed by the naked eye with 152 being a deep purple powder and 129a an intense orange 
solid. However, the Stokes shift are very similar with around 25 nm for each compound. 
Finally, the reduction potential on the ground and excited state are drastically different with 
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the newly synthesized acridinium salt 152 displaying a higher oxidative power  
(E1/2(P*/P–) = 1.79 V). 
 
Dye 
labs 
[nm]a 
lem 
[nm]a 
E0,0 
[eV]a 
E1/2(P/P–) 
[V]b 
E1/2(P*/P–) 
[V] 
129a 503 530 2.40 –1.15 +1.25 
152 543 566 2.23 –0.44 +1.79 
[a] Measured in MeCN (15 μmolL–1); [b] Measured in 0.1 μmolL–1 n-Bu4NPF6 in degassed, dry MeCN against SCE. 
Table 18: Photophysical properties of 152. 
 
Thrilled with these preliminary results, we proceeded next to improve further the synthesis 
in order to scale-up 152. We were also interested in introducing other substituents that would 
favor photostability instead of the carbazolyl units, such as diphenylamine moieties for 
example. Therefore, we started to explore alternative synthetic routes with an intermediate 
that would offer the possibility of a late stage functionalization and a more flexible synthesis 
(Scheme 88). Maintaining the direct ester to acridinium transformation to obtain the desired 
product, the same key intermediates 153 and 153b could be received after a double 
Buchwald-Hartwig C-N cross-coupling with double triflated compound 166. The latter would 
be achieved through a demethylation/triflation sequence of triarylamine 167. Another double 
Buchwald-Hartwig C-N cross-coupling between aniline and triflate 168 would lead to 167. 
Finally, 168 could easily be synthesized by a selective bromination of 3-methoxyphenol 169 
followed by a triflation. 
 
SYNTHESIS	OF	ACRIDINIUM	SALTS	FOR	PHOTOREDOX	CATALYSIS	
	 106	
 
Scheme 88: Retrosynthetic analysis for an alternative route to 152 and 152a. 
 
The first steps proceeded smoothly with a selective bromination achieved with 78% yield 
followed by a triflation with 91% yield. However, after several failed attempts at cross-
coupling 168 with aniline, our strategy was adjusted (Table 19). 
 
 
Entry a, b Catalyst Ligand Base Solvent Observation 
1 Pd2(dba)3, XantPhos K3PO4 toluene No conversion 
2 Pd2(dba)3, (rac)-BINAP Cs2CO3 toluene Hydrolysis of the triflate 
3 c Pd2(dba)3, RuPhos t-BuONa toluene Hydrolysis of the triflate 
[a] Reaction performed on a 100 µmol scale at 100 °C unless stated otherwise; [b] Observation determined by NMR; [c] Reaction performed 
at  110 °C. 
Table 19: Reaction conditions for the double C-N cross-coupling. 
 
Inspired by the scale-up synthesis of Nicewicz and coworkers,[117] we envisaged a 
retrosynthetic pathway relying on a late stage nucleophilic aromatic substitution of 
xanthilium dye 170/170a by aniline (Scheme 89). The direct ester to xanthylium salt 
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transformation should lead us from intermediate 171/171a to 170a/170. As previously 
described, a demethylation/triflation/double C-O cross-coupling could achieve 171a/171 
from diarylether 172. Finally, the coupling of triflate 168 with phenol 173, both issued from 
169 would result in compound 172. 
 
 
Scheme 89: Retrosynthetic strategy using a xanthilium dye intermediate. 
 
Unfortunately, the C-O cross-coupling product 172 could not be achieved using standard 
conditions with XPhos Pd G2 (Scheme 90). 
 
 
Scheme 90: C-O cross-coupling for the synthesis of intermediate 172. 
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iodobiphenyl 177. A similar coupling between 176 and 179 could lead to 178. Finally, 179 
could be formed through an iodination/reduction sequence from 4-bromonitrobenzene 180. 
 
 
Scheme 91: Retrosynthetic pathway with the de novo construction of the carbazolyl moiety. 
 
The oxidation of compound 177 by m-CPBA and TFA according to the conditions described by 
Wen, Huang and coworkers,[197] effortlessly led to iodonium 176 with 85% yield (Table 20). 
The first attempt of copper-catalyzed coupling with 175 gave a promising result with an 
isolated yield of 20% under the standard conditions reported by Wen, Huang and 
coworkers.[198] However, despite our optimization attempts, the yield could not be improved 
any further, forcing us to disregard this new route (Table 20). 
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Entry a, b Ligand Solvent Temperature Observation 
1 Et(OH)2 i-PrOH 85 °C 20%c 
2 Et(OH)2  Toluene 110 °C conversion + degradation products 
3 Phenanthroline  Toluene 110 °C No conversion 
4 TMEDA  Toluene 110 °C No conversion 
5 EDA Toluene 110 °C No conversion 
6 
Trans-4-
hydroxyproline  
i-PrOH 90 °C conversion + degradation products 
7 PEG i-PrOH 90 °C conversion + degradation products 
8 Diethylene glycol i-PrOH 90 °C conversion + degradation products 
9 Glycerin i-PrOH 90 °C No conversion 
10 Glucose i-PrOH 90 °C No conversion 
11 1,3 propanediol i-PrOH 90 °C No conversion 
[a] Reaction performed on a 100 µmol scale; [b] Observation determined by NMR; [c] Isolated yield. 
Table 20: Reaction conditions for the coupling of 175 and the cyclic diphenyliodonium salt 176. 
 
In reference to our original approach, we reasoned that the steric hindrance induced by the 
bromine in ortho position would most likely hamper the second coupling. This would explain 
the low conversion and low yield for intermediate 153. Therefore, the replacement of a 
bromine by a chlorine, significantly smaller yet still suitable for C-N cross coupling, might 
increase the conversion and thus the yield for an analogous intermediate. 
Our retrosynthetic strategy relied on key intermediate 181 with chlorine instead of bromine 
(Scheme 92). This compound could be generated from 182 after a double C-N cross-coupling 
with two carbazoles followed by another one with iodobenzene. A C-N cross coupling 
between 183 and 184 could deliver 182. Finally, 183 could easily be prepared directly from 
184 by a Sandmeyer reaction. 
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Scheme 92: Retrosynthetic strategy with chlorinated intermediates. 
 
Commercially available 184 underwent a Sandmeyer reaction to give 183 in very good yield 
(88%). The following C-N cross-coupling of 183 with 184 catalyzed by Pd2(dba)3 and dppf 
resulted effortlessly in compound 182 with an identical yield (Scheme 93).  
 
 
Scheme 93: Synthesis of compound 182. 
 
We then started to investigate the C-N cross coupling between 182 and the two carbazole 
units (Table 21). First adopting the conditions described by Yamakawa and coworkers,[197] the 
product was isolated with only 17% yield because of a significant side product formation 
(Table 21, entry 1) which was also observed when replacing the t-BuXPhos by cBRIDP (Table 
21, entry 3). Switching to standard conditions with RuPhos in refluxing toluene proceeded 
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unfortunately with a low conversion (Table 21, entry 2). Additionally, our attempt to turn to 
an Ullmann coupling was unsuccessful (Table 21, entry 4). Finally, by using t-BuXPhos in 
refluxing toluene we achieved full conversion to the desired product and isolated 
intermediate 185 with 72% yield (Table 21, entry 5).  
 
Entry a, b Catalyst Ligand Base Solvent Temperature Observation 
1 Pd2dba3 t-BuXPhos Nat-BuO Xylene 140 °C 17% c 
2 Pd2dba3 RuPhos Nat-BuO Toluene 110 °C < 20% conversion 
3 Pd2dba3 cBRIDP Nat-BuO Xylene 140 °C Side product formation 
4 CuI Phenanthroline K2CO3 DMF 150 °C < 10% conversion 
5 Pd2dba3 t-BuXPhos Nat-BuO Toluene 110 °C 72% c 
[a] Reaction performed on a 100 µmol scale; [b] Observation determined by NMR; [c] Isolated yield. 
Table 21: Optimization of the C-N cross-coupling with carbazole. 
 
Encouraged by this success, we undertook the next challenging coupling between 185 and 
iodobenzene (Table 22). Unfortunately, no conversion to the desired product was observed, 
despite several optimization attempts. 
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Entry Catalyst Ligand Base Solvent Temperature Observation 
1 Pd2dba3 RuPhos Nat-BuO Toluene 110 °C No conversion 
2 CuCl Phenanthroline KOH Toluene 110 °C No conversion 
3 CuI Phenanthroline K2CO3 DMF 150 °C No conversion 
4 Pd2dba3 RuPhos Nat-BuO Mesitylene 170 °C No conversion 
5 NiCl2(PPh3)2 PPh3 EtMgBr THF/Toluene 100 °C No conversion 
6 CuCl - K2CO3 DMSO 200 °C No conversion 
[a] Reaction performed on a 100 µmol scale; [b] Observation determined by NMR; [c] Isolated yield. 
Table 22: Reaction conditions for the cross-coupling of 185 with iodobenzene. 
 
Other coupling strategies involving a double C-N cross-coupling between 183 and aniline to 
get to intermediate 186 or the direct C-N cross-coupling of 182 with iodobenzene were also 
experimented. However, none of these options led to the desired product and prevented 
further synthetic steps (Scheme 94). 
 
 
Scheme 94:  C-N cross coupling strategies to obtain the acridinium dye precursor. 
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Nevertheless, we then moved to install a methyl group instead of the phenyl group which was 
successfully achieved employing our standard conditions with iodomethane and sodium 
hydride (Scheme 95). Finally, with our key substrate 187 in hand, we proceeded to test the 
direct ester to acridinium formation. Despite the use of several organometallic reagents (Mg, 
n-BuLi, sec-BuLi, t-BuLi) and even the formation of the 1,5-organometallic species (monitored 
by NMR and LC-MS), the addition on the ester did not occur (Scheme 95). This result 
corroborates the hypothesis that the bromine would plays a crucial role in the addition of the 
organometallic reagent to the ester.  
 
 
Scheme 95: Direct ester to acridinium transformation attempts.  
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and fully characterized two carbazole derivatives 190a and 190b originating from a C-H 
activation in ortho and para of the methoxy group (see experimental section). In the 
literature, this reaction was exhaustively studied by Fagnou and coworkers for the synthesis 
of similar compounds and natural products.[199] Unfortunately, our attempts to circumvent 
this activation pathway by lowering the temperature did not yield any product.  
 
 
Scheme 96: Unsought C-H activation for the synthesis of carbazole derivatives. 
 
Aware of the synthetic complexity to install the carbazole motif, we decided to switch to a 
diphenylamine unit. An entirely new substrate route was thus designed starting with the 
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(Scheme 97). After 15 minutes, the conversion was complete, and aniline was directly added 
to the reaction mixture. Subsequently, the desired compound 193 underwent a second 
coupling, without any further purification, to deliver quantitatively intermediate 194. Even 
though the purification of this compound proved to be challenging, we pursued the synthesis 
with the coupling of 3-iodoanisole 195. To our delight, our key substrate 196 could be 
synthesized however, the product could not be purified by column chromatography. Further 
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investigations are currently ongoing to find recrystallization methods in order to purify this 
compound.  
 
Scheme 97: Substrate synthesis of photostable asymmetric acridinium salts. 
 
Nevertheless, we decided to engage this substrate into the direct ester to acridinium 
transformation with several carboxylic acid esters (Scheme 98). Four new photostable 
acridinium salts could be synthesized. However, despite multiple column chromatographies 
and recrystallization attempts, the purification of these compounds remained challenging.  
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Scheme 98: Direct ester to photostable acridinium salts. 
 
Nonetheless, we were excited to explore the photostability of these newly synthesized dyes. 
Thus, using similar conditions described in 2.2.1, we irradiated degassed solutions (30 µM) of 
197a-b for 24 h with blue light. NMR and HPLC analysis of both samples were identical to 
freshly prepared solutions which indicates the high inherent photostability of those dyes. 
Moreover, the study of the photophysical properties (Table 23) showed surprisingly different 
excited state reduction potentials for such analogous structures (E1/2(P*/P–) = + 1.37 V and 
+1.57 V for 197a and 197b, respectively). Compounds 197c–d are currently under ongoing 
investigations. 
 
Dye 
labs 
[nm]a 
lem 
[nm]a 
E0,0 
[eV]a 
E1/2(P/P–) 
[V]b 
E1/2(P*/P–) 
[V] 
197a 502 726 2.13 – 0,760 + 1.37 
197b 504 698 2.34 – 0.769 + 1.57 
[a] Measured in MeCN (15 μmolL–1); [b] Measured in 0.1 μmolL–1 n-Bu4NPF6 in degassed, dry MeCN against SCE. 
Table 23: Photophysical properties of 197a–b. 
 
In conclusion, we achieved the synthesis of five new photostable acridinium catalysts with 
carbazole or diphenylamine units to replace the labile dimethyl amino group. The challenging 
issues regarding the routes established to reach symmetric dyes with carbazole units drove 
us to consider asymmetric analogues bearing a methoxy group on one side and a 
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diphenylamine on the other side of the acridinium core. Finally, the photophysical properties 
measured showed an interesting excited state reduction potential for compound 197b with 
potential application in trifluoromethylation reactions. 
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 Application in photoredox catalysis 
 
2.2.3.1 Photoredox deuteration10 
 
Isotopic labelling is a key part of several important aspects in drug discovery. By enabling a 
signaling unit on a molecule without altering its function, this method can play a crucial role 
in the quantification of drug metabolites in ADME (Absorption, Distribution, Metabolism, 
Excretion) studies or in ligand-binding essays.[200,201] Among these isotopes, deuterium-
labeled compounds are commonly used due their availability and low-cost.[202,203] Previously 
synthesized in multi-step procedures, the development of C-H activation promoted their 
single step reaction through a hydrogen isotope exchange (HIE).[204] Taking advantage of the 
photoinduction of a-amino radicals perfected in their group, MacMillan and coworkers 
designed a photoredox catalyzed deuteration and tritiation of pharmaceutically relevant 
scaffolds.[200] Therefore, we decided to use this transformation as a benchmarking reaction 
for our photocatalysts, using clomipramine 198 as a substrate (Table 24). 
An average isotopic incorporation of seven deuterium atoms per molecule with a distribution 
between aliphatic and benzylic positions (C5, C6, C1ʹ, C3ʹ, NMe2) has been reported by 
MacMillan and co-workers using 4CzIPN [2,4,5,6-tetra(9H-carbazol-9-yl)isophthalonitrile] as 
photocatalyst. We thus tested several acridinium photocatalysts, under identical reaction 
conditions. Gratifyingly, a high selectivity for the aliphatic positions (C1ʹ = 20%, C3ʹ = 64%, 
NMe2 = 39%), with an average of four deuterium atoms per molecule was observed when 
using 129a with 1 mol% catalyst loading. A similar pattern was observed when employing 
129b with an even higher selectivity for the C3ʹ position (70%) and an identical average 
incorporation of 4 deuterium atoms per molecule. As the site of the label is crucial in regard 
to the metabolic pathway of the substrate, these results are promising for further 
investigation on other drug-like molecules. 
 
 
10 Together with Christian Fischer. 
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Photocat.a Yieldb 
(%) 
Average 
2H/molecule 
2H Incorporationc (%) 
C5 C6 C1’ C3’ NMe2 
4CzIPN 80 7.1 13 13 47 71 70 
Fukuzumi 95 <1.0 - - - 11 4 
128ad 86 1.0 - - - 25 9 
128bd 88 <1.0 - - - 10 - 
129a  92 4.0 - - 20 64 39 
129ad 92 4.0 - - 20 64 39 
129bd 98 4.0 - - 15 70 39 
144a 96 <1.0 - - 3 19 5 
144b 88 3.0 - - 12 49 30 
144e 76 1.3 - - 6 22 13 
144f 98 <1.0 - - 3 15 7 
144i 97 1.0 - - - 25 8 
200 97 2.2 - - 4 43 21 
 
 
[a] Reaction performed with clomipramine HCl (100 µmol), Li2CO3 (480 µmol), triisopropylsilanethiol (30 mol%), photocat. (2.5 mol%), unless 
stated otherwise, D2O (5.00 mmol) in NMP (1.6 mL) at RT, 24 h irradiation with Kessil A160WE tuna blue; [b] Yield of isolated products;  
[c] Determined by 1H NMR of the free base; [d] Using 1 mol% of photocatalyst. 
Table 24: Photochemical deuteration of Clomipramine. 
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2.2.3.2 Stilbene isomerization 
 
After successful tests on benchmark reactions involving a singlet electron transfer mechanism 
(decarboxylative fluorination, [3+2] cycloaddition, deuteration), we decided to test the 
efficiency of the TTET of our photocatalysts. Therefore, a stilbene isomerization using 
identical conditions described in 2.2.1 for acridinium salts 129a was performed (Table 25). It 
appears that the highly oxidative photocatalysts displaying a CT electronic transition were not 
able to efficiently perform the cis isomerization (Fukuzumi, 144a, 144h). On the contrary, the 
ones with a low excited state reduction potential coupled with a π–π* electronic transition 
gave excellent results (144b, 144d, 144e) the best being acridinium salt 144i with 84% 
conversion to the cis-stilbene.  
 
 
 
Dye cis-stilbene Dye cis-stilbene Dye cis-stilbene 
129a 78% 144e 70% 144j 41% 
144a 16% 144f 36% 144k 45% 
144b 72% 144g 37% 144l 47% 
144c 54% 144h 17% 
Fukuzumi 
catalyst 
18% 
144d 77% 144i 84% 
Dimethyl-
acridinium[188] 
28% 
Table 25: Acridinium Stilbene isomerization. 
  
Photocatalyst* (1mol%)
CD3CN, 2h
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cis-stilbene
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 CONCLUSION AND OUTLOOK 
 
3.1 ROTATIONALLY RESTRICTED SYSTEMS 
 
The stereochemistry of different types of rotationally restricted systems was explored during 
this thesis. From the synthesis of compounds with quaternary stereocenter to macrocycles 
with a stereogenic plane including scaffolds with multi-axis systems, a detailed investigation 
about spatial positioning and molecular arrangement was conducted. 
 
An enantiospecific electrophilic addition involving rotationally restricted enamine 
intermediates was first investigated. The use of ortho-substituted anilines bearing EDG as 
organocatalysts allowed the formation of a-fluorinated and chlorinated compounds. 
Nevertheless, only a low selectivity was achieved (10% ee) in spite of several attempts to 
increase the rotational barrier of the enamine intermediate. Further investigations could 
involve the use of a poly-substituted ketone bearing large functional groups as a substrate to 
increase the steric bulk of the enamine intermediate and therefore improve the selectivity. 
Moreover, a Lewis acid could enhance the reactivity of the ketone to allow the addition of 
the hindered secondary anilines (Scheme 99).  
 
 
 
Scheme 99: Proposal for further investigations. 
 
Progressing towards more complex structures, we tackled next the synthesis and study of 
rotationally restricted multi-axis systems. The preparation of atropisomeric aromatic amides 
with three stereogenic axes was thus successfully achieved, with substantial selectivity for 
the phenanthrene scaffold (cis/trans ratio of 1:3 and e.r. trans = 87:13 and e.r. cis = 75:25). An 
in-depth study of the molecular spatial arrangement of this compound was then conducted 
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to determine the nature of the major isomer and led us to extend the scope. Fine-tuned 
reaction conditions allowed the synthesis of a more dynamic naphthalene system that 
substantiated the hypothesis of a free rotation about the Ar-N bond as opposed to a 
rotational hindrance about the Ar-CO and N-CO bonds. Further research involving the 
synthesis of a derivative with a bulkier substituent than the methyl group on the nitrogen (i-
Pr with an alternative route or t-Bu) could be explored in order to lock the configuration about 
the Ar-N bond and generate a third pair of enantiomers. 
 
Finally, we explored compounds displaying a stereogenic plane with the synthesis of 
paracyclophanes. The de novo construction of a functionalized naphthalene core combined 
to an alkyl chain with fifteen methylene units was therefore obtained and revealed interesting 
stereolabile properties. Although synthetic issues prevented the completion of the substrate 
synthesis and thus the enantioselective arene forming aldol condensation step, an alternative 
to the Sonogashira cross-coupling could be envisaged. A Seyferth-Gilbert homologation using 
Ohira-Bestmann reagent followed by a lithiation and ring opening of an oxirane, would 
represent an interesting option for the synthesis of the corresponding alkyne (Scheme 100).  
 
 
 
Scheme 100: Potential Seyferth-Gilbert reaction to complete the substrate synthesis. 
  
[CH2]15
CHO
CHO
[CH2]15
OH
Me
O
P
N
N
O
OMe
OMe
K2CO3, MeOH, 0 °C
1)
2) n-BuLi, oxirane,
THF/n-hexane,
 – 78 °C to RT
[CH2]15
CHO
OH
SYNTHESIS	OF	ACRIDINIUM	SALTS	AND	APPLICATION	IN	ORGANOPHOTOCATALYSIS	
	 123	
3.2 SYNTHESIS OF ACRIDINIUM SALTS AND APPLICATION IN 
ORGANOPHOTOCATALYSIS 
 
Efficient synthetic strategies to access a variety of acridinium salts with suitable photophysical 
properties were described. The direct transformation of esters into acridinium catalysts using 
1,5-bifunctional organomagnesium reagents allowed the synthesis of photocatalysts with 
unsubstituted cores displaying high oxidative properties. A fine-tuning of reaction conditions 
and purification protocols allowed the large-scale synthesis of amino functionalized 
photocatalysts with attenuated photoredox features.  
 
An extensive study of a divergent organophotocatalytic reaction pathway disclosed 
interesting photophysical and photochemical properties of amino acridinium catalysts. These 
findings guided a modular synthesis of organophotocatalysts with an extended range of 
excited state reduction potential, complementing the polypyridyl transition metal complexes. 
Using a combination of halogen-metal exchange with directed ortho-metalation, twelve new 
acridinium salts with various energetic electronic transitions and flexible triplet energies were 
obtained, some of them in gram-scale. 
 
In order to improve the photostability, the design of a new generation of catalysts was then 
examined. Replacing the labile dimethyl amino group, five new photostable acridinium 
catalysts with carbazole or diphenylamine units combined with methoxy groups were 
prepared. An early analysis of the photophysical properties showed an interesting excited 
state reduction potential with potential application in trifluoromethylation reactions. 
 
Finally, the utility of the catalysts was demonstrated by the deuteration of clomipramine, 
providing high selectivity for aliphatic positions and reaching an average of 4 deuterium 
atoms per molecule using low catalyst loadings. A stilbene isomerization study allowed to test 
the efficiency of the triplet excited state of the acridinium photocatalysts with up to 84% 
conversion to the cis-stilbene. 
 
Some of these catalysts are part of a patent licensed by Solvias and will be soon commercially 
available.  
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 EXPERIMENTAL SECTION 
 
4.1 GENERAL INFORMATION 
 
All reactions were carried out in dried glassware under an Ar atmosphere. All chemicals were 
reagent grade and used as supplied unless stated otherwise. (S)-2-fluoro-3-phenylpropan-1-
ol (2),[154] (S)-2-fluoro-3-phenylpropyl acetate (3), [154] N-benzyl-4-chloro-2,5-
dimethoxyaniline (61),[205] N-benzyl-2-(tert-butyl)aniline (62),[205] N-benzyl-[1,1'-biphenyl]-2-
amine (63),[205] N-benzyl-2-ethoxyaniline (64),[205] N-benzyl-2-isopropylaniline (65),[205] N-
benzyl-2-methylaniline (66),[205] N-benzyl-2-methoxyaniline (67),[205] N-benzyl-2-chloroaniline 
(68),[205] N-benzyl-2-(piperidin-1-yl)aniline (69),[205] tert-butyl (S)-(2-hydroxy-1-
phenylethyl)carbamate (81a),[206] tert-butyl (S)-(1-hydroxy-3-phenylpropan-2-yl)carbamate 
(81b),[206] 2-(tert-butyl)-N-methylaniline (92a),[163] N-methyl-[1,1'-biphenyl]-2-amine 
(92b),[163] 2-(tert-butyl)-N-isopropylaniline (102),[207] 2-methylbut-1-en-3-yne (110),[167] 3,16-
dimethyleneoctadeca-1,17-diyne (112),[167] 2-methylene-1(1,4)-
benzenacyclohexadecaphane (113),[167] 1(1,4)-benzenacyclohexadecaphan-2-one (114),[167] 
1(1,4)-benzenacyclohexadecaphane (108),[167,169] bis(2-bromophenyl)amine (126),[208] 2-
bromo-5-methoxyphenyl trifluoromethanesulfonate (168),[209,210] 2-bromo-5-methoxyphenol 
(173),[209] dibenzo[b,d]iodol-5-ium trifluoromethanesulfonate (176)[198] were prepared 
according to a literature known procedure. Ozone was generated with an ozone generator 
BMT 802 N from BMT Messtechnik GmBH and oxygen from Pangas (quality = 5.0). n-BuLi 
solution in hexane was purchased from Acros Organics (Nr. 181271) and the concentration 
was determined by titration with 1,10-phenanthroline in THF against s-BuOH according to 
Eastham and Watson.[211] Magnesium chips, 4-30 mesh, were purchased from Aldrich (Nr. 
254118) and were cut freshly followed by heating with a heat gun under vacuum (10–2 mbar) 
directly in the reaction flask prior to use. All photoreactions were performed in a sealed 
Biotage® 2-5 mL microwave vial equipped with a 10 mm x 5 mm magnetic stir bar stirring at 
1400 rpm. The vial was placed on a stirring plate laterally in 3 cm distance to a Kessil LED 
A160WE Tuna Blue, 40 W, adjusted to maximum intensity and white (lmax: 464 nm). A 
sideward fan was used to keep ambient temperature (~30 °C). All starting materials and 
reaction solvents were purchased from commercial sources and used without further 
purification. Solvents for extractions and column chromatography were technical grade and 
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distilled prior to use. Analytical thin layer column chromatography (TLC) was performed on 
pre-coated Merck silica gel 60 F254 plates (0.25 mm) and visualized by UV and VIS. Flash 
column chromatography was carried out on Silicycle SiliaFlash P60 (230–400 mesh). 
Concentration in vacuo was performed by rotary evaporation to ~ 10 mbar at 40 °C and drying 
at high vacuum at 10-2 mbar and RT. 1H NMR, 13C NMR and 19F spectra were recorded on a 
Bruker Avance III 500 MHz and Avance III 400 MHz spectrometer at 298 K in CDCl3, CD3OD or 
C6D6 supplied by Cambridge Isotope Laboratories. Chemical shifts (δ) are reported in ppm 
relative to tetramethylsilane (0.00 ppm). The multiplicities are reported in Hz as: s = singlet, 
br = broad singlet, d = doublet, t = triplet, q = quartet and m = multiplet. Melting points were 
measured on a Büchi M-565 melting point apparatus and are uncorrected. IR spectra were 
measured on a ATR Varian Scimitar 800 FT-IR spectrometer and reported in cm–1. The 
intensities of the bands are reported as: w = weak, m = medium, s = strong. High-resolution 
mass spectrometry (HR-ESI) was performed by Dr. Michael Pfeffer of the University of Basel 
on a Bruker maXis 4G QTOF ESI mass spectrometer. X-ray crystallographic analysis was 
performed by Dr. Alessandro Prescimone of the University of Basel. Cyclic Voltammetry was 
performed in dry, degassed 0.1 molL–1 tetra n-butylammonium hexafluorophosphate in 
MeCN. Voltammograms were recorded with a Versastat3-200 potentiostat from Princeton 
Applied Research employing a glassy carbon disk working electrode, SCE reference electrode 
and a silver wire counter electrode and a potential sweep rate of 0.1 Vs–1. The glassy carbon 
electrode and Ag wire were polished prior to measurement. UV/Vis spectroscopy was 
performed on a Shimadzu UV-1650 PC spectrometer and steady-state luminescence 
spectroscopy was performed on a Fluorolog-3-22 instrument from Horiba Jobin-Yvon. 
Excitation occurred at the long-wavelength absorption band of the respective dye. All 
emission spectra were recorded in argon-saturated acetonitrile, and strongly diluted dye 
solutions (c < 15 μmol L–1) were used to avoid inner filter effects. All spectra so obtained 
were corrected for the wavelength-dependent sensitivity of the spectrometer. Additional 
emission spectra of the pure solvent at all excitation and detection conditions were measured 
to ensure the absence of stray light or impurity signals. Fluorescent lifetime (tS) of a 
~15μmolL– 1 solution was measured using a Hamamatsu Compact Fluorescence Lifetime 
Spectrometer C11367 Quantaurus- Tau using an LED light source with excitation wavelength 
of 470 nm with a peak count of up to 10000 and repetition rate of 5 MHz. The fluorescence 
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decay was satisfactorily fit to a first order rate equation. All Data was handled with Igor Pro 
(Wavemetrics, Lake Oswego, OR, USA) and Origin (OriginLab, Northampton, MA). 
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4.2 EXPERIMENTAL PROCEDURES 
 
 Rotationally restricted systems 
 
Enantiospecific electrophilic substitution through atropisomeric enamines 
 
Methyl (R)-2-chloro-2-fluoro-3-phenylpropanoate (25) 
 
To a solution of (2S)-fluoro-3-phenyl-propan-1-ol (38.5 mg, 0.25 mmol) in CH3CN (2 mL) was 
added IBX (105 mg, 0.38 mmol) and the reaction mixture was stirred at reflux for 2h. The IBX 
was filtered off and the solvent evaporated in vacuo. The residue was dissolved in CDCl3  
(2 mL) and cooled down to 0 °C before adding the aniline (10 mol%) and NCS  
(43.4 mg, 0.33 mmol). The reaction was allowed to warm up to RT and stirred for 24 h. The 
solution was diluted in THF/t-BuOH (1:1, 15 mL) and 2-methyl-2-butene was added. In 
another flask, NaClO2 (45.2 mg, 0.50mmol) and NaH4PO5 (138 mg, 1.00 mmol) were dissolved 
in water (3 mL) before the solution previously prepared was added over 2 min. The biphasic 
reaction mixture was stirred vigorously for 2 h at RT. HCl 1M solution (20 mL) was added and 
the aqueous layer was extracted with Et2O (3 x 20 mL). The combined organic layer was 
extracted with NaOH 1M solution (5 x 12 mL) then acidified with conc. HCl. The aqueous layer 
was extracted with CH2Cl2 (5 x 12 mL), dried over Na2SO4 and the solvent was removed in 
vacuo. The residue was dissolved in MeOH (1 mL) and thionyl chloride (0.02 mL, 0.25 mmol) 
was added at 0 °C. The reaction mixture was stirred for 12 h at RT. The solvent was removed 
in vacuo and the crude was purified by column chromatography (Toluene 100%) to afford 25 
as a colorless oil; yield: 0.8 mg (1.5% over three steps). This compound could not be scaled up 
to measure additional analytical data. 
1H NMR (400 MHz, CDCl3): d = 7.24 (m, 3H, CHar), 7.19 (m, 2H, CHar), 3.75 [s, 3 H, (CH3)], 3.57 
(d, 1H, CHaliphatic), 3.51 (d, 1H, CHaliphatic) . 
19F NMR (471 MHz, CDCl3): d = – 116,79 (s, 1F, CF).  
  
5'
2' 3 1
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O
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N-Benzyl-2-(diphenyl((trimethylsilyl)oxy)methyl)aniline (79) 
 
Prepared according to a modified literature procedure.[212]  
To a solution of methyl-anthranilate (806 mg, 5.33 mmol) and zinc chloride (872 mg, 6.4 
mmol) in MeOH (17 mL) under argon was added benzaldehyde (0.65 mL, 6.4 mmol). The 
reaction mixture was cooled down to 0 °C and sodium cyanoborohydride (402 mg, 6.4 mmol) 
was added. The reaction mixture was stirred at reflux for 2 h. A solution of NaOH 1M (17 mL) 
was added and the aqueous layer was extracted with Et2O (3 x 50 mL). The combined organic 
layer was washed with brine (50 mL), dried over Na2SO4 and the solvent was removed in 
vacuo. The crude was used without further purification in the next step.  
 
Prepared according to a modified literature procedure.[213] 
Under argon, methyl 2-(benzylamino)benzoate (531 mg, 2.20 mmol) was dissolved in dry THF 
(5 mL) and cooled to 0 °C. PhMgBr (8.00 mL, 8.00 mmol) was added dropwise over 30 min. 
The reaction mixture was stirred overnight at RT. A sat. aqueous solution of NH4Cl (5 mL) was 
added and the aqueous layer was extracted with CH2Cl2 (3 x 15 mL). The combined organic 
layer was washed with brine (10 mL), dried over Na2SO4 and the solvent was removed in 
vacuo. The residue was dissolved in CH2Cl2 (3 mL) at 0 °C and NEt3 (0.40 mL, 2.86 mmol) as 
long as TMSOTf (0.52 mL, 2.86 mmol) were added dropwise. The reaction mixture was stirred 
1 h at 0 °C the allowed to warm up to RT and stirred overnight. A sat. aqueous solution of 
NH4Cl (10 mL) was added and the aqueous layer was extracted with CH2Cl2 (3 x 20 mL). The 
combined organic layer was washed with brine (15 mL), dried over Na2SO4 and the solvent 
was removed in vacuo. The crude mixture was purified by column chromatography (Pentane/ 
CH2Cl2 5:1) to afford 79 as a white solid; yield: 193 mg (22%); m.p. 67.0–83.3 °C; Rf = 0.27 
(pentane/CH2Cl2 1:1). 
IR (ATR, neat): 3444m, 3022w, 2954w, 2364w, 1600m, 1514m, 1450m, 1323m, 1250s, 1160m, 
1051s, 876m, 837s, 746s, 710s, 633m cm–1. 
1H NMR (500 MHz, CDCl3): d = 7.49–7.40 (m, 10 H, CHar), 7.34–7.33 (m, 3 H, CHar), 7.27 (td, 3J 
= 7.8 Hz, 4J = 1.5 Hz 1 H, C5H), 7.10 (dd, 3J = 8.2 Hz, 4J = 1.6 Hz 1 H 1 H, C3H), 6.70–6.67 (m, 2 
4
2
NH OTMS
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H, C4H, C6H), 5.61 (t, 3J = 5.60 Hz, 1 H, NH), 4.29 (d, 3J = 5.60 Hz, 2 H, CH2), 0.00 [s, 9 H, 3 x 
(CH3)]. 
13C NMR (125 MHz, CDCl3): d = 145.5 (C1), 144.0 (CarN), 137.61 (Car), 128.5 (C3), 127.1 (C2), 
127.0 (C5), 126.4 (Car), 125.8 (Car), 125.5 (Car), 125.2 (Car), 125.0 (Car), 112.8 (C4), 109.5 (C6), 
84.9 (CO), 45.8 (CH2), 0.0 (CH3). 
HRMS (ESI): m/z [M + Na+] calcd. for C29H32NOSi+: 438.2244; found: 438.2248. 
 
Atropisomeric Secondary Amides 
 
1-(2-((2-(Tert-butyl)phenyl)amino)-2-oxoacetyl)naphthalen-2-yl 
trifluoromethanesulfonate (89) 
 
To a mixture of naphtho[2,1-b]furan-1,2-dione[52] (1.00 g, 5.05 mmol) in toluene (25 mL) was 
added 2-t-Bu-aniline (0.94 mL, 6.03 mmol) and the reaction mixture was stirred for 5 h at 
50 °C. The solvent was removed in vacuo and the residue was dissolved in CH2Cl2 (12 mL). 
Et3N (0.752 mL, 5.35 mmol) and Tf2O (0.888 mL, 5.32 mmol) were added at 0 °C. The reaction 
mixture was stirred for 30 min at RT and sat. aqueous solution of NH4Cl (10 mL) was added. 
The aqueous layer was extracted with CH2Cl2 (3 x 25 mL), the combined organic layer was 
washed with brine (25 mL), dried over Na2SO4 and the solvent was removed in vacuo. The 
crude was purified by column chromatography (pentane/CH2Cl2 9:1 to 1:1) to afford 89 as a 
yellow solid; yield: 2.08 g (86%); m.p. 64.3–66.5 °C; Rf = 0.36 (pentane/CH2Cl2 1:1). 
IR (ATR, neat): 3407m, 2976m, 2360s, 1693w, 1415w, 1210w, 1136w, 937w, 816w, 752w, 
690m, 630m cm–1. 
1H NMR (500 MHz, CDCl3): d = 9.23 (bs, 1 H, NH), 8.12 (d, 3J = 9.4 Hz, 1 H, C3H), 8.10 (dd, 3J = 
7.8 Hz, 4J = 1.5 Hz, 1 H, C6”H), 7.97 (m, 1 H, C8H), 7.83 (m, 1 H, C5H), 7.64 (m, 2 H, C6H, C7H), 
7.52 (d, 3J = 9.4 Hz, 1 H, C4H), 7.47 (dd, 3J = 7.8 Hz, 4J = 1.5 Hz, 1 H, C3”H), 7.29 (td, 3J = 7.8 Hz, 
4J = 1.5 Hz, 1 H, C5”H), 7.21 (td, 3J = 7.8 Hz, 4J = 1.5 Hz, 1 H, C4”H), 1.57 [s, 9 H, 3 x (CH3)]. 
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13C NMR (125 MHz, CDCl3): d = 192.0 (C1’), 156.7 (C2’), 145.0 (C2), 141.0 (C2”), 134.1 (C1”), 
134.0 (C3), 132.5 (C8a), 131.4 (C4a), 129.1 (C6), 128.8 (C8), 127.8 (C7), 127.1 (C5”), 126.8 
(C3”), 126.3 (C4”), 125.0 (C5), 125.5 (C1), 124.3 (C6”), 118.9 (C4), 34.5 [C(CH3)3], 30.8 (CH3). 
HRMS (ESI): m/z [M + Na+] calcd. for C23H20F3NNaO5S+: 502.0906; found: 502.0913. 
 
N-(2-(Tert-butyl)phenyl)-2-(2-(4-hydroxybut-1-yn-1-yl)naphthalen-1-yl)-2-oxoacetamide 
(85) 
 
To a solution of 89 (801 mg, 1.67 mmol) in DMF (7 mL) was added iPr2NH (0.707 mL, 5 mmol), 
Pd(PPh3)4 (19.6 mg, 17.0 µmol), CuI (3.24 mg, 17.0 µmol) and finally 3-butyn-1-ol (378 µL, 5.00 
mmol). The reaction mixture was heated for 2 h at 80 °C then the solvent was removed in 
vacuo. The residue dissolved in EtOAc (10 mL) was filtered through Celite and washed with 
more EtOAc (60 mL). The solvent was then removed in vacuo. The residue was purified by 
flash column chromatography (CH2Cl2 100% to CH2Cl2/EtOAc 9:1) to obtain 85 as a light 
orange solid; yield: 290 mg (44%); m.p. 123.7–125 °C; Rf = 0.15 (CH2Cl2 100%).  
IR (ATR, neat): 3735w, 3505w, 3393w, 2969w, 2361s, 1686s, 1581m, 1527s, 1447w, 1374w, 
1228m, 1170w, 1098w, 1044m, 950w, 883w, 826m, 826m, 762s, 679m cm–1. 
1H NMR (500 MHz, CDCl3): d = 9.32 (bs, 1 H, NH), 8.21 (dd, 3J = 8.0 Hz, 4J = 1.3 Hz, 1 H, C6”H), 
7.92 (d, 3J = 8.2 Hz, 1 H, C4H), 7.88 (m, 1 H, C8H), 7.73 (m, 1 H, C5H), 7.54 (m, 3 H, C3H, C7H, 
C8H), 7.46 (dd, 3J = 8.0 Hz, 4J = 1.3 Hz, 1 H, C3”H), 7.28 (td, 3J = 8.0 Hz, 4J = 1.3 Hz, 1 H, C5”H), 
7.18 (td, 3J = 8.0 Hz, 4J = 1.3 Hz, 1 H, C4”H), 3.65 (t, 3J = 6.4 Hz, 2 H, C4”’H), 2.59 (t, 3J = 6.4 Hz, 
2 H, C3”’H), 1.56 [s, 9 H, 3 x (CH3)]. 
13C NMR (125 MHz, CDCl3): d = 195.0 (C1’), 157.0 (C2’), 140.1 (C2”), 136.0 (C8a), 134.5 (C1”), 
132.7 (C1), 131.0 (C4), 130.3 (C4a), 128.5 (C6), 128.4 (C8), 128.3 (C7), 127.9 (C3), 127.1 (C5”), 
126.7 (C3”), 125.9 (C4”), 124.4 (C5), 123.4 (C6”), 120.6 (C2), 94.7 (C2”’), 80.6 (C1”’), 61.0 
(C4”’), 34.9 [C(CH3)3], 30.8 (CH3), 24.3 (C3”’). 
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HRMS (ESI): m/z [M + Na+] calcd. for C26H25NNaO3+: 422.1727; found: 422.1723. 
 
1-(2-((2-(Tert-butyl)phenyl)(methyl)amino)-2-oxoacetyl)naphthalen-2-yl 
trifluoromethanesulfonate (93a) 
 
 
To a mixture of naphtho[2,1-b]furan-1,2-dione[52] (2.00 g, 10.1 mmol) in toluene (50 mL) was 
added 2-t-Bu-N-methylaniline (1.96 g, 12.0 mmol) and the reaction mixture was stirred for 
10 h at 50 °C. The solvent was removed in vacuo and the residue was dissolved in CH2Cl2 (25 
mL), Et3N (1.50 mL, 10.7 mmol) and Tf2O (1.80 mL, 10.7 mmol) were added at 0 °C. The 
reaction mixture was stirred for 30 min at RT and sat. aqueous solution of NH4Cl (20 mL) was 
added. The aqueous layer was extracted with CH2Cl2 (3 x 50 mL), the combined organic layer 
was washed with brine (50 mL), dried over Na2SO4 and the solvent was removed in vacuo. 
The crude was purified by column chromatography (pentane/CH2Cl2 9:1 to 1:1) to afford 94a 
as a yellow solid; yield: 1.84 g (74%); m.p. 94.3–97.5 °C; Rf = 0.26 and 0.44 (pentane/CH2Cl2 
3:2) for the cis and trans diastereoisomer, respectively. 
IR (ATR, neat): 3735w, 3482w, 2973w, 2362s, 1650s, 1558w, 1511w, 1420m, 1197m, 1075m, 
956m, 863m, 777m, 650m cm–1. 
1H NMR (500 MHz, CDCl3): d = 8.15–6.87 (m, CHar, cis/trans 1:2), 3.64–3.33 (s, NCH3, cis/trans 
1:2), 1.44–1.42 [s, 3 x (CH3), cis/trans 1:2]. 
HRMS (ESI): m/z [M + Na+] calcd. for C24H22F3NNaO5S+: 516.1063; found: 516.1067. 
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1-(2-([1,1'-Biphenyl]-2-yl(methyl)amino)-2-oxoacetyl)naphthalen-2-yl 
trifluoromethanesulfonate (93b) 
 
 
To a mixture of naphtho[2,1-b]furan-1,2-dione[52] (1.01 g, 5.05 mmol) in toluene (25 mL) was 
added 2-t-Bu-N-methylaniline (1.10 g, 6.0 mmol) and the reaction mixture was stirred for 10 h 
at 50 °C. The solvent was removed in vacuo and the residue was dissolved in CH2Cl2 (12 mL). 
Et3N (0.72 mL, 5.09 mmol) and Tf2O (0.86 mL, 5.09 mmol) were added at 0 °C. The reaction 
mixture was stirred for 30 min at RT and sat. aqueous solution of NH4Cl (10 mL) was added. 
The aqueous layer was extracted with CH2Cl2 (3 x 25 mL), the combined organic layer was 
washed with brine (25 mL), dried over Na2SO4 and the solvent was removed in vacuo. The 
crude was purified by column chromatography (pentane/CH2Cl2 1:1 to 1:2) to afford 93b as a 
beige solid; yield: 1.56 g (60%); Rf = 0.31 and 0.67 (pentane/CH2Cl2 3:7) for the cis and trans 
diastereoisomer, respectively. 
1H NMR (500 MHz, CDCl3): d = 8.07–7.22 (m, CHar, cis/trans 1:3), 3.32–2.98 (s, NCH3, cis/trans 
1:3). 
 
N-(2-(Tert-butyl)phenyl)-2-(2-(4-hydroxybut-1-yn-1-yl)naphthalen-1-yl)-N-methyl-2-
oxoacetamide (94a) 
 
To a solution of 93a (1.00 g, 2.77 mmol) in DMF (10 mL) was added iPr2NH (1.20 mL, 8.39 
mmol), Pd(PPh3)4 (32.0 mg, 27.7 µmol), CuI (5.28 mg, 27.7 µmol) and finally 3-butyn-1-ol (635 
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µL, 8.39 mmol). The reaction mixture was heated for 2 h at 80 °C then the solvent was 
removed in vacuo. The residue dissolved in EtOAc (10 mL) was filtered through Celite and 
washed with more EtOAc (60 mL). The solvent was then removed in vacuo. The residue was 
purified by flash column chromatography (CH2Cl2 100% to CH2Cl2/EtOAc 9:1) to obtain 94a as 
a light orange solid; yield: 910 mg (79%); m.p. 60.4–63.7 °C; Rf = 0.05 and 0.15 (CH2Cl2 100%) 
for the cis and trans diastereoisomer, respectively.  
IR (ATR, neat): 3735w, 3505w, 3393w, 2969w, 2361s, 1686s, 1581m, 1527s, 1447w, 1374w, 
1228m, 1170w, 1098w, 1044m, 950w, 883w, 826m, 826m, 762w, 679m cm–1. 
1H NMR (500 MHz, CDCl3): d = 8.14–6.44 (m, CHar, cis/trans 1:5), 3.97–3.79 (m, C4”’H, cis/trans 
1:5), 3.47–3.35 (s, NCH3, cis/trans 1:5), 2.85–2.74 (m, C3”’H, cis/trans 1:5), 1.44–1.35 [s, 3 x 
(CH3), cis/trans 1:5].  
HRMS (ESI): m/z [M + Na+] calcd. for C27H27NNaO3+: 436.1883; found: 436.1896. 
 
 N-([1,1'-Biphenyl]-2-yl)-2-(2-(4-hydroxybut-1-yn-1-yl)naphthalen-1-yl)-N-methyl-2-
oxoacetamide (94b) 
 
To a solution of 93b (1.27 g, 2.00 mmol) in DMF (7 mL) was added iPr2NH (0.86 mL, 6.06 
mmol), Pd(PPh3)4 (23.1 mg, 20.0 µmol), CuI (3.81 mg, 20.0 µmol) and finally 3-butyn-1-ol (460 
µL, 6.06 mmol). The reaction mixture was heated for 2 h at 80 °C then the solvent was 
removed in vacuo. The residue dissolved in EtOAc (6 mL) was filtered through Celite and 
washed with more EtOAc (50 mL). The solvent was then removed in vacuo. The residue was 
purified by flash column chromatography (CH2Cl2/EtOAc 9:1) to obtain 94b as a beige solid; 
yield: 594 mg (69%); Rf = 0.5 (CH2Cl2/EtOAc 4:1).  
1H NMR (500 MHz, CDCl3): d = 8.06–6.92 (m, CHar, cis/trans 1:6), 4.13–3.86 (m, C4”’H, cis/trans 
1:6), 3.07–3.05 (s, NCH3, cis/trans 1:6), 3.33–2.76 (m, C3”’H, cis/trans 1:6). 
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N-(2-(Tert-butyl)phenyl)-3-(hydroxymethyl)-N-methylphenanthrene-4-carboxamide (96) 
 
To a solution of the 95a (440 mg, 1.06 mmol) in pyridine (20 ml) was added palladium 
activated on charcoal (56.4 mg, 5.00 mol%). The flask was evacuated and H2 was introduced 
in five cycles. The reaction mixture was stirred for 5 h under H2 atmosphere then filtered 
through a plug of Celite and washed with Et2O (20 mL). The solution was further washed with 
citric acid 1M (3 x 10 mL) and the solvent was removed in vacuo. A portion of the residue (166 
mg, 0.40 mmol) was dissolved in CDCl3 (4.4 mL) and DMP was added (256 mg, 0.60 mmol). 
The reaction mixture was placed into an ultrasonic bath for 1 min then stirred at RT for 30 min. 
CDCl3 (4 mL) was added along with KHCO3 (604 mg, 6.03 mmol) and (S)-5-(2-Pyrrolidinyl)-1H-
tetrazole (1.85 mg, 5 mol%). The flask was placed into an ultrasonic bath for 1 min and the 
reaction was stirred at RT overnight. EtOH (9 mL) and NaBH4 (150 mg, 3.96 mmol) were added 
at RT and the mixture was stirred for 15 min. Sat aqueous solution of Rochelle salt (9 mL) was 
added. The organic layer was washed with brine (10 mL), dried over Na2SO4 and the solvent 
was removed in vacuo. The residue was purified by flash column chromatography (CH2Cl2 
100% to CH2Cl2/EtOAc 4:1) to obtain trans-96 as a transparent oil; yield: 51.0 mg (33%);  
Rf = 0.68 (CH2Cl2/EtOAc 4:1).  
IR (ATR, neat): 3410s, 3056w, 2924m, 1736m, 1620s, 1470m, 1364m, 1243m, 1172w, 1046m, 
846s, 753s, 670m, 634m cm–1. 
1H NMR (600 MHz, C6D6): d = 9.25 (d, 3J = 8.2 Hz, 1 H, C5H), 7.60 (d, 3J = 8.2 Hz, 1 H, C8H), 7.57 
(m, 2 H, C2H, C6’H), 7.49 (dd, 3J = 8.0 Hz, 4J = 1.3 Hz, 1 H, C3H), 7.42 (d, 3J = 8.5 Hz, 1 H, C9H), 
7.39–7.36 (m, 3 H, C6H, C10H, C3’H), 7.32 (t, 1 H, 3J = 8.2 Hz, C7H), 7.16 (td, 3J = 7.3 Hz, 4J = 
1.6 Hz, 1 H, C5’H), 7.10 (m, 1 H, C4’H), 5.43 (d, 2J = 13 Hz, 1 H, CHal), 4.75 (d, 2J = 13 Hz, 1 H, 
CHal), 3.86 (bs, 1H, OH), 1.92 (s, 3 H, NCH3), 1.38 [s, 9 H, 3 x (CH3)]. 
13C NMR (125 MHz, C6D6): d = 176.6 (CO), 149.9 (C2’), 145.3 (C1’), 141.9 (C1), 135.7 (C8a), 
134.7 (C4), 134.5 (C10a), 132.7 (C4b), 132.2 (C3), 131.2 (C3’), 131.1 (C6’), 131.0 (C8), 131.0 
(C2), 130.5 (C4a), 130.6 (C4’), 130.4 (C5), 129.8 (C9, C7, C5’), 129.7 (C10), 129.3 (C6), 66.7 
(CH2), 43.8 (NCH3), 38.2 (C(CH3)3), 34.0 (CH3). 
HRMS (ESI): m/z [M + Na+] calcd. for C27H27NNaO2+: 420.1934; found: 420.1936. 
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 2-(2-((2-(Tert-butyl)phenyl)(methyl)amino)-2-oxoacetyl)phenyl 
trifluoromethanesulfonate (98) 
 
To a mixture of coumarandione (1.48 g, 10.0 mmol) in toluene (50 mL) was added 2-t-Bu-N-
methylaniline 87 (1.96 mL, 12.0 mmol) and the reaction mixture was stirred for 16 h at 50 °C. 
The solvent was removed in vacuo and the residue was dissolved in CH2Cl2 (25 mL). Et3N (1.50 
mL, 10.7 mmol) and Tf2O (2.69 mL, 16.0 mmol) were added at 0 °C. The reaction mixture was 
stirred for 1 h at RT and sat. aqueous solution of NH4Cl (20 mL) was added. The aqueous layer 
was extracted with CH2Cl2 (3 x 50 mL), the combined organic layer was washed with brine 
(50 mL), dried over Na2SO4 and the solvent was removed in vacuo. The crude was purified by 
column chromatography (pentane/CH2Cl2 1:1) to afford 98 as a yellow solid; yield: 2.33 g 
(53%); m.p. 106.8–108.3 °C; Rf = 0.32 and 0.47 (pentane/CH2Cl2 3:2) for the cis and trans 
diastereoisomer, respectively. 
IR (ATR, neat): 3734w, 2964w, 2361s, 1893m, 1651s, 1604m, 1489m, 1425s, 1212w, 1139m, 
1049m, 893s, 776s, 651m cm–1. 
1H NMR (500 MHz, CDCl3): d = 8.08–6.79 (m, CHar, cis/trans 1:2), 3.38–3.35 (s, NCH3, cis/trans 
1:2), 1.46–1.44 [s, 3 x (CH3), cis/trans 1:2]. 
HRMS (ESI): m/z [M + Na+] calcd. for C20H20F3NNaO5S+: 466.0906; found: 466.0901. 
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N-(2-(Tert-butyl)phenyl)-2-(2-(4-hydroxybut-1-yn-1-yl)phenyl)-N-methyl-2-oxoacetamide 
(99) 
 
 
To a solution of 98 (2.22 g, 5.00 mmol) in THF (25 mL) was added NEt3 (5.00 mL, 35.6 mmol), 
Pd(PPh3)2Cl2 (351 mg, 0.5 mmol), CuI (286 mg, 27.7 µmol), TBAI (3.69 g, 10.0 mmol) and finally 
3-butyn-1-ol (1.14 mL, 15 mmol). The reaction mixture was heated for 5 h at 80 °C then the 
solvent was removed in vacuo. The residue dissolved in EtOAc (25 mL) was filtered through 
Celite and washed with more EtOAc (200 mL). The solvent was then removed in vacuo. The 
residue was purified by flash column chromatography (CH2Cl2 100% to CH2Cl2/EtOAc 9:1) to 
obtain 99 as a light orange solid; yield: 910 mg (79%); m.p. 71.5–74.9 °C; Rf = 0.46 and 0.56 
(CH2Cl2/EtOAc 9:1) for the cis and trans diastereoisomer, respectively.  
IR (ATR, neat): 3733w, 3629w, 3442w, 3361w, 2361s, 1733w, 1649m, 1559s, 1488w, 1390w, 
1267w, 1153w, 1115w, 1051w, 957w, 917w, 847w, 757m, 645m cm–1. 
1H NMR (500 MHz, CDCl3): d = 7.97–6.83 (m, CHar, cis/trans 1:5), 3.85–3.78 (m, C4”’H, cis/trans 
1:5), 3.37–3.26 (s, NCH3, cis/trans 1:5), 2.74–2.66 (m, C3”’H, cis/trans 1:5), 1.45–1.42 [s, 3 x 
(CH3), cis/trans 1:5].  
HRMS (ESI): m/z [M + Na+] calcd. for C23H25NNaO3+: 386.1727; found: 386.1725. 
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N-(2-(Tert-butyl)phenyl)-2-(hydroxymethyl)-N-methyl-1-naphthamide (101) 
 
To a solution of 99 (109 mg, 0.30 mmol) in EtOH (1 ml) was added ethylenediamine (1.05 
mmol, 0.07 mL). In a separate flask Ni(OAc)2•4H2O (74.7 mg, 0.30 mmol) was dissolved in 
EtOH (0.5 mL) and was treated with a solution of NaBH4 (11.3 mg, 0.30 mmol) in EtOH (0.3 
mL) over 5 min at RT. The solution was stirred for 1 h at RT under an atmosphere of H2. The 
resulting mixture was combined with the previously prepared solution of the alkyne and the 
reaction mixture was vigorously stirred at RT under an atmosphere of H2 for 20 h. A sat. 
aqueous solution of NH4Cl (2 mL) was added and the aqueous layer was extracted with Et2O 
(3 x 5 mL). The combined organic layer was dried over Na2SO4 and evaporated in vacuo. The 
residue was dissolved in Et2O (5 mL) and filtered through a plug of Celite to remove the resin. 
The solvent was removed in vacuo. The residue was dissolved in CDCl3 (3 mL) and DMP was 
added (192 mg, 0.45 mmol). The reaction mixture was placed into an ultrasonic bath for 1 min 
then stirred at RT for 72 h. CDCl3 (3 mL) was added along with KHCO3 (453 mg, 4.52 mmol) 
and (S)-5-(2-Pyrrolidinyl)-1H-tetrazole (2.09 mg, 15 mol%). The flask was placed into an 
ultrasonic bath for 1 min and the reaction was stirred at RT for 5 h. EtOH (6 mL) and NaBH4 
(113 mg, 3.00 mmol) were added at RT and the mixture was stirred for 1 h. Sat aqueous 
solution of Rochelle salt (6 mL) was added. The organic layer was washed with brine (10 mL), 
dried over Na2SO4 and the solvent was removed in vacuo. The residue was purified by flash 
column chromatography (CH2Cl2 100% to CH2Cl2/EtOAc 4:1) to obtain 101 as a transparent 
oil; yield: 12.0 mg (12%); Rf = 0.27 and 0.42 (CH2Cl2/EtOAc 4:1) for respectively the cis and 
trans diastereoisomer. 
IR (ATR, neat): 3404s, 2923m, 2362w, 1626s, 1471m, 1360m, 1263w, 1178s, 1107m, 1074m, 
1033m, 821m, 753s, 694m, 640m cm–1. 
1H NMR (600 MHz, C6D6): d = 8.53–7.23 (m, CHar, cis/trans 2:3), 5.14–4.85 (m, CHal, cis/trans 
2:3), 2.61 (s, NCH3, cis/trans 2:3), 1.62–1.54 [s, 3 x (CH3), cis/trans 2:3]. 
13C NMR (600 MHz, C6D6): d = 173.3–172.4 (CO), 147.9 (Car), 147.4 (Car), 144.2 (Car), 143.5 (Car), 
136.7 (Car), 136.4 (Car), 134.0 (Car), 133.3 (Car), 133.2 (Car), 130.9 (Car), 130.5 (Car), 130.2 (Car), 
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130.0 (Car), 129.4 (Car), 129.2 (Car), 129.0 (Car), 128.8 (Car), 128. 6 (Car), 128.3 (Car), 128.2 (Car), 
128.0 (Car), 127.4 (Car), 127.1–127.0 (Car), 126.4–126.3 (Car), 125.4 (Car), 124.8 (Car), 63.6–63.3 
(CH2), 41.8 (NCH3), 35.7–35.6 (C(CH3)3), 31.2 (CH3). 
HRMS (ESI): m/z [M + Na+] calcd. for C23H25NNaO2+: 370.1778; found: 370.1773. 
 
Paracyclophanes 
 
12,13,15,16-Tetrabromo-1(1,4)-benzenacyclohexadecaphane (107) 
 
Under argon, 108 (115 mg, 0.40 mmol) along with AlBr3 (42.7 mg, 0.16 mmol) were introduced 
in a microwave tube at 0 °C. Bromine (0.21 mL, 4.00 mmol) was added and the reaction 
mixture was stirred overnight. The reaction mixture was diluted in CH2Cl2 (2 mL) and treated 
with a solution of KOH 20% (2 mL). The solvent was removed in vacuo and the residue was 
purified by recrystallization in EtOH (0.5 mL) to obtain 107 as a white solid; yield: 54 mg (22%); 
m.p. 100.0–112.8 °C; Rf = 0.7 (Pentane 100%).  
IR (ATR, neat): 2923s, 2852s, 2361s, 1670w, 1543w, 1457m, 1342m, 1281w, 1092s, 977w, 
962w, 819m, 726m, 660m cm–1. 
1H NMR (500 MHz, CDCl3): d = 3.40 (t, 3J = 6 Hz, 4 H, C1’H2, C15’H2), 1.70 (m, 4 H, C14’H2, 
C2’H2), 1.30–1.10 (m, 22 H, 11xCH2). 
13C NMR (125 MHz, CDCl3): d = 143.2 (C1, C4), 128.2 (C2, C3, C5, C6), 40.8 (C1’, C15’), 29.0 (Cal), 
28.4 (Cal), 28.3 (C14’, C2’), 28.2 (Cal), 27.7 (Cal), 27.1 (Cal). 
 
12,13-Dibromo-1(1,4)-naphthalenacyclohexadecaphane (106) 
 
Under argon, to a solution of 107 (903 mg, 1.50 mmol) and furane (0.76 mL, 10.5 mmol) in 
dry toluene (15 mL) was added a solution of n-BuLi (1.47 M, 1.12 mL, 1.65 mmol) at –23 °C. 
The reaction mixture was allowed to warm up to RT and was stirred overnight. The reaction 
Br
Br
4
1
15'
1'
Br
Br
2'
12
4
1
15'
1'
Br
Br
2'
12
EXPERIMENTAL	PROCEDURES	
	 139	
mixture was quenched with slow addition of methanol (0.2 mL) and washed with water. The 
aqueous layer was extracted with Et2O (3 x 20 mL), the combined organic layer was dried over 
Na2SO4 and the solvent was removed in vacuo. The crude was used without further 
purification. 
Under argon, TiCl4 (1.12 mL, 10.2 mmol) was carefully added to a suspension of Zn dust (1.04 
g, 15.9 mmol) in THF (26 mL) at 0 °C. The reaction mixture was stirred at reflux for 10 min. 
After cooling back to 0 °C, a solution of the crude before mentioned (766 mg, 1.5 mmol) in 
anhydrous THF (10 mL) was added dropwise. The reaction mixture was refluxed for 1 h before 
being cooled down to 0 °C. An ice cold HCl 10% solution (45 mL) was slowly added and the 
aqueous layer was extracted with CH2Cl2 (3 x 100 mL). The combined organic layer was 
washed with brine (100 mL), dried over Na2SO4 and the solvent was removed in vacuo. The 
crude was purified by column chromatography (pentane 100%) to afford 106 as a white solid; 
yield: 229 mg (31%); m.p. 68.4–71.5 °C; Rf = 0.45 (pentane 100%). 
IR (ATR, neat): 2923s, 2852s, 2671w, 2359w, 1459m, 1364w, 1163w, 840w, 755s, 655w cm–1. 
1H NMR (500 MHz, CDCl3): d = 8.10 (dd, 3J = 6.6 Hz, 4J = 3.4 Hz, 2 H, C5H, C8H), 7.52 (dd, 3J = 
6.6 Hz, 4J = 3.4 Hz, 2 H, C6H, C7H), 3.55 (t, 3J = 5.8 Hz, 2 H, C1’H, C15’H), 1.89–1.70 (m, 4H, 
C14’H2, C2’H2), 1.24–0.84 (m, 22 H, 11xCH2). 
13C NMR (125 MHz, CDCl3): d = 138.8 (C1, C4), 132.0 (C4a, C8a), 126.3 (C6, C7), 126.2 (C2, C3) 
125.7 (C5, C8), 33.8 (C1’, C15’), 29.6 (C2’, C14’), 28.4 (Cal), 27.4 (Cal), 27.3 (Cal). 
MALDI-MS: m/z calcd. for C25H34Br2+: 492.100; found: 492.154. 
 
1(1,4)-Naphthalenacyclohexadecaphane-12-carbaldehyde (116) 
 
Under argon, to a solution of 106 (49.4 mg, 0.10 mmol) in dry Et2O (0.5 mL) was added a 
solution of n-BuLi (1.50 M, 0.08 mL, 0.12 mmol) at -98 °C (MeOH/liq. N2). The reaction mixture 
was stirred for 30 min and DMF was added (0.01 mL, 0.15 mmol). The reaction mixture was 
allowed to warm up to RT and was stirred for 1 h. Water was added (1 mL) and the aqueous 
layer was extracted with Et2O (3 x 2 mL), the combined organic layer was dried over Na2SO4 
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and the solvent was removed in vacuo. The crude was purified by column chromatography 
(pentane/CH2Cl2 4:1) to afford 116 as a white solid; yield: 9 mg (25%); m.p. 53.4–55.8 °C; Rf = 
0.64 (pentane/CH2Cl2 1:1). 
IR (ATR, neat): 2922s, 2853s, 2361m, 1670s, 1605w, 1459w, 1375w, 1194w, 1081w, 968w, 
766m, 682w cm–1. 
1H NMR (500 MHz, CDCl3): d = 10.68 (s, 1 H, CHO), 8.30 (d, 3J = 8.53 Hz, 1 H, C5H), 8.12 (d, 3J 
= 8.53 Hz, 1 H, C8H), 7.79 (s, 1 H, C2H), 7.65 (ddd, 3J = 8.20 Hz, 3J = 8.53 Hz, 4J = 1.30 Hz, 1 H, 
C7H), 7.58 (ddd, 3J = 8.20 Hz, 3J = 8.53 Hz, 4J = 1.30 Hz, 1 H, C6H), 3.74 (m, 1 H, C1’H), 3.51 (m, 
2 H, C1’H, C15’H), 2.77 (m, 1 H, C15’H), 1.67–1.91 (m, 4H, C14’H2, C2’H2), 1.18–0.84 (m, 22 H, 
11xCH2). 
13C NMR (125 MHz, CDCl3): d = 192.0 (C1), 143.1 (C4), 136.9 (C1), 135.1 (C8a), 132.5 (C4a), 
131.0 (C3), 128,1 (C7), 126.2 (C5), 126.0 (C6), 125.1 (C8), 124.1 (C2), 32.8 (C15’), 31.1 (C14’), 
29.3 (C2’), 28.4 (Cal), 28.3 (Cal), 28.2 (Cal), 28.1 (Cal) 27.5 (Cal), 27.4 (Cal), 24.8 (C1’). 
MALDI-MS: m/z calcd. for C26H36O+: 364.28; found: 363.087. 
 
 Acridinium salts 
 
Synthesis of acridinium salts with an unsubstituted core 
 
2-Bromo-N-(2-bromophenyl)-N-methylaniline (127) 
[CAS Reg. No.:87345-09-3] 
 
Prepared according to a modified literature procedure.[214] 
Bis-(2-bromophenyl)amine 126 (4.59 g, 14.0 mmol) in THF (70 mL) was treated with sodium 
hydride (60% dispersion in mineral oil, 700 mg, 17.5 mmol) at RT and refluxed for 30 min. 
Iodomethane (3.78 g, 1.66 mL, 26.6 mmol) was added and the mixture was refluxed for 
another 2 h, cooled to RT, treated with H2O (50 mL). The resulting mixture was extracted with 
Et2O (3 x 65 mL), the combined organic layers were dried over Na2SO4 and concentrated in 
vacuo. The residue was washed with pentane and dried in vacuo to obtain a white solid; yield: 
3.87 g (81%); m.p. 106-108 °C.  
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IR (ATR, neat): 3434w, 3286w, 2959w, 2872w, 166w, 1544w, 1468m, 1341w, 1232w, 1141m, 
1074m, 1017m, 990w, 866m, 755s, 625m. 
1H NMR (500 MHz, CDCl3): d =7.55 (dd, 3J 7.9, 4J 1.5, 2H, C3H), 7.24 (ddd, 3J  8.0, 7.3, 4J 1.5, 
2H, C5H), 7.00 (dd, 3J  8.0, 4J  1.6, 2H, C6H), 6.94 (ddd, 3J  7.9, 7.4, 4 J 1.6, 2H, C4H), 3.23 (s, 3H, 
NCH3 ). 
13C NMR (125 MHz, CDCl3): d = 148.7 (C1), 134.4 (C3), 128.1 (C5), 124.8 (C4), 123.8 (C6), 120.3 
(C2), 41.3 (CH3). 
HRMS (ESI): m/z calcd. for C13H11Br2N+ 339.9331 found 339.9334 [M+H+]. 
 
1,5-Bifunctional Organomagnesium Reagent for the Ester to Acridinium Transformation 
To a suspension of magnesium turnings (13.6 mg, 560 μmol) in anhydrous THF (0.20 mL) at 
60 °C was added a solution of 2-bromo-N-(2 bromophenyl)-N-methylaniline (126) (47.7 mg, 
140 μmol) in anhydrous THF (0.60 mL). The mixture was stirred at 60 °C for 3 h during which 
the reaction mixture turned yellow, leading to the 1,5-bifunctional organomagnesium 
reagent which was used directly in the next step. 
 
General Procedure A 
To a solution of this reagent in THF (140 μmol) at 60 °C was added a solution of carboxylic 
acid ester (100 μmol) in anhydrous THF (1.00 mL) and the reaction mixture was stirred at the 
same temperature for 12 h. Aqueous HBr (1.00 mL, 8.8 molL-1) was added and the solvent 
was removed in vacuo. The residue was dissolved in MeOH and filtered over a bed (d x h: 2 
cm x 2 cm) of Amberlyst® A21 free base. The solvent was removed in vacuo, the residue was 
dissolved in CH2Cl2 and 3.0 g silica gel was added. The solvent was removed in vacuo and the 
residue purified by column chromatography (silica gel: 10 g, d x h: 2 cm x 7 cm) with CH2Cl2 
100% to CH2Cl2/MeOH 100:2 to 100:5 to 100:8 to yield acridinium salts 128a–b. 
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9-(4-Fluorophenyl)-10-methylacridinium bromide salt (128a) 
 
Prepared according to general procedure A using methyl 4-fluorobenzoate (15.4 mg, 100 
μmol) and the 1,5-bifunctional organomagnesium reagent to afford a yellow solid; yield: 22.8 
mg (63%); m.p. 212–214 °C; Rf 0.10 (CH2Cl2/MeOH 10:1). 
IR (ATR, neat): 3377w, 3059w, 2999w, 2923w, 2848w, 1601m, 1574m, 1544, 1504m, 1482w, 
1446w, 1373m, 1272w, 1217m, 1156m, 1094m, 1023m, 926w, 866w, 816w, 767s, 722m, 
666m, 614m. 
1H NMR (500 MHz, CDCl3): d = 9.05 (d, 3J 9.2, 2H,  C4H, C5H), 8.41–8.44 (m, 2H, C3H, C6H), 
7.97 (dd, 3J 8.8, 4J 1.2, 2H, C1H, C8H), 7.82 (dd, 3J 8.7, 6.7, 2H, C2H, C7H), 7.47–7.50 (m, 2H, 
C2’H, C6’H), 7.42–7.45 (m, 2H, C3’H, C5’H), 5.34 (s, 3H, NCH3). 
13C NMR (125 MHz, CDCl3): d = 164.1 (d, 1JCF 253, C4’), 160.0 (C9), 141.8 (C4a, C10a), 139.4 
(C3, C6), 132.0 (d, 3JCF 8.3, C2’, C6’), 129.8 (C1, C8), 128.8 (d, 4JCF 3.7, C1’) 128.3 (C2, C7), 126.3 
(C8a, C9a), 120.0 (C4, C5), 116.7 (d, 2JCF 22, C3’, C5’), 41.5 (NCH3). 
HRMS (ESI): m/z calcd. for C20H15FN+ 288.1183 found 288.1185 [M+]. 
Absorption spectroscopy (in MeCN): labs: 426 nm; eabs: 8.4·102 Lcm–1mol–1; lem(exc 410): 512 
nm; Stokes shift: 86 nm; E0,0: 2.83 eV; Cyclic voltammetry (vs SCE): E1/2(P*/P–): +2.32 V, 
E1/2(P/P–): –0.51 V. 
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 9-(4-Methoxyphenyl)-10-methylacridinium bromide salt (128b) 
 
Prepared according to general procedure A using 4-methoxybenzoate (16.6 mg, 100 μmol) 
and the 1,5-bifunctional organomagnesium reagent to afford an orange solid; yield: 29.6 mg 
(78 %); decomp. at 185.7 °C; Rf 0.16 (CH2Cl2/MeOH 10:1).  
IR (ATR, neat): 3336m, 3092w, 2931w, 1605s, 1547m, 1457m, 1376m, 1250s, 1176s, 1113w, 
1022m, 922w, 932m, 761s, 725s, 666m, 617s. 
1H NMR (500 MHz, CDCl3): d =  8.93 (d, 3J 8.8 Hz, 2H, C4H, C5H), 8.34 (t, 3J 7.5 Hz, 2H, C3H, 
C6H), 8.02 (d, 3J 8.6, 2H, C1H, C8H), 7.73 (dd, 3J 8.9, 6.6, 2H, C2H, C7H), 7.33–7.37 (m, 2H, 
C2’H, C6’H), 7.16–7.18 (m, 2H, C3’H, C5’H), 5.23 (s, 3H, NCH3), 3.93 (3H, s, OCH3).  
13C NMR (125 MHz, CDCl3): d = 161.4 (C4’), 161.4 (C9), 141.6 (C4a, C10a), 139.0 (C3, C6), 131.7 
(C2’, C6’), 130.2 (C1, C8), 127.8 (C2, C7), 126.2 (C8a, C9a), 124.8 (C1’), 119.7 (C4, C5), 114.6 
(C3’, C5’), 55.7 (OCH3), 41.0 (NCH3). 
 HRMS (ESI): m/z calcd. for C21H18NO+ 300.1383 found 300.1384 [M+]. 
Absorption spectroscopy (in MeCN): labs: 438 nm; eabs: 3.2·102 Lcm–1mol–1; lem(exc 360): 499 
nm; Stokes shift: 61 nm; E0,0: 2.77 eV; Cyclic voltammetry (vs SCE): E1/2(P*/P–): +2.21 V, 
E1/2(P/P–): –0.56 V. 
 
Large-scale synthesis of acridinium salts 
 
4-Bromo-N1,N1-dimethylbenzene-1,3-diamine (131)  
[CAS Reg. No.: 90555-68-3] 
 
Prepared according to a modified literature procedure.[215,216] To a solution of 4-bromo-N,N-
dimethylaniline (50.0 g, 250 mmol) in TBME/THF (1 : 1, 340 mL) was added dropwise aq. nitric 
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acid (68%, 16.5 mL). The mixture was stirred for 1 h at room temperature. The formed 
precipitate was filtered off and the residue was washed with TBME (2 x 30 mL) and dried 
under vacuum overnight.11 The yellow salt (35.0 g, 133 mmol) was then dissolved in CH2Cl2 
(210 mL) and the solution was added to conc. H2SO4 (58.0 mL) while maintaining the 
temperature below 5 °C. The mixture was allowed to warm up to room temperature and was 
stirred for 1 h. The mixture was then slowly added to cold water (210 mL) and aq. NH4OH 
(28%) was added until the mixture reached pH 10. The aq. residue was extracted with DCM 
(2 x 500 mL), the combined organic layers were dried over Na2SO4 and concentrated in vacuo 
to obtain 4-bromo-N,N-dimethyl-3-nitroaniline as an orange solid; yield: 32.0 g (52%); m.p. 
90.4–91.9 °C; Rf 0.73 (CH2Cl2 100%). 
IR (ATR, neat): 2920w, 1609m, 1530s, 1443w, 1369m, 1234w, 1190w, 1129w, 1069w, 881w, 
679w.  
1H NMR (500 MHz, CDCl3): d = 7.46 (d, 3J 9.0, 1H, C5H), 7.07 (d, 4J 3.1, 1H, C2H), 6.69 (dd, 3J 
9.1, 4J 3.1, 1H, C6H), 3.00 (s, 6H, N(CH3)2). 
13C NMR (125 MHz, CDCl3): d = 150.4 (C3), 149.7 (C1), 134.9 (C5), 116.4 (C6), 108.3 (C2), 98.6 
(C4), 40.3 (N(CH3)2).  
HRMS (ESI): m/z calcd. for C8H10BrN2O2+ 244.9920 found 244.9921 [M+H+]. 
In agreement with literature data.[216] 
Prepared according to a modified literature procedure.[217] To a solution of 4-bromo-N,N-
dimethyl-3-nitroaniline (36.8 g, 150 mmol) in methanol/water (1 : 1, 430 mL), was added 
ammonium chloride (64.2 g, 1200 mmol) and iron powder (41.9 g, 750 mmol). The reaction 
mixture was stirred for 1 h at 70 °C, filtered over celite and concentrated to remove 
methanol.12 The aq. residue was treated with aq. HCl (10%) and washed with diethylether (2 
x 500 mL). Then, aq. NH4OH (28%) was added until the residue reached basic pH. The aq. 
residue was extracted with CH2Cl2 (3 x 1 L). The combined organic layers were washed with 
brine, dried over Na2SO4 and concentrated in vacuo to yield 4-bromo-N1,N1-
dimethylbenzene-1,3-diamine as a black solid; yield: 28.1 g (87%); m.p. 57.1–58.7 °C; Rf  0.29 
(CH2Cl2 100%). 
 
11 The precipitate was slowly formed after the addition of nitric acid and can be either grey or yellow (it will 
turn eventually yellow after drying under vacuum). 
12 The Celite was washed with EtOAc. 
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IR (ATR, neat): 3460w, 3355w, 2956w, 2843w, 2794w, 1604s, 1568s, 1491m, 1350m, 1291m, 
1153m, 1123m, 1057w, 972w, 893w, 817s, 778s, 710w. 
1H NMR (500 MHz, CDCl3): d = 7.20 (d, 3J 8.8, 1H, C5H), 6.12 (d, 4J 2.9, 1H, C2H), 6.08 (dd, 3J 
8.8, 4J 2.9, 1H, C6H), 3.97 (br, 2H, NH2 ), 2.88 (s, 6H, N(CH3)2 ). 
13C NMR (125 MHz, CDCl3): d = 151.0 (C1), 144.3 (C3), 132.5 (C5), 105.2 (C6), 99.7 (C2), 97.0 
(C4), 40.6 (N(CH3)2). 
HRMS (ESI): m/z calcd. for C8H12BrN2+ 215.0178 found 215.0181 [M+H+].  
In agreement with literature data.[216]  
 
4-Bromo-3-iodo-N,N-dimethylaniline (133)  
[CAS Reg. No.: 1291063-32-5] 
 
Prepared according to a modified literature procedure.[218] To a suspension of NaI (39.0 g, 260 
mmol), CuI (1.24 g, 6.50 mmol), N,N’-dimethylethylenediamine (1.40 mL, 13.0 mmol) in 1,4-
dioxane (130 mL) at RT was added 3-bromo-N,N-dimethylaniline (18.6 mL, 130 mmol). The 
reaction mixture was stirred for 22 h at 110 °C and then cooled to RT, treated with aq. NH4OH 
(28%, 650 mL) and H2O (300 mL) and was extracted with CH2Cl2 (3 x 1.5 L). The combined 
organic layers were dried over Na2SO4 and concentrated in vacuo to give 3-iodo-N,N-
dimethylaniline as a brownish oil; yield: 31.3 g (97%).  
1H NMR (500 MHz, CDCl3): d = 7.01–7.03 (m, 2H, C4H, C6H), 6.91–6.94 (m, 1H, C5H), 6.65–
6.67 (m, 1H, C2H), 2.92 (s, 6H, N(CH3)2). 
13C NMR (125 MHz, CDCl3): d	= 151.6 (C1), 130.4 (C5), 125.2 (C4), 121.1 (C6), 111.6 (C2), 95.5 
(C3), 40.3 (N(CH3)2).  
In agreement with literature data.[216,219] 
 
To a solution of 3-iodo-N,N-dimethylaniline (31.3 g, 127 mmol) in CH2Cl2 (200 mL) at 10 °C 
was added bromine (6.53 mL, 127 mmol). The reaction mixture was stirred 1 h at that 
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temperature.13 The suspension was treated with aq. sat. Na2SO3 (76.0 mL) and H2O (170 mL) 
and was extracted with CH2Cl2 (3 x 350 mL). The combined organic layers were dried over 
Na2SO4 and concentrated in vacuo. The red crude solid was recrystallized from hexane/EtOAc 
(50 mL; 4:1) to give 4-bromo-3-iodo-N,N -dimethylaniline as a beige solid; yield: 23.7 g (57%).14 
In agreement with literature data.[216,219] 
 
4-Bromo-N3-(2-bromo-5-(dimethylamino)phenyl)-N1,N1,N3-trimethylbenzene-1,3-diamine 
(137)  
 
Prepared according to a modified literature procedure.[208,216] To a degassed mixture of 4-
bromo-3-iodo-N,N-dimethylaniline (55.4 g, 170 mmol), 4-bromo-N1,N1-dimethylbenzene-1,3-
diamine (36.6 g, 170 mmol) tris(dibenzylideneacetone)dipalladium(0) (3.89 g, 4.25 mmol), 
1,1’-bis(diphenylphosphino)ferrocene (4.71 g, 8.50 mmol) and sodium t-butoxide (24.5 g, 
255.0 mmol) was added PhMe (560 mL) at RT. The reaction mixture was stirred for 14 h at 
105 °C. The solution was diluted with H2O (800 mL) and extracted with CH2Cl2 (3 x 2 L). The 
combined organic layer was dried over Na2SO4 and concentrated in vacuo. The crude was 
purified by column chromatography on silica gel (pentane/CH2Cl2 3:1 to 2:1 to 1:1) giving 4-
bromo-N3-(2-bromo-5-(dimethylamino)phenyl)-N1,N1-dimethyl-benzene-1,3-diamine as a 
beige solid; yield: 48.9 g (70%); m.p. 132.2–134.7 °C; Rf 0.53 CH2Cl2 (100%). 
IR (ATR, neat): 3399w, 2895w, 2804w, 1590m, 1562s, 1496s, 1441m, 1354s, 1284s, 1230w, 
1161m, 1065w, 989w, 921w, 814m, 770s, 737w, 682w. 
1H NMR (500 MHz, CDCl3): d = 7.36 (d, 3J 8.7, 2H, C3H), 6.76 (d, 4J 2.9, 2H, C6H), 6.32 (br, 1H, 
NH), 6.24 (dd, 3J 8.7, 4J 3.0, 2H, C4H) 2.89 (s, 12H, N(CH3)2). 
13C NMR (125 MHz, CDCl3): d = 150.5 (C5), 140.3 (C1), 133.0 (C3), 107.3 (C4), 102.1 (C6), 100.8 
(C2), 40.7 (N(CH3)2).  
HRMS (ESI): m/z calcd. for C16H20Br2N3+ 412.0018 found 412.0019 [M+H+]. 
 
13 The reaction mixture turns beige immediately and the color remains until the end of the reaction. 
14 After heating up to 80 °C, a hot filtration allowed to remove insoluble red solids, while the precipitated 
product could be isolated at RT. 
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In agreement with literature data.[216]  
 
Prepared according to a modified literature procedure.[214,216] To a solution of of 4-bromo-N3-
(2-bromo-5-(dimethylamino)phenyl)-N,N1-dimethyl-benzene-1,3-diamine (48.3 g, 117.0 
mmol) in THF (334 mL) at RT was added sodium hydride (60% dispersion in mineral oil, 14.0 g, 
351.0 mmol). The suspension was heated to 75 °C and stirred for 30 min at this temperature. 
Iodomethane (7.28 mL, 117.0 mmol) was added within 5 min at 75 °C and the reaction mixture 
was stirred for 2 h at this temperature. The suspension was treated with water (585 mL) and 
extracted with CH2Cl2 (3 x 1.5 L). The combined organic layers were dried over Na2SO4 and 
concentrated in vacuo. The crude solid was recrystallized from hexane/EtOAc (70 mL; 4:1) to 
give 4-bromo-N3-(2-bromo-5-(dimethylamino)phenyl)-N1,N1,N3-trimethylbenzene-1,3-
diamine as a beige solid; yield: 35.6 g (71%); m.p. 102.5–104.1°C; Rf  0.55 (CH2Cl2 100%). 
IR (ATR, neat): 2883w, 2806w, 1588s, 1554s, 1492s, 1446m, 1358s, 1304m, 1233m, 1170s, 
1133m, 1084m, 1022w, 987m, 909w, 801m, 735w. 
1H NMR (500 MHz, CDCl3): d = 7.33 (d, 3J  8.8, 2H, C3H); 6.35 (d, 4J  3.0, 2H, C6H), 6.31 (dd, 3J  
8.8, 4J  3.0, 2H, C4H), 3.21 (s, 3H, NCH3), 2.87 (s, 12H, 2 x N(CH3)2). 
13C NMR (125 MHz, CDCl3): d = 150.7 (C5), 149.1 (C1), 134.0 (C3), 109.1 (C4), 108.3 (C6), 106.7 
(C2), 41.3 (NCH3), 40.6 (2 x N(CH3)2). 
HRMS (ESI): m/z calcd. for C17H22Br2N3+ 426.0175 found 426.0177 [M+H+]. 
In agreement with literature data.[216]  
 
General Procedure B 
To a suspension of magnesium turnings (1.36 g, 56.0 mmol) in anhydrous THF (20.0 mL) at  
60 °C was added a solution of 4-bromo-N3-(2-bromo-5-(dimethylamino)phenyl)-N1,N1,N3-
trimethylbenzene-1,3-diamine (5.98 g, 14.0 mmol) in anhydrous THF (60 mL) followed by 1,2-
dibromoethane (0.319 mL, 4.20 mmol). The mixture was stirred at 60 °C for 3 h during which 
the reaction mixture turned yellow. To this solution at 60 °C was added a solution of carboxylic 
acid ester (10.0 mmol) in anhydrous THF (100 mL) and the reaction mixture was stirred at the 
same temperature for 12 h. Aqueous HBr (100 mL, 8.8 molL-1) was added and the aq. phase 
extracted with CHCl3/i-PrOH (3 x 200 mL; 85:15). The solvent was removed in vacuo and the 
residue was recrystallized from water (10 mL) to yield acridinium salts 129a–b. 
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3,6-Bis(dimethylamino)-9-mesityl-10-methylacridinium bromide salt (129a) 
 
Prepared according to general procedure B using methyl 2,4,6 trimethyl benzoate (1.78 g, 10 
mmol) to afford an orange solid; yield: 3.9 g (82%); decomp. at 192.9 °C; Rf 0.13 (CH2Cl2/MeOH 
10:1). 
IR (ATR, neat): 3373w, 2918w, 2170w, 1591s, 1497s, 1435m, 1352s, 1210s, 1148s, 985w, 
921s, 807m, 711s. 
1H NMR (500 MHz, CDCl3): d = 7.26 (d, 3J 9.5, 2H, C1H, C8H), 7.06 (br, 2H, C3’H, C5’H), 6.95–
6.96 (m, 2H, C4H, C5H), 6.94 (dd, 3J 9.4, 4J 2.1, 2H, C2H , C7H), 4.56 (s, 3H, NCH3), 3.36 (s, 12H, 
2 x N(CH3)2), 2.43 (s, 3H, CH3) 1.80 (s, 6H, 2 x CH3).  
13C NMR (125 MHz, CDCl3): d = 155.4 (C3, C6), 154.0 (C9), 143.9 (C4a, C10a), 139.0 (C4’), 136.0 
(C2’, C6’), 130.4 (C1, C8, C1’), 128.6 (C3’, C5’), 116.1 (C8a, C9a), 114.3 (C2, C7), 94.3 (C4, C5), 
41.1 (2 x N(CH3)2), 38.3 (NCH3), 21.2 (CH3), 19.8 (2 x CH3). 
HRMS (ESI): m/z calcd. For C27H32N3+ 398.2591 found 398.2594 [M+H+]. 
In agreement with literature data.[216]  
 
3,6-Bis(dimethylamino)-9-(2,6-Dimethylphenyl)-10-methylacridinium bromide salt (129b) 
 
Prepared according to general procedure B using methyl 2,4,6 trimethyl 
benzoate (1.78 g, 10 mmol) to afford an orange solid; yield: 3.9 g (84%); decomp. at 238.6 °C; 
Rf 0.17 (CH2Cl2/MeOH 10:1). 
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IR (ATR, neat): 2917w, 2662w, 1595m, 1502m, 1439s, 1354m, 1259s, 1215m, 1147m, 1067s, 
981s, 924m, 809m, 712s, 649s. 
1H NMR (500 MHz, MeOD): d = 7.44 (t, 3J 7.6, 1H, C4’H),7.31 (d, 3J 7.6, 2H, C3’H, C5’H),  7.28 
(d, 3J 9.5, 2H, C1H, C8H), 7.18 (dd, 3J 9.5, 4J 2.2, 2H, C2H , C7H), 6.88 (d, 4J 2.2, 2H, C4H, C5H), 
4.30 (s, 3H, NCH3), 3.34 (s, 12H, 2 x N(CH3)2), 1.85 (s, 6H, 2 x CH3).  
13C NMR (125 MHz, MeOD): d = 157.2 (C3, C6), 155.3 (C9), 145.4 (C4a, C10a), 137.3 (C2’, C6’), 
135.0 (C1’), 131.4 (C1, C8), 130.6 (C4’), 129.1 (C3’, C5’), 117.3 (C8a, C9a), 116.1 (C2, C7), 94.5 
(C4, C5), 40.8 (2 x N(CH3)2), 36.7 (NCH3), 19.8 (2 x CH3). 
HRMS (ESI): m/z calcd. For C26H30N3+ 384.2434 found 384.2440 [M+H+]. 
Absorption spectroscopy (in MeCN): labs: 504 nm; eabs: 7.1·104 Lcm–1mol–1; lem(exc 450): 533 
nm; Stokes shift: 29 nm; E0,0: 2.4 eV; Cyclic voltammetry (vs SCE): E1/2(P*/P–): +1.25 V,  
E1/2(P/P–): –1.15 V. 
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Modular synthesis of acridinium salts 
 
Overview of the synthesis 
 
 
  
NH2
OMe
+
Br
I
1) Pd2(dba)3, dppf,  NaOt-Bu,
toluene, 110 °C, 12h (97%)
2) NaH, THF, 75 °C, then MeI, 
2 h (quant.)
NMeO
Me Br
139a
(4 g)
NH2
MeO NH
Ph
2-bromoiodobenzene
Pd2(dba)3, RuPhos, 
Nat-BuO, toluene, 
90 °C, 11 h (84%)
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I MeO N
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NMe2
Pd2(dba)3, RuPhos, Nat-BuO, 
toluene, 90 °C, 12 h (93%)
NMe2
BnNMe3+ ICl2-, 
CaCO3, 
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2-Bromo-N-(3-methoxyphenyl)-N-methylaniline (139a): 
 
To a degassed mixture of tris(dibenzylideneacetone)dipalladium(0) (916 mg, 1.00 mmol), 
1,1’-ferrocenediyl-bis(diphenylphosphine) (1.11 g, 2.00 mmol) and sodium tert-butoxide 
(5.77 g, 60.0 mmol) in toluene (50 mL) at RT was added m-anisidine 138 (4.48 mL, 40.0 mmol) 
and 1-bromo-2-iodobenzene 125 (5.14 mL, 40.0 mmol). The mixture was stirred at 110 °C for 
12 h, then cooled to RT, diluted with water (400 mL), extracted with CH2Cl2 (4 x 500 mL) and 
dried over Na2SO4 and concentrated in vacuo. The crude was purified by column 
chromatography on silica gel (pentane/CH2Cl2 1:1 to 1:2) to give 2-bromo-N-(3-
methoxyphenyl)aniline as a yellowish oil; yield: 5.40 g (73%); Rf = 0.53 (CH2Cl2 100%). 
IR (ATR, neat): 3395w, 2955w, 2833w, 1583s, 1512m, 1491s, 1467s, 1450m, 1306m, 1273m, 
1196m, 1155s, 1042m, 1021m, 960w, 840w, 740s, 688m. 
1H NMR (500 MHz, CDCl3) d = 7.52 (1H, dd, 3J 8.0, 4J 1.5, C3H), 7.29 (1H, dd, 3J 8.2, 4J 1.6, C6H), 
7.19–7.14 (1H, m, C5’H), 7.15–7.18 (1H, m, C5H), 6.72–6.76 (2H, m, C4H, C6’H), 6.70–6.71 
(1H, m, C2’H), 6.58 (1H, ddd, 3J 8.3, 4J 2.5, 0.8, C4’H), 6.06 (1H, br, NH), 3.79 (3H, s, OCH3). 
13C NMR (125 MHz, CDCl3) d = 143.0 (C1’), 141.1 (C1), 133.0 (C3), 130.2 (C5’), 128.1 (C3), 121.2 
(C4), 116.5 (C6), 112.5 (C2), 112.4 (C6’), 108.0 (C4’), 105.7 (C2’), 55.3 (OCH3). 
HRMS (ESI): m/z [M+H+] calcd. for C13H13BrNO+: 278.0175; found: 278.0176. 
 
To a solution of 2-bromo-N-(3-methoxyphenyl)aniline (3.89 g, 14.0 mmol) in THF (40 mL) at 
RT was added sodium hydride (60% dispersion in mineral oil, 1.68 g, 42.0 mmol). The 
suspension was heated to 75 °C and stirred for 30 min at this temperature. Iodomethane 
(0.872 mL, 14.0 mmol) was added within 5 min at 75 °C and the reaction mixture was 
continued to stir for 2 h at this temperature. The suspension was treated with water (60 mL) 
and extracted with Et2O (4 x 150 mL). The combined organic layer was washed with brine, 
dried over Na2SO4 and concentrated in vacuo. The crude was used without further 
purification. If purified, 2-bromo-N-(3-methoxyphenyl)-N-methylaniline 139a is obtained as a 
colorless oil; Rf = 0.61 (pentane/CH2Cl2 1:1). 
IR (ATR, neat): 2937w, 2833w, 1610s, 1577s, 1492s, 1464s, 1347w, 1278w, 1212s, 1168s, 
1135m, 1039s, 931w, 828w, 755s, 730s, 687s. 
3’ N 2MeO
Me Br
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1H NMR (500 MHz, CDCl3) d = 7.67 (1H, dd, 3J 8.0, 4J 1.4, C3H), 7.34 (1H, ddd, 3J 7.9, 7.3, 4J 1.5, 
C5H), 7.27 (1H, dd, 3J 7.9, 4J 1.7, C6H), 7.14 (1H, ddd, 3J 8.0, 7.3 4J 1.7, C4H), 7.07–7.11 (1H, m, 
C5’H), 6.33 (1H, ddd, 3J 8.1, 4J 2.4, 0.7, C4’H), 6.17 (1H, ddd, 3J 8.2, 4J 2.4, 0.7, C6’H), 6.13 (1H, 
t, 4J 2.4, C2’H), 3.74 (3H, s, OCH3), 3.22 (3H, s, NCH3). 13C NMR (125 MHz, CDCl3) d = 160.6 
(C3’), 149.9 (C1’), 146.7 (C1), 134.1 (C3), 130.6 (C6), 129.6 (C5’), 128.9 (C5), 127.9 (C4), 124.3 
(C2), 106.5 (C6’), 102.3 (C4’), 99.9 (C2’), 55.1 (OCH3), 39.0 (NCH3). 
HRMS (ESI): m/z [M+H+] calcd. for C14H15BrNO+: 292.0332; found: 292.0333. 
 
3-Methoxy-N-phenylaniline (141): 
 
To a degassed mixture of tris(dibenzylideneacetone)dipalladium(0) (4.58 g, 5.00 mmol), 1,1’-
ferrocenediyl-bis(diphenylphosphine) (5.54 g, 10.0 mmol) and sodium tert-butoxide (28.8 g, 
300 mmol) in toluene (265 mL) at RT were added aniline (27.4 mL, 300 mmol) and 
3-iodoanisole (23.8 mL, 200 mmol). The mixture was stirred at 100 °C for 12 h, then cooled to 
RT, diluted with water (1 L), extracted with CH2Cl2 (4 x 2 L), dried over Na2SO4 and 
concentrated in vacuo. The crude was filtered through silica gel (pentane/CH2Cl2 2:1) then 
recrystallized from cyclohexane (50 mL) to obtain 3-methoxy-N-phenylaniline 141 as a white 
solid; yield: 35 g (91%); m.p. 67.8-69.5 °C; Rf 0.40 (pentane/CH2Cl2 1:1). 
IR (ATR, neat): 3380m, 3052w, 2998w, 2839w, 1585s, 1492s, 1451s, 1305m, 1263s, 1239m, 
1200m, 1176m, 1157m, 1087w, 1033m, 953m, 895w, 834m, 779s, 738m, 688s. 
1H NMR (500 MHz, CDCl3) d = 7.25–7.28 (2H, m, C3’H, C5’H), 7.15–7.18 (1H, m, C5H), 7.08–
7.10 (2H, m, C2’H, C6’H), 6.92–6.96 (1H, m, C4’H), 6.63–6.66 (2H, m, C2’H, C6H), 6.47–6.49 
(1H, m, C4H), 5.73 (1H, br, NH), 3.78 (3H, s, NCH3). 
13C NMR (125 MHz, CDCl3) d = 160.7 (C3), 144.6 (C1), 142.8 (C1’), 130.1 (C5), 129.3 (C3’, C5’), 
121.3 (C4’), 118.4 (C2’, C6’), 110.2 (C6), 106.2 (C4), 103.3 (C2), 55.2 (OCH3). 
HRMS (ESI): m/z [M+H+] calcd. for C13H14NO+: 200.1070; found:  200.1072. 
  
3MeO NH
Ph
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2-Bromo-N-(3-methoxyphenyl)-N-phenylaniline (139b): 
 
To a degassed mixture of tris(dibenzylideneacetone)dipalladium(0) (572 mg, 625 µmol), 
2-dicyclohexylphosphino-2’,6’-diisopropoxybiphenyl (583 mg, 1.25 mmol), sodium tert-
butoxide (3.6 g, 37.5 mmol), and 3-methoxy-N-phenylaniline (4.98 g, 25.0 mmol) in toluene 
(50 mL) was added 1-bromo-2-iodobenzene (3.86 mL, 30.0 mmol) at RT. The mixture was 
stirred at 90 °C for 11 h, then cooled to RT, diluted with water (500 mL), extracted with CH2Cl2 
(4 x 600 mL), dried over Na2SO4 and concentrated in vacuo. The crude was purified by column 
chromatography on silica gel (pentane/CH2Cl2 2:1) to give 2-bromo-N-(3-methoxyphenyl)-N-
phenylaniline 139b as a yellowish oil; yield: 7.4 g, (84%); Rf = 0.88 (pentane:CH2Cl2 1:1). 
IR (ATR, neat): 3059w, 2954w, 2834w, 1583s, 1486s, 1469s, 1309m, 1272m, 1222s, 1149s, 
1046m, 1029m, 978w, 855w, 751s, 722m, 690s, 636w. 
1H NMR (500 MHz, CDCl3) d = 7.63 (1H, dd, 3J 8.0, 4J 1.5, C3H), 7.29–7.33 (1H, m, C5H), 7.21–
7.25 (3H, m, C6H, C3”H, C5”H), 7.09–7.14 (2H, m, C4H, C5’H), 6.96–7.02 (3H, m, C2”H, C4”H, 
C6”H), 6.51–6.55 (3H, m, C2’H, C4’H, C6’H), 3.71 (3H, s, OCH3). 
13C NMR (125 MHz, CDCl3) d = 160.4 (C3’), 148.3 (C1’), 146.8 (C1”), 145.4 (C1), 134.5 (C3), 
131.7 (C6), 129.6 (C5’), 129.0 (C3”, C5”), 128.8 (C5), 127.4 (C4), 123.8 (C2), 122.5 (C2”, C6”), 
122.3 (C4”), 114.3 (C2’), 107.8 (C4’), 107.0 (C6’), 55.2 (OCH3). 
HRMS (ESI): m/z [M+H+] calcd. for C19H17BrNO+: 354.0488; found: 354.0494. 
 
4-Bromo-N3-(3-methoxyphenyl)-N1,N1-dimethyl-N3-phenylbenzene-1,3-diamine (139c): 
 
To a degassed mixture of tris(dibenzylideneacetone)dipalladium(0) (1.72 g, 1.88 mmol), 
2-dicyclohexylphosphino-2’,6’-diisopropoxybiphenyl (1.75 mg, 3.75 mmol), sodium tert-
butoxide (10.8 g, 112 mmol), and 3-methoxy-N-phenylaniline (14.9 g, 75.0 mmol) and 4-
bromo-3-iodo-N,N-dimethylaniline (29.3 g, 90.0 mmol) was added toluene (150 mL) at RT. 
The mixture was stirred at 100 °C for 3 h, cooled to RT, diluted with water (1 L), extracted with 
3’MeO N
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2
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4
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CH2Cl2 (4 x 1 L), dried over Na2SO4 and concentrated in vacuo. The crude was purified by 
column chromatography on silica gel (pentane/CH2Cl2 2:1 to 1:1 to 1:2) to obtain 139c as a 
brown oil; yield:  27.7 g, (93%); Rf = 0.44 (pentane/CH2Cl2 1:1). 
IR (ATR, neat): 2935w, 1585s, 1555w, 1485s, 1445m, 1360w, 1305m, 1268m, 1220m, 1162m, 
1146m, 1045m, 989w, 848w, 797w, 764w, 743m, 690s, 639w. 
1H NMR (500 MHz, CDCl3) d = 7.41 (1H, d, 3J 8.9, C5H), 7.20–7.23 (2H, m, C3”H, C5”H), 7.11 
(1H, t, 3J 8.1, C5’H), 7.04–7.05 (2H, m, C2”H, C6”H), 6.93–6.96 (1H, m, C6”H), 6.57–6.59 (1H, 
m, C6’H), 6.55–6.57 (2H, m, C2H, C2’H), 6.48–6.51 (2H, m, C6H, C4’H), 3.72 (3H, s, OCH3), 2.87 
(6H, s, N(CH3)2). 
13C NMR (125 MHz, CDCl3) d = 160.3 (C3’), 151.1 (C1), 148.2 (C1’), 146.7 (C1”), 145.3 (C3), 
134.2 (C5), 129.5 (C5’), 128.9 (C3”, C5”), 122.1 (C2”, C6”), 121.8 (C4”), 115.3 (C2), 114.0 (C6’), 
112.1 (C6), 109.7 (C4), 107.4 (C2’), 106.5 (C4’), 55.2 (OCH3), 40.5 (N(CH3)2). 
HRMS (ESI): m/z [M+H+] calcd. for C21H22BrN2O+: 397.0910; found: 397.0905.  
 
3-Bromo-4-iodo-N,N-dimethylaniline (143): 
 
Prepared according to a modified literature procedure.[220]  
To a mixture of 3-bromo-N,N-dimethylaniline (40.0 g, 200 mmol) and calcium carbonate 
(80.1 g, 800 mmol) in CH2Cl2:MeOH (1:4, 4 L) was added benzyltrimethylammonium 
dichloroiodate4 (76.6 g, 220 mmol) at RT. The mixture was stirred at RT for 1 h, filtered and 
the filtrate was concentrated in vacuo, treated with aqueous sat. Na2SO3 (1 L), extracted with 
CH2Cl2 (3 x 2L), dried over Na2SO4 and concentrated in vacuo to afford 3-bromo-4-iodo-N,N-
dimethylaniline as a brown solid. The crude was filtered through a plug of silica gel 
(pentane/CH2Cl2 1:1), followed by recrystallization from i-PrOH (90 mL) to afford 3-bromo-4-
iodo-N,N-dimethylaniline 143 as a yellowish solid; yield: 62.3 g (96%); m.p. 76.8-78.6 °C; Rf = 
0.86 (pentane/CH2Cl2 1:1).  
IR (ATR, neat): 3082w, 2890m, 2814m, 1581s, 1496s, 1439s, 1365m, 1231s, 1177m, 1107m, 
1066m, 981m, 956m, 825m, 793s, 664m. 
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1H NMR (500 MHz, CDCl3) d = 7.56 (1H, d, 3J 9.2, C5H), 6.96 (1H, d, 4J 2.9, C2H), 6.37 (1H, dd, 
3J 8.9, 4J 2.9, C6H), 2.92 (12H, s, N(CH3)2). 
13C NMR (125 MHz, CDCl3) d = 151.2 (C1), 139.8 (C5), 130.1 (C3), 116.3 (C2), 113.2 (C6), 83.0 
(C4), 40.2 (N(CH3)2); ESI-MS: m/z [M+H+] calcd. for C8H10BrIN+: 325.9036; found: 325.9032. 
 
2-Bromo-N1-(3-methoxyphenyl)-N4,N4-dimethyl-N1-phenylbenzene-1,4-diamine (139e): 
 
To a degassed mixture of tris(dibenzylideneacetone)dipalladium(0) (137 mg, 150 µmol), 2-
dicyclohexylphosphino-2’,6’-diisopropoxybiphenyl (140 mg, 300 µmol), sodium tert-butoxide 
(865 mg, 9 mmol), 3-methoxy-N-phenylaniline (1.20 g, 6.00 mmol) and 4-bromo-3-iodo-N,N-
dimethylaniline (2.35 g, 7.20 mmol) was added toluene (12 mL) at RT. The mixture was stirred 
at 90 °C for 11 h, then cooled to RT, diluted with water (60 mL), extracted with CH2Cl2 (3 x 120 
mL), dried over Na2SO4 and concentrated in vacuo. The crude was purified by column 
chromatography on silica gel (pentane/CH2Cl2 2:1 to 1:1) to obtain 139e as a yellow oil; yield: 
1.08 g (45%) Rf = 0.63 (pentane/CH2Cl2 1:1). 
IR (ATR, neat): 2935w, 1588s, 1488s, 1443m, 1313m, 1272m, 1225s, 1151s, 1050m, 957m, 
907s, 831m, 728s, 691s, 628w. 
1H NMR (500 MHz, CDCl3) d = 7.19–7.22 (2H, m, C3”H, C5”H), 7.11 (1H, d, 3J 8.8, C6H), 7.10 
(1H, t, 3J 8.1, C5’H), 7.02–7.04 (2H, m, C2”H, C6”H), 6.95 (1H, d, 4J 2.9, C3H), 6.90–6.93 (1H, 
m, C4”H), 6.66 (1H, dd, 3J 8.8, 4J 2.9, C5H), 6.54 (1H, t, 4J 2.3, C2’H), 6.56 (1H, ddd, 3J 8.1, 4J 
2.2, 0.8, C6’H), 6.46 (1H, ddd, 3J 8.2, 4J 2.4, 0.8, C4’H), 3.71 (3H, s, OCH3), 2.96 (6H, s, N(CH3)2). 
13C NMR (125 MHz, CDCl3) d = 160.3 (C3’), 149.8 (C4), 148.6 (C1’), 147.0 (C1”), 133.5 (C1), 
132.0 (C6), 129.5 (C5’), 128.9 (C3”, C5”), 125.3 (C2), 121.7 (C2”, C6”), 121.5 (C2”), 116.9 (C3), 
113.4 (C6’), 112.8 (C5), 106.9 (C2’), 106.1 (C4’), 55.2 (OCH3), 40.5 (N(CH3)2). 
HRMS (ESI): m/z [M•+] calcd. for C21H21BrN2O•+: 396.0832; found: 396.0827. 
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General procedure C: 
To a solution of tertiary amine 139a-e (19.8 mmol) in Et2O (24 mL) and n-hexane (247 mL) 
was added a solution of n-butyllithium in hexanes (24.8 mL, 1.60 molL–1, 39.6 mmol) at RT. 
The mixture was stirred for 6 h at 65 °C. The reaction mixture was directly used in the next 
step. 
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General procedure D: 
To the reaction mixture of the metalated aryl aniline in n- hexane/Et2O (271 mL) at −20 °C 
was added a solution of carboxylic acid ester (23.8 mmol) in anhydrous THF (100 mL) and the 
reaction mixture was allowed to warm to RT over 12 h. Aqueous HBr (238 mL, 48%) was 
added, followed by water (1 L) and the mixture was extracted by CHCl3/i-PrOH solution (4 × 1 
L; 85:15). The combined organic layer was dried over Na2SO4, filtered and concentrated in 
vacuo. The crude was triturated in THF (5 mL) and filtered to afford the product. 
 
9-(2,6-Dimethylphenyl)-1-methoxy-10-phenylacridinium bromide salt (144a) 
 
The compound was prepared according to the general procedures C and D, using 2-bromo-N-
(3-methoxyphenyl)-N-phenylaniline 139b (7.01 g, 19.8 mmol) and methyl 
2,6-dimethylbenzoate (3.90 g, 23.8 mmol). Purification gave a brown red solid; yield: 4.37 g 
(57%); m.p. at 139 °C (decomp.); Rf = 0.14 (CH2Cl2/MeOH 10:1) 
IR (ATR, neat): 3013w, 2361w, 1606m, 1582m, 1517m, 1466s, 1366m, 1271s, 1243m, 1197w, 
1087s, 1030w, 977w, 771s, 738m, 701m, 670w, 626w cm–1. 
1H NMR (500 MHz, CDCl3): d = 8.22 (1H, dd, 3J 8.7, 8.4, C3H), 8.14 (1H, ddd, 3J 9.2, 7.0, 4J 1.5, 
C6H), 7.94–7.97 (2H, m, C3”H, C5”H), 7.88–7.91 (1H, m, C4”H), 7.78–7.80 (1H, m, C8H), 7.72–
7.75 (3H, m, C7H, C2”H, C6”H), 7.51 (1H, 3J 9.0, C5H), 7.41 (1H, t, 3J 7.5, C4’H), 7.26–7.28 (3H, 
m, C2H, C3’H, C5’H), 7.10 (1H, d, 3J 9.1, C4H), 3.69 (3H, s, OCH3), 1.86 (6H, s, 2 x CH3). 
13C NMR (125 MHz, CDCl3): d = 163.6 (C9), 159.6 (C1), 143.2 (C4a), 141.6 (C3), 141.4 (C10a), 
138.9 (C6), 137.3 (C1”), 136.8 (C1’), 133.8 (C2’, C6’), 132.0 (C4”), 131.9 (C3”, C5”), 129.0 (C4’), 
128.9 (C8), 128.3 (C7), 127.9 (C2”, C6”), 127.6 (C3’, C5’), 125.2 (C8a), 119.6 (C5), 119.4 (C9a), 
111.6 (C4), 107.1 (C2), 57.5 (OCH3), 20.6 (2 x CH3). 
HRMS (ESI): m/z [M+] calcd. for C28H24NO+: 390.1852; found: 390.1857. 
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Absorption spectroscopy (in MeCN): labs: 480 nm; eabs: 4.1·103 L cm mol–1; lem(exc 480): 628 
nm; Stokes shift: 148 nm; E0,0: 2.25 eV; Cyclic voltammetry (vs SCE): E1/2(P*/P–): +1.69 V, 
E1/2(P/P–): –0.56 V. 
 
6-(Dimethylamino)-9-mesityl-1-methoxy-10-phenylacridinium bromide salt (144b) 
 
The compound was prepared according to the general procedures C and D, using 4-bromo-
N3-(3-methoxyphenyl)-N1,N1-dimethyl-N3-phenylbenzene-1,3-diamine 139c (1.19 g, 3 mmol) 
and methyl 2,4,6-trimethylbenzoate (381 mg, 2.14 mmol). Purification gave a brown red solid; 
yield: 325 mg (29%); m.p. 106 °C (decomp.); Rf = 0.18 (CH2Cl2/MeOH 10:1) 
IR (ATR, neat): 3380w, 2934w, 2360w, 1623m, 1597s, 1502s, 1473s, 1431s, 1383m, 1343m, 
1255s, 1211m, 1094s, 916w, 813m, 794m, 687m, 647w cm–1. 
1H NMR (500 MHz, CDCl3): d = 7.89–7.92 (2H, m, C3”H, C5”H), 7.81–7.84 (1H, m, C4”H), 7.74 
(1H, dd, 3J 8.9, 8.2, C3H), 7.48–7.50 (2H, m, C2”H, C6”H), 7.42 (1H, d, 3J 9.9, C8H), 7.25 (1H, 
dd, 3J 10, 4J 2.4, C7H), 7.02 (2H, d, 4J 0.5, C3’H, C5’H), 6.89 (1H, d, 3J 7.8, C2H), 6.70 (1H, dd, 3J 
8.7, 4J 0.9, C4H), 5.80 (1H, d, 4J 2.4, C5H), 3.57 (3H, s, OCH3), 3.18 (6H, br, N(CH3)2), 2.43 (3H, 
s, CH3), 1.85 (6H, s, 2 x CH3). 
13C NMR (125 MHz, CDCl3): d = 159.7 (C1), 157.2 (C9), 156.3 (C6), 144.8 (C10a), 142.4 (C4a), 
137.9 (C4’), 137.8 (C1”), 136.9 (C3), 134.3 (C1’), 133.7 (C2’, C6’), 132.0 (C3”, C5”), 131.3 (C4”), 
131.1 (C8), 128.0 (C3’, C5’), 128.0 (C2”, C6”), 120.3 (C8a), 118.4 (C7), 114.8 (C9a), 110.3 (C4), 
105.4 (C2), 93.6 (C5), 56.8 (OCH3), 41.0 (N(CH3)2), 21.2 (CH3), 20.2 (2 x CH3). 
HRMS (ESI): m/z [M+] calcd. for C31H31N2O+: 447.2431; found: 447.2439. 
Absorption spectroscopy (in MeCN): labs: 513 nm; eabs: 1.1·104 L cm mol–1; lem(exc 503): 566 
nm; Stokes shift: 53 nm; E0,0: 2.31 eV; Cyclic voltammetry (vs SCE): E1/2(P*/P–): +1.42 V, 
E1/2(P/P–): –0.89 V. 
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(±)-6-(Dimethylamino)-1-methoxy-9-(naphthalen-1-yl)-10-phenylacridinium bromide salt 
(144c) 
 
The compound was prepared according to the general procedures C and D, using 4-bromo-
N3-(3-methoxyphenyl)-N1,N1-dimethyl-N3-phenylbenzene-1,3-diamine 139c (595 mg, 1.5 
mmol) and methyl 1-naphthoate (199 mg, 1.07 mmol). Purification gave a brown red solid; 
yield: 286 mg (95%); m.p. 154 °C (decomp.): Rf = 0.18 (CH2Cl2/MeOH 10:1). 
IR (ATR, neat): 3385w, 2934w, 2361w, 1624m, 1597s, 1503s, 1473s, 1430s, 1385m, 1361m, 
1254s, 1211s, 1178m, 1097s, 1029w, 922w, 785s, 703m, 690m cm–1. 
1H NMR (500 MHz, CDCl3): d = 8.03–8.05 (1H, m, C4’H), 8.01–8.02 (1H, m, C5’H), 7.91–7.96 
(2H, m, C3”H, C5”H), 7.82–7.85 (1H, m, C4”H), 7.72 (1H, dd, 3J 8.9, 8.2, C3H), 7.65 (1H, dd, 3J 
7.7, 7.0, C3’H), 7.59–7.61 (1H, m, C2”H), 7.53–7.56 (2H, m, C6’H, C6”H), 7.38 (1H, ddd, 3J 8.5, 
7.7, 4J 1.1, C7’H), 7.35 (1H, dd, 3J 6.8, 4J 1.0, C2’H), 7.35 (1H, d, 3J 10, C8H), 7.25 (1H, dd, 3J 8.2, 
4J 0.6, C8’H), 7.11 (1H, dd, 3J 10, 4J 2.4, C7H), 6.77 (1H, d, 3J 8.0, C2H), 6.74 (1H, dd, 3J 8.8, 4J 
0.5, C4H), 5.85 (1H, d, 3J 2.4, C5H), 3.16 (6H, br, N(CH3)2), 3.13 (3H, s, OCH3). 
13C NMR (125 MHz, CDCl3): d = 159.2 (C1), 156.3 (C6), 155.4 (C9), 145.0 (C10a), 142.3 (C4a), 
137.9 (C1”), 136.9 (C3), 135.6 (C1’), 132.9 (C4’a), 132.2 (C8), 132.2 (C3”), 132.1 (C5”), 131.6 
(C8’a), 131.3 (C4”), 128.7 (C4’), 128.5 (C5’), 128.0 (C2”), 128.0 (C6”), 127.0 (C7’), 126.4 (C6’), 
125.3 (C2’), 125.1 (C8’), 125.1 (C3’), 121.6 (C8a), 117.9 (C7), 115.6 (C9a), 110.3 (C4), 105.8 
(C2), 93.5 (C5), 56.4 (OCH3), 41.0 (N(CH3)2). 
HRMS (ESI): m/z [M+] calcd. for C32H27N2O+: 455.2118; found: 455.2122. 
Absorption spectroscopy (in MeCN): labs: 516 nm; eabs: 1.1·104 L cm mol–1; lem(exc 506): 568 
nm; Stokes shift: 52 nm; E0,0: 2.29 eV; Cyclic voltammetry (vs SCE): E1/2(P*/P–): +1.42 V, 
E1/2(P/P–): –0.87 V. 
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(±)-7-(Dimethylamino)-1-methoxy-9-(naphthalen-1-yl)-10-phenylacridinium bromide salt 
(144d) 
 
The compound was prepared according to the general procedures C and D, using 2-bromo-
N1-(3-methoxyphenyl)-N4,N4-dimethyl-N1-phenylbenzene-1,4-diamine 139e (2.30 g, 5.79 
mmol) and methyl 1-naphthoate (674 mg, 3.62 mmol). Purification gave a blue solid; yield: 
1.77 g (91%); m.p. 113 °C (decomp.): Rf = 0.20 (CH2Cl2/MeOH 10:1). 
IR (ATR, neat): 3365w, 3002w, 2934w, 2361w, 1619m, 1573m, 1518m, 1490m, 1456m, 1361s, 
1267s, 1207s, 1169m, 1089m, 976w, 924w, 782s, 692m cm–1. 
1H NMR (500 MHz, CDCl3): d = 8.05–8.07 (1H, m, C4’H), 8.02–8.03 (1H, m, C5’H), 7.91–7.98 
(2H, m, C3”H, C5”H), 7.88–7.90 (1H, m, C4”H), 7.82–7.85 (2H, m, C3H, C6H), 7.66–7.73 (3H, 
m, C3’H, C2”H, C6”H), 7.53–7.56 (1H, m, C6’H), 7.42 (1H, dd, 3J 7.0, 4J 0.9, C2’H), 7.39 (1H, d, 
3J 10, C5H), 7.37 (1H, 3J 8.2, 7.5, 4J 1.3, C7’H), 7.23–7.25 (1H, m, C8’H), 6.97 (1H, d, 3J 9.5, C4H), 
6.89 (1H, d, 3J 8.0, C2H), 6.33 (1H, d, 4J 2.9, C8H), 3.21 (3H, s, OCH3), 2.81 (6H, s, N(CH3)2). 
13C NMR (125 MHz, CDCl3): d = 158.1 (C1), 155.1 (C9), 148.3 (C7), 140.1 (C4a), 137.6 (C1”), 
137.0 (C3), 136.1 (C1’), 135.8 (C10a), 132.9 (C4’a), 131.8 (C3”, C5”), 131.7 (C4”), 131.0 (C8’a), 
129.5 (C8a), 129.2 (C6), 128.7 (C4’), 128.5 (C5’), 127.8 (C2”), 127.8 (C6”), 127.0 (C7’), 126.4 
(C6’), 125.3 (C3’), 125.1 (C8’), 125.0 (C2’), 120.4 (C9a), 120.0 (C5), 111.4 (C4), 106.3 (C2), 103.4 
(C8), 56.6 (OCH3), 40.0 (N(CH3)2). 
HRMS (ESI): m/z [M+] calcd. for C32H27N2O+: 455.2118; found: 455.2120. 
Absorption spectroscopy (in MeCN): labs: 590 nm; eabs: 5.8·103 L cm mol–1; lem(exc 582): 717 
nm; Stokes shift: 137 nm; E0,0: 1.90 eV; Cyclic voltammetry (vs SCE): E1/2(P*/P–): +1.22 V, 
E1/2(P/P–): –0.68 V. 
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6-(Dimethylamino)-9-(2,6-dimethylphenyl)-1-methoxy-10-phenylacridinium bromide salt 
(144e) 
 
The compound was prepared according to the general procedures C and D, using 4-bromo-
N3-(3-methoxyphenyl)-N1,N1-dimethyl-N3-phenylbenzene-1,3-diamine 139c (1.32 g, 3.33 
mmol) and methyl 2,6-dimethylbenzoate (342 mg, 2.08 mmol). Purification gave a brown red 
solid; yield: 350 mg, (33%); m.p. 121 °C (decomp.); Rf = 0.18 (CH2Cl2/MeOH 10:1). 
IR (ATR, neat): 3379w, 2925w, 2360w, 1623m, 1597s, 1503s, 1473s, 1431s, 1383m, 1343m, 
1255s, 1211m, 1097s, 1002w, 966w, 915w, 764m, 702w, 685w cm–1. 
1H NMR (500 MHz, CDCl3): d  = 7.90–7.93 (2H, m, C3”H, C5”H), 7.83–7.85 (1H, m, C4”H), 7.74 
(1H, dd, 3J 8.9, 8.2, C3H), 7.50–7.52 (2H, m, C2”H, C6”H), 7.39 (1H, d, 3J 9.7, C8H), 7.33 (1H, t, 
3J 7.6, C4’H), 7.26 (1H, dd, 3J 9.9, 4J 2.4, C7H), 7.21 (2H, d, 3J 7.6, C3’H, C5’H), 6.88 (1H, d, 3J 
7.9, C2H), 6.72 (1H, 3J 9.0, 4J 0.7, C4H), 5.82 (1H, d, 3J 2.4, C5H), 3.54 (3H, s, OCH3), 3.20 (6H, 
br, N(CH3)2), 1.90 (6H, s, 2 x CH3). 
13C NMR (125 MHz, CDCl3): d  = 159.6 (C1), 156.6 (C9), 156.3 (C6), 144.9 (C10a), 142.5 (C4a), 
137.8 (C1”), 137.3 (C1’), 136.9 (C3), 133.9 (C2’, C6’), 132.1 (C3”, C5”), 131.3 (C4”), 130.9 (C8), 
128.4 (C4’), 128.0 (C2”, C6”), 127.3 (C3’, C5’), 120.1 (C8a), 118.5 (C7), 114.5 (C9a), 110.4 (C4), 
105.4 (C2), 93.7 (C5), 56.8 (OCH3), 41.1 (N(CH3)2), 20.3 (2 x CH3). 
HRMS (ESI): m/z [M+] calcd. for C30H29N2O+: 433.2274 found 433.2282. 
Absorption spectroscopy (in MeCN): labs: 514 nm; eabs: 1.1·104 L cm mol–1; lem(exc 504): 565 
nm; Stokes shift: 51 nm; E0,0: 2.30 eV; Cyclic voltammetry (vs SCE): E1/2(P*/P–): +1.40 V, 
E1/2(P/P–): –0.90 V. 
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9-Mesityl-1-methoxy-10-phenylacridinium bromide salt (144f) 
 
The compound was prepared according to the general procedures C and D, using 2-bromo-N-
(3-methoxyphenyl)-N-phenylaniline 139b (2.27 g, 6.40 mmol) and methyl 2,4,6-
trimethylbenzoate (713 mg, 4 mmol). Purification gave an orange solid; yield: 924 mg (71%); 
m.p. 139 °C (decomp.); Rf = 0.21 (CH2Cl2/MeOH 10:1). 
IR (ATR, neat): 3002w, 2913w, 2361w, 1609m, 1582m, 1549m, 1518m, 1462s, 1372m, 1265m, 
1242s, 1189m, 1090s, 1034w, 983w, 846w, 808w, 770s, 736m, 702m, 672w, 629w cm–1. 
1H NMR (500 MHz, CDCl3): d = 8.22 (1H, dd, 3J 9.1, 8.1, C3H), 8.14 (1H, ddd, 3J 9.0, 6.8, 4J 1.6, 
C6H), 7.94–7.97 (2H, m, C3”H, C5”H), 7.88–7.91 (1H, m, C4”H), 7.80–7.82 (1H, m, C8H), 7.74 
(1H, ddd, 3J 9.0, 6.7, 4J 1.0, C7H), 7.69–7.71 (2H, m, C2”H, C6”H), 7.48–7.49 (1H, m, C5H), 7.28–
7.29 (1H, m, C2H), 7.07–7.09 (3H, m, C4H, C3’H, C5’H), 3.71 (3H, s, OCH3), 2.47 (3H, s, CH3), 
1.81 (6H, s, 2 x CH3). 
13C NMR (125 MHz, CDCl3): d = 164.3 (C9), 159.7 (C1), 143.1 (C4a), 141.5 (C3), 141.3 (C10a), 
139.0 (C6), 138.7 (C4’), 137.3 (C1”), 133.9 (C1’), 133.6 (C2’, C6’), 132.0 (C4”), 131.9 (C3”, C5”), 
129.1 (C8), 128.3 (C3’, C5’), 128.2 (C7), 127.9 (C2”, C6”), 125.5 (C8a), 119.6 (C9a), 119.5 (C5), 
111.4 (C4), 107.1 (C2), 57.6 (OCH3), 21.2 (CH3), 20.4 (2 x CH3). 
HRMS (ESI): m/z [M+] calcd. for C29H26NO+: 404.2009; found: 404.2016. 
Absorption spectroscopy (in MeCN): labs: 479 nm; eabs: 5.9·103 L cm mol–1; lem(exc 479): 601 
nm; Stokes shift: 122 nm; E0,0: 2.28 eV; Cyclic voltammetry (vs SCE): E1/2(P*/P–): +1.71 V, 
E1/2(P/P–): –0.57 V. 
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1-Methoxy-9,10-diphenylacridinium bromide salt (144g) 
 
The compound was prepared according to the general procedures C and D, using 2-bromo-N-
(3-methoxyphenyl)-N-phenylaniline 139b (2.27 g, 6.40 mmol) and methyl benzoate (545 mg, 
4.00 mmol). The purification gave a red solid; yield: 1.67 g (78%); m.p.  
135 °C (decomp.): Rf = 0.21 (CH2Cl2/MeOH 10:1). 
IR (ATR, neat): 2985w, 2161w, 1605m, 1578m, 1513m, 1468s, 1359m, 1273m, 1249s, 1197w, 
1091s, 977w, 926w, 816w, 787s, 757s, 725s, 701s, 669m, 635w cm–1. 
1H NMR (500 MHz, CDCl3): d = 8.14 (1H, dd, 3J 9.1, 8.1, C3H), 8.10 (1H, ddd, 3J 9.0, 6.8, 1.5, 
C6H), 7.91–7.94 (2H, m, C3”H, C5”H), 7.86–7.90 (2H, m, C8H, C4”H), 7.70–7.73 (3H, m, C7H, 
C2”H, 6”H), 7.60–7.63 (3H, m, C3’H, C4’H, C5’H), 7.43–7.45 (3H, m, C5H, C2’H, C6’H), 7.18 (1H, 
d, 3J 8.0, C2H), 7.04 (1H, d, 3J 8.6, C4H), 3.62 (3H, s, OCH3). 
13C NMR (125 MHz, CDCl3): d = 162.7 (C9), 159.5 (C1), 143.3 (C4a), 141.5 (C10a), 141.2 (C3), 
138.5 (C6), 137.5 (C1”), 137.3 (C1’), 131.9 (C4”), 131.8 (C3”, C5”), 130.5 (C8), 128.8 (C4’), 128.0 
(C3’, C5’), 127.9 (C2”, C6”), 127.6 (C7), 127.4 (C2’, C6’), 126.5 (C8a), 119.4 (C9a), 119.1 (C5), 
111.2 (C4), 107.1 (C2), 57.0 (OCH3). 
HRMS (ESI): m/z [M+] calcd. for C26H20NO+: 362.1539; found: 362.1543. 
Absorption spectroscopy (in MeCN): labs: 479 nm; eabs: 5.1·103 L cm mol–1; lem(exc 490): 604 
nm; Stokes shift: 125 nm; E0,0: 2.28 eV; Cyclic voltammetry (vs SCE): E1/2(P*/P–): +1.74 V, 
E1/2(P/P–): –0.54 V. 
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1-Methoxy-10-methyl-9-phenylacridinium bromide salt (144h) 
 
The compound was prepared according to the general procedures C and D, using 2-bromo-N-
(3-methoxyphenyl)-N-methylaniline 139a (1.87 g, 6.40 mmol) and methyl benzoate (545 mg, 
4.00 mmol). The purification gave a brown red solid; yield: 1.3 g (53%); m.p. at 160 °C 
(decomp.); Rf = 0.06 (CH2Cl2:MeOH 10:1). 
IR (ATR, neat): 3364w, 3012w, 1604s, 1577m, 1554m, 1516m, 1466s, 1355s, 1252s, 1176m, 
1079m, 1017m, 925w, 762s, 699s, 660s cm–1. 
1H NMR (500 MHz, CDCl3): d = 8.93 (1H, d, 3J 9.2, C5H), 8.36–8.40 (3H, m, C3H, C4H, C6H), 
7.82 (1H, dd, 3J 8.7, 4J 1.2, C8H), 7.71 (1H, dd, 3J 8.6, 6.9, C7H), 7.58–7.60 (3H, m, C3’H, C4’H, 
C5’H), 7.26–7.30 (2H, m, C2’H, C6’H), 7.13 (1H, dd, 3J 6.0, 4J 2.6, C2H), 5.18 (3H, s, NCH3), 3.58 
(3H, s, OCH3). 
13C NMR (125 MHz, CDCl3): d = 160.6 (C9), 159.4 (C1), 142.7 (C4a), 141.2 (C3), 141.1 (C10a), 
139.0 (C6), 137.6 (C1’), 130.4 (C8), 128.6 (C4’), 128.0 (C3’, C5’), 127.3 (C7), 127.2 (C2’, C6’), 
126.5 (C8a), 119.2 (C9a), 119.1 (C5), 110.7 (C4), 106.6 (C2), 56.7 (OCH3), 41.5 (NCH3). 
HRMS (ESI): m/z [M+] calcd. for C21H18NO+: 300.1383; found: 300.1380.  
Absorption spectroscopy (in MeCN): labs: 473 nm; eabs: 4.7·103 L cm mol–1; lem(exc 352): 502 
nm; Stokes shift: 29 nm; E0,0: 2.53 eV; Cyclic voltammetry (vs SCE): E1/2(P*/P–): +2.05 V, 
E1/2(P/P–): –0.48 V. 
  
Br–N
Me
1 8
MeO
4’
EXPERIMENTAL	PROCEDURES	
	 165	
Synthesis of a new generation of acridinium salts 
 
9-(4-Bromo-3-iodophenyl)-9H-carbazole (154) 
 
Prepared according to a modified literature procedure.[221] 
To a mixture of carbazole 155 (3.34 g, 20 mmol) and cesium carbonate (26.1 g, 80.0 mmol) in 
DMF (80 mL) was added 2-t-Bu-aniline (0.94 mL, 6.03 mmol) was added 1-bromo-4-fluoro-2-
iodobenzene 156 (10.5 mL, 80.0 mmol) and the reaction mixture was heated for 24 h at 
150 °C. Brine (600 mL) was added and the aqueous layer was extracted with CH2Cl2 (3 x 600 
mL), the combined organic layer was dried over Na2SO4 and the solvent was removed in 
vacuo. The crude was purified by column chromatography (Pentane/CH2Cl2 50:1 to 10:1) to 
afford 154 as a white solid; yield: 2.52 g (28%); m.p. 102.0–142.4 °C; Rf = 0.63 (pentane/CH2Cl2 
10:1). 
IR (ATR, neat): 3589w, 3056w, 2922s, 2833m, 2361s, 1909w, 1747w, 1596w, 1453s, 1336m, 
1230s, 1177m, 1011m, 819m, 749s cm–1. 
1H NMR (500 MHz, CDCl3): d = 8.13 (d, 3J = 7.6 Hz, 2 H, C4’Hx2), 8.08 (d, 3J = 2.3 Hz, 1 H, C2H), 
7.83 (d, 3J = 8.5 Hz, 1 H, C5H), 7.45 (d, 3J = 8.5 Hz, 1 H, C6H), 7.44 (t, 3J = 8.1 Hz, 2 H, C2’Hx2), 
7.38 (d, 3J = 7.8 Hz, 2 H, C1’Hx2), 7.31 (t, 3J = 8.1 Hz, 2 H, C3’Hx2). 
13C NMR (125 MHz, CDCl3): d = 140.4 (C1’a), 138.5 (C2), 137.5 (C1), 133.6 (C5), 128.4 (C4), 
128.1 (C6) 126.3 (C2’), 123.6 (C4’a), 120.6 (C3’), 120.5 (C4’), 109.5 (C1’), 102.0 (C3). 
HRMS (ESI): m/z [M + H+] calcd. for C18H12F3NBrI+: 447.9192; found: 447.9189. 
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2-Bromo-5-(9H-carbazol-9-yl)-N-phenylaniline (153a) 
 
 
To a degassed mixture of 154 (269 mg, 0.60 mmol), tris(dibenzylideneacetone)dipalladium(0) 
(13.7 mg, 15.0 µmol), 1,1’-bis(diphenylphosphino)ferrocene (16.6 mg, 30.0 µmol) and sodium 
t-butoxide (86.5 mg, 0.90 mmol) was added aniline (0.05 mL, 0.60 mmol) and toluene (2 mL) 
at RT. The reaction mixture was stirred for 14 h at 105 °C. The solution was diluted with H2O 
(3 mL) and extracted with CH2Cl2 (3 x 6 mL). The combined organic layer was dried over Na2SO4 
and concentrated in vacuo. The crude was purified by column chromatography on silica gel 
(pentane/CH2Cl2 100:1) giving 153a as a white solid; yield: 234 mg (94%); m.p. 140.6–154.6 
°C; Rf 0.42 (pentane/CH2Cl2 10:1) 
IR (ATR, neat): 3401w, 2925w, 2362s, 1554m, 1501m, 1451m, 1312w, 1227m, 1167w, 1027w, 
940w, 808s, 750w cm–1. 
1H NMR (500 MHz, CDCl3): d = 8.14 (d, 3J = 7.7 Hz, 2 H, C4’Hx2), 7.74 (d, 3J = 8.5 Hz, 1 H, C3H), 
7.43 (m, 4 H, C1’Hx2, C2’Hx2), 7.39 (d, 4J = 1.7 Hz, 1 H, C6H), 7.31 (m, 4 H, C3’Hx2, C3”Hx2), 
7.22 (dd, 3J = 7.8 Hz, 4J = 1 Hz, 2 H, C2”Hx2), 7.05 (td, 3J = 7.5 Hz, 4J = 1 Hz, 1 H, C4’’H), 6.94 (dd, 
3J = 8.5 Hz, 4J = 1.7 Hz, 1 H, C4H). 
13C NMR (125 MHz, CDCl3): d = 143.2 (C1), 140.7 (C1’a, C1”), 138.5 (C2), 137.9 (C5), 134.0 (C3), 
129.7 (C3”), 126.0 (C2’), 123.7 (C4”), 123.4 (C4’a), 121.2 (C2”), 120.3 (C4’), 120.0 (C3’), 118.9 
(C4), 113.4 (C6), 109.9 (C2), 109.8 (C2). 
HRMS (ESI): m/z [M + H+] calcd. for C24H18N2Br+: 413.0648; found: 413.0641. 
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2-Bromo-N-(2-bromo-5-(9H-carbazol-9-yl)phenyl)-5-(9H-carbazol-9-yl)-N-phenylaniline 
(153) 
 
To a degassed mixture of 153a (1.24 g, 3 mmol), tris(dibenzylideneacetone)dipalladium(0) 
(137 mg, 0.15 mmol), RuPhos (308 mg, 0.66 mmol) and sodium t-butoxide (432 mg, 4.5 mmol) 
and 154 (1.34 g, 3 mmol) was added toluene (10 mL) at RT. The reaction mixture was stirred 
for 14 h at 105 °C. The solution was diluted with H2O (15 mL) and extracted with CH2Cl2 (3 x 
30 mL). The combined organic layer was dried over Na2SO4 and concentrated in vacuo. The 
crude was purified by column chromatography on silica gel (pentane/CH2Cl2 100:1) giving 153 
as a white solid; yield: 1.08 g (33%); m.p. 240.0–280.1 °C; Rf 0.27 (pentane/CH2Cl2 10:1). 
IR (ATR, neat): 3417w, 3047w, 2361w, 1583m, 1475m, 1311w, 1227m, 1038w, 918w, 816m, 
744s, 647m cm–1. 
1H NMR (500 MHz, CDCl3): d = 8.08 (d, 3J = 7.8 Hz, 4 H, C4’Hx4), 7.86 (d, 3J = 8.5 Hz, 2 H, C3Hx2), 
7.36–7.24 (m, 18 H, CHar), 7.07 (td, 3J = 7.5 Hz, 4J = 1 Hz, 1 H, C4’’H), 7.03 (dd, 3J = 8.5 Hz, 4J = 
1 Hz, 2 H, C4Hx2). 
13C NMR (125 MHz, CDCl3): d = 146.9 (Car), 140.3 (Car), 138.1 (Car), 135.9 (C3), 129.4 (Car), 127.0 
(Car), 126.1 (Car), 124.5 (Car), 123.5 (Car), 123.4 (C4”), 122.4 (C4), 120.4 (Car), 120.3 (C4’),119.6 
(Car), 109.6 (C1’). 
HRMS (ESI): m/z [M + H+] calcd for C42H28N3Br+: 732.0644; found: 732.0643. 
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3,6-Di(9H-carbazol-9-yl)-9-mesityl-10-phenylacridin-10-ium bromide (152): 
 
To a suspension of magnesium turnings (27.2 mg, 1.12 mmol) in a mixture of anhydrous THF 
(0.4 mL) at 60 °C was added a solution of 153 (205 mg, 0.28 mmol) in a mixture of anhydrous 
Me-THF and toluene 1:1 (1.2 mL) followed by 1,2-dibromoethane (6.00 µL, 84.0 µmol). The 
mixture was stirred at 60 °C for 3 h during which the reaction mixture turned yellow. To this 
solution at 60 °C was added a solution of mesityl methyl ester (35.6 mg, 0.20 mmol) in 
anhydrous THF (1 mL) and the reaction mixture was stirred at the same temperature for 12 h. 
Aqueous HBr (1 mL, 8.8 molL-1) was added and the aq. phase extracted with CHCl3/i-PrOH (3 
x 2 mL; 85:15). The solvent was removed in vacuo and the residue was triturated in Et2O (1 
mL) giving 152 as a purple solid; yield: 49 mg (31%); decomp. at 350 °C; Rf 0.32 (CH2Cl2/MeOH 
10:1). 
IR (ATR, neat): 3727w, 3057w, 2925w, 2361s, 1599s, 1452s, 1331s, 1227m, 1131w, 930w, 
818s, 771s, 722s, 645s cm–1. 
1H NMR (500 MHz, MeOD): d = 8.27 (dd, 3J = 9.4 Hz, 4J = 2 Hz, 2 H, C2H, C7H), 8.17 (d, 3J = 9.4 
Hz, 2 H, C1H, C8H), 8.12 (d, 3J = 7.8 Hz, 4 H, C4’Hx4), 8.07 (d, 3J = 7.4 Hz, 2 H, C2”Hx2), 7.92 
(dd, 3J = 7.4 Hz, 3J = 7.7 Hz, 2 H, C3”Hx2), 7.79 (t, 3J = 7.7 Hz, 1 H, C4’’H), 7.70 (d, 4J = 2 Hz, 2 H, 
C4H, C5H), 7.66 (d, 3J = 8.3 Hz, 4 H, C1’Hx4), 7.42 (dd, 3J = 8.3 Hz, 3J = 1.5 Hz, 4 H, C2’Hx4), 
7.36–7.33 (m, 6 H, C3”Hx2, C3’Hx4), 2.55 (s, 3H, CH3), 2.09 (s, 6H, CH3x2). 
13C NMR (125 MHz, MeOD): d = 163.5 (C9), 148.4 (C4a), 145.3 (C3), 142.0 (C4”’), 140.3 (C1’a), 
138.7 (C1”), 137.7 (C1”’), 132.7 (C1, C3”), 130.5 (C2”’), 130.2 (C3”’), 129.6 (C2”), 128.0 (C2’), 
127.3 (C2), 126.4 (C4’a), 125.4 (C9a), 123.8 (C3’), 121.8 (C4’), 114.6 (C4), 111.2 (C1’), 21.4 
(CH3), 20.3 (CH3x2).   
HRMS (ESI): m/z [M+] calcd for C52H38N3+: 704.3060; found: 704.3068. 
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4-Bromo-1-chloro-2-iodobenzene (183) 
[CAS Reg. No.: 774608-49-0] 
 
To a suspension of 5-bromo-2-chloroaniline 184 (10.3 g, 50.0 mmol) in HCl 37% (10 mL) and 
water 50 mL at 0 °C was added a solution of sodium nitrite (4.14 g, 60.0 mmol) in water (20 
mL) over 5 min. The dark red brown mixture was stirred at 0 °C for 45 min and was added to 
a solution of potassium iodide (16.6 g, 100 mmol) in water (100 mL) at 0 °C. The reaction 
mixture was stirred at 0 °C for 30 min and at RT for 2 h. The reaction was extracted with Et2O 
(3x1000 mL) and the organic phase was washed with 2M HCl (3x750 mL), NaHCO3 (2x500 mL) 
and brine (1000 mL). The organic phase was dried over Na2SO4 and the solvent removed in 
vacuo. The crude mixture was used without further purification. 
The spectral data were in agreement with literature data.[222]  
 
Bis(5-bromo-2-chlorophenyl)amine (182) 
 
To a degassed mixture of 4-bromo-1-chloro-2-iodobenzene 183 (635 mg, 2.00 mmol), 5-
bromo-2-chloro-aniline 184 (413 mg, 2.00 mmol), tris(dibenzylideneacetone)dipalladium(0) 
(45.8 mg, 0.05 mmol), 1,1’-bis(diphenylphosphino)ferrocene (55.4 mg, 0.10 mmol) and 
sodium t-butoxide (288 mg, 3.00 mmol) was added toluene (6 mL) at RT. The reaction mixture 
was stirred for 1 h at 105 °C. The solution was diluted with H2O (8 mL) and extracted with 
CH2Cl2 (3 x 15 mL). The combined organic layer was dried over Na2SO4 and concentrated in 
vacuo. The crude was purified by column chromatography on silica gel (pentane/CH2Cl2 100:1) 
giving 182 as a white solid; yield: 698 mg (88%); m.p. 114.5–127.9 °C; Rf 0.67 (pentane/CH2Cl2 
10:1). 
IR (ATR, neat): 1588m, 1512m, 1313w, 1046w, 918w, 869w, 803w, 642s, 620s cm–1. 
1H NMR (500 MHz, CDCl3): d = 7.41 (d, 4J = 2.3 Hz, 2 H, C6H), 7.28 (d, 3J = 8.5 Hz, 1 H, C3H), 
7.08 (dd, 3J = 8.5 Hz, 4J = 2.3 Hz, 1 H, C4H).  
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13C NMR (125 MHz, CDCl3): d = 139.3 (C1), 131.1 (C3), 125.6 (C4), 122.8 (C2), 121.0 (C5), 120.7 
(C6).  
HRMS (ESI): m/z [M – H–] calcd. for C12H6NBr2Cl2–: 391.8250; found: 391.8246. 
 
Bis(5-(9H-carbazol-9-yl)-2-chlorophenyl)amine (185): 
 
To a degassed mixture of 182 (1.98 g, 5.00 mmol), tris(dibenzylideneacetone)dipalladium(0) 
(229 mg, 0.25 mmol), Ruphos (425 mg, 1.00 mmol), sodium t-butoxide (1.44 g, 15.0 mmol) 
and carbazole (1.84 g, 11.0 mmol) was added toluene (25 mL) at RT. The reaction mixture was 
stirred for 14 h at 105 °C. The solution was diluted with H2O (30 mL) and extracted with CH2Cl2 
(3 x 40 mL). The combined organic layer was dried over Na2SO4 and concentrated in vacuo. 
The crude was purified by column chromatography on silica gel (pentane/CH2Cl2 5:1) giving 
185 as a white solid; yield: 2.03 g (72%); m.p. 183.0–191.5 °C; Rf 0.54 (pentane/CH2Cl2 1:1). 
IR (ATR, neat): 3623w, 3386w, 2361s, 1891w, 1575m, 1493m, 1450s, 1312m, 1226s, 1163m, 
1047m, 919w, 813s, 767s, 722s, 681s cm–1. 
1H NMR (500 MHz, CDCl3): d = 8.07 (d, 3J = 7.6 Hz, 4 H, C4’Hx4), 7.62 (d, 3J = 8.9 Hz, 2 H, C3Hx2), 
7.58 (d, 4J = 2.5 Hz, 2 H, C6Hx2), 7.24 (d, 3J = 8.2 Hz, 4 H, C1’Hx4), 7.17 (td, 3J = 7.6 Hz, 4J = 1 
Hz, 4 H, C3’Hx4), 7.12 (dd, 3J = 8.9 Hz, 4J = 2.5 Hz, 2 H, C4Hx2), 7.01 (ddd, 3J = 7.6 Hz, 3J = 8.2 
Hz, 4J = 1 Hz, 1 H, C2’Hx4). 
13C NMR (125 MHz, CDCl3): d = 140.4 (C1’a), 139.5 (C1), 137.3 (C5), 131.2 (C3), 126.0 (C2’), 
123.4 (C4’a), 122.2 (C2), 120.9 (C4), 120.2 (C3, C4’), 116.0 (C6), 109.5 (C1’). 
HRMS (ESI): m/z [M + H+] calcd. for C36H24N3Cl2+: 568.1342; found: 568.1331. 
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N-(5-(9H-Carbazol-9-yl)-2-chlorophenyl)-5-(9H-carbazol-9-yl)-2-chloro-N-methylaniline  
(187)  
 
To a solution of 185 (56.9 mg, 0.10 mmol) in THF (1 mL) at RT was added sodium hydride (60% 
dispersion in mineral oil, 12.0 mg, 0.30 mmol). The suspension was heated to 75 °C and stirred 
for 30 min at this temperature. Iodomethane (6.23 µL, 0.1 mmol) was added within 5 min at 
75 °C and the reaction mixture was stirred for 2 h at this temperature. The suspension was 
treated with water (3 mL) and extracted with CH2Cl2 (3 x 5 mL). The combined organic layers 
were dried over Na2SO4 and concentrated in vacuo. The crude solid was recrystallized from 
pentane/EtOH to give 187 as a white solid; yield: 38.0 mg (65%); m.p. 80.2–120.0°C; Rf 0.62 
(pentane/CH2Cl2 1:1) 
IR (ATR, neat): 3058w, 2924w, 2361w, 1897w, 1587m, 1478s, 1227s, 1132w, 1042w, 919w, 
881w, 816m, 747s, 655m cm–1. 
1H NMR (500 MHz, CDCl3): d = 8.12 (d, 3J = 7.7 Hz, 4 H, C4’H), 7.64 (d, 3J  = 8.4 Hz, 2 H, C3H), 
7.38 (m, 4 H, C2’H), 7.34 (d, 3J = 7.8 Hz, 4 H, C1’H), 7.30 (d, 3J  = 2.4 Hz, 2 H, C6H), 7.29–7.25 
(m, 8 H, C3’H, C4H), 3.35 (s, 3H, NCH3). 
13C NMR (125 MHz, CDCl3): d = 147.9 (C1), 140.6 (C1’a), 137.3 (C5), 132.3 (C3), 127.8 (C2), 
126.1 (C2’), 123.4 (C4’a), 123.1 (C4), 122.1 (C6), 120.4 (C4’), 120.2 (C3’), 109.6 (C1’). 
HRMS (ESI): m/z calcd. for C37H26Cl2N3+ 582.1498 found 582.1494 [M+H+]. 
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5-Methoxy-9-phenyl-9H-2,9'-bicarbazole (190a) 
 
To a degassed mixture of 141 (199 mg, 1.00 mmol), 154 (448 mg, 1.00 mmol) 
tris(dibenzylideneacetone)dipalladium(0) (45.8 mg, 0.05 mmol), RuPhos (103 mg, 0.22 mmol) 
and sodium t-butoxide (288 mg, 3.00 mmol) was added toluene (5 mL) at RT. The reaction 
mixture was stirred for 14 h at 105 °C. The solution was diluted with H2O (5 mL) and extracted 
with CH2Cl2 (3 x 10 mL). The combined organic layer was dried over Na2SO4 and concentrated 
in vacuo. The crude was purified by column chromatography on silica gel (pentane/CH2Cl2 
100:1) giving 190a as a white solid; yield: 125 mg (29%); m.p. 144.4–183.4 °C; Rf 0.34 
(pentane/CH2Cl2 10:1). 
IR (ATR, neat): 3626w, 2361m, 1597m, 1442m, 1331w, 1229m, 1164m, 1030w, 931w, 818m, 
747s, 724s cm–1. 
1H NMR (500 MHz, CDCl3): d = 8.60 (d, 3J = 8.3 Hz, 1 H, C5H), 8.15 (d, 3J = 8.0 Hz, 2 H, C4’Hx2), 
7.57 (m, 2 H, C3”Hx2), 7.55 (m, 1 H, C4’’H), 7.52 (d, 4J = 2.0 Hz, 1 H, C8H), 7.46 (dd, 3J = 8.3 Hz, 
4J = 2.0 Hz, 1 H, C6H), 7.37–7.42 (m, 7 H, C2’’Hx2, C1’Hx2, C2’Hx2, C2H), 7.27 (m, 2 H, C3’Hx2), 
7.06 (d, 3J = 8.3 Hz, 1 H, C1H), 6.81 (d, 3J = 8.4 Hz, 1 H, C3H), 4.17 (s, 3 H, OCH3). 
13C NMR (125 MHz, CDCl3): d = 156.4 (C4), 143.2 (C1a), 141.8 (C1’a), 141.0 (C7), 137.4 (C1”), 
134.6 (C8a), 130.0 (C4”), 127.8 (C2”), 127.2 (C2), 127.1 (C3”), 125.9 (C2’), 124.2 (C5), 123.2 
(C4’a), 122.2 (C5a), 120.2 (C4’), 119.7 (C3’), 119.6 (C6), 112.3 (C4a), 109.9 (C1’), 108.2 (C8), 
103.0 (C1), 101.3 (C3), 55.7 (CH3). 
HRMS (ESI): m/z [M + H+] calcd. for C31H23N2O+:439.1805; found: 439.1807. 
  
4
1 N
5
8
OMe
4"
N
4'1'
EXPERIMENTAL	PROCEDURES	
	 173	
7-Methoxy-9-phenyl-9H-2,9'-bicarbazole (190b): 
 
To a degassed mixture of 141 (199 mg, 1.00 mmol), 154 (448 mg, 1.00 mmol) 
tris(dibenzylideneacetone)dipalladium(0) (45.8 mg, 0.05 mmol), RuPhos (103 mg, 0.22 mmol) 
and sodium t-butoxide (288 mg, 3.00 mmol) was added toluene (5 mL) at RT. The reaction 
mixture was stirred for 14 h at 105 °C. The solution was diluted with H2O (5 mL) and extracted 
with CH2Cl2 (3 x 10 mL). The combined organic layer was dried over Na2SO4 and concentrated 
in vacuo. The crude was purified by column chromatography on silica gel (pentane/CH2Cl2 
100:1) giving 190b as a white solid; yield: 79.0 mg (18%); m.p. 111.0–150.6 °C; Rf 0.22 
(pentane/CH2Cl2 10:1). 
IR (ATR, neat): 3050w, 2924w, 2362m, 1596m, 1496m, 1451m, 1266w, 1229m, 1156w, 
1092m, 1000s, 919w, 821s, 748w, 721m, 648m cm–1. 
1H NMR (500 MHz, CDCl3): d = 8.21 (d, 3J = 8.3 Hz, 1 H, C5H), 8.15 (d, 3J = 8.0 Hz, 2 H, C4’Hx2), 
8.08 (d, 3J = 8.6 Hz, 1 H, C4H), 7.57–7.55 (m, 4 H, C2”Hx2, C3”Hx2), 7.47 (d, 4J = 2.0 Hz, 1 H, 
C8H), 7.43–7.41 (m, 2 H, C4”H, C6H), 7.38 (m, 4 H, C1’Hx2, C2’Hx2), 7.27 (m, 2 H, C3’Hx2), 
6.97 (dd, 3J = 8.6 Hz, 4J = 2.2 Hz, 1 H, C3H), 6.90 (d, 4J = 2.2 Hz, 1 H, C1H), 3.87 (s, 3 H, OCH3). 
13C NMR (125 MHz, CDCl3): d = 159.5 (C2), 143.1 (C1a), 141.8 (C7), 141.5 (C1’a), 137.2 (C1”), 
134.3 (C8a), 130.1 (C2”), 127.9 (C4”), 127.0 (C3”), 125.9 (C2’), 123.2 (C4’a), 123.0 (C5a), 121.2 
(C4), 120.4 (C5), 120.2 (C4’), 119.7 (C3’), 119.5 (C6), 116.8 (C4a), 109.8 (C1’), 109.2 (C3), 108.7 
(C8), 94.2 (C1), 55.7 (CH3). 
HRMS (ESI): m/z [M + H+] calcd. for C31H23N2O+:439.1805; found: 439.1807. 
 
N1,N1,N3-Triphenylbenzene-1,3-diamine (193) 
 
Prepared according to a modified literature procedure.[223] 
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To a degassed mixture of 1-bromo-3-iodobenzene 191 (2.55 g, 9.00 mmol), diphenylamine 
192 (1.52 g, 9.00 mmol) palladium acetate (II) (20.2 mg, 0.09 mmol), XantPhos ( 52.1 mg, 0.09 
mmol) and sodium t-butoxide (2.60 g, 27.0 mmol) was added toluene (18 mL) at RT. The 
reaction mixture was stirred for 15 min at 110 °C. After this time, aniline (0.86 mL, 9.45 mmol) 
was added and the reaction mixture stirred for an additional 3 h.15 The solution was diluted 
with H2O (20 mL) and extracted with CH2Cl2 (3 x 30 mL). The combined organic layer was dried 
over Na2SO4 and concentrated in vacuo. The crude was dissolved in CH2Cl2, filtered through a 
plug of silica and was used without any further purification. 
 
4-Bromo-N1,N1,N3-triphenylbenzene-1,3-diamine (194) 
 
Prepared according to a modified literature procedure.[224] 
To a solution of 193 (3.03 g, 9.00 mmol) in CH2Cl2 (80 mL) at 0 °C was added NBS (1.60 g, 9.00 
mmol) and the reaction mixture stirred at this temperature for 1 h. The solution was diluted 
with H2O (100 mL) and extracted with CH2Cl2 (3 x 150 mL). The combined organic layer was 
dried over Na2SO4 and concentrated in vacuo. The crude was submitted to a column 
chromatography on silica gel (Cyclohexane/EtOAc 200:1) followed by recrystallizations in 
(MeOH, EtOH, H2O) however the product could not be purified and was used as is in the next 
reaction. 
 
15 If a full conversion is not achieved after 3 h, Pd2dba3 (5 mol%) along with dppf (10 mol%) can be added to 
drive the reaction to completion. 
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General procedure E: 
To a solution of tertiary amine 196 (1.40 mmol) in Et2O (1.7 mL) and n-hexane (17 mL) was 
added a solution of n-butyllithium in hexanes (1.75 mL, 1.60 molL–1, 2.80 mmol) at RT. The 
mixture was stirred for 5 h at 65 °C. The reaction mixture was directly used in the next step. 
 
General procedure F: 
To the reaction mixture of the metalated aryl aniline in n- hexane/Et2O (18.7 mL) at −20 °C 
was added a solution of carboxylic acid ester (1.00 mmol) in anhydrous THF (3.6 mL) and the 
reaction mixture was allowed to warm to RT over 12 h. Aqueous HBr (9 mL, 48%) was added, 
followed by water (40 mL) and the mixture was extracted by CHCl3/i-PrOH solution (4 × 80 
mL; 85:15). The combined organic layer was dried over Na2SO4, filtered and concentrated in 
vacuo. The crude was purified by column chromatography on silica gel (CH2Cl2/ MeOH 100:0.5 
to 100:5) affording acridinium salts 197a–d. 
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9-(2,6-Dimethylphenyl)-6-(diphenylamino)-1-methoxy-10-phenylacridin-10-ium bromide 
salt (197a) 
 
The compound was prepared according to the general procedures E and F, using 4-bromo-
N1,N1,N3-triphenylbenzene-1,3-diamine 194 (730 mg, 1.40 mmol) and methyl 2,6-
dimethylbenzoate (164 mg, 1.00 mmol). Purification gave a black red solid; yield: 239 mg 
(42%); decomp. > 350 °C; Rf = 0.61 (CH2Cl2/MeOH 10:1). 
IR (ATR, neat): 3372w, 2361w, 1939w, 1587s, 1469s, 1342m, 1243s, 1171w, 1098m, 1005w, 
907w, 818s, 756s, 641s cm–1. 
1H NMR (500 MHz, CDCl3): d = 7.87 (1H, dd, 3J 8.6, 8.3, C3H), 7.70–7.63 (3H, m, C3”H, C4”H, 
C5”H), 7.50 (2H, m, C2”H, C6”H), 7.42–7.39 (5H, m, C8H, C3”’H x 2, C5”’H x 2), 7.36 (1H, t, 3J 
7.5, C4’H), 7.32 (2H, t, 3J 7.5, C4”’H x 2), 7.24 (1H, t, 3J 7.5, C4’H), 7.27–7.23 (6H, m, C3’H, C5’H, 
C2”’H x 2, C6”’H x 2), 7.17 (1H, dd, 3J 9.3, 4J 2.0, C7H), 7.07 (1H, d, 3J 8.6, C2H), 6.86 (1H, d, 3J 
8.3, C4H), 6.11 (1H, d, 4J 2.0, C5H), 3.56 (3H, s, OCH3), 1.92 (6H, s, 2 x CH3). 
13C NMR (125 MHz, CDCl3): d = 161.0 (C1), 159.1 (C6), 157.4 (C9), 146.2 (C10a), 144.7 (C1”’), 
144.1 (C4a), 139.3 (C1”), 139.0 (C3), 138.8 (C2’, C6’), 135.2 (C1”), 132.4 (C3”, C4”, C5”), 131.4 
(C8, C3”’, C5”’), 129.6 (C4’), 129.2 (C2”, C6”), 129.0 (C4”’), 128.4 (C2”’, C6”’), 128.2 (C3’, C5’), 
122.2 (C7), 122.6 (C8a), 117.2 (C9a), 111.8 (C4), 106.8 (C2), 101.1 (C5), 57.3 (OCH3), 20.2 (2 x 
CH3). 
HRMS (ESI): m/z [M+] calcd. for C40H33N2O+: 557.2587; found: 557.2587. 
Absorption spectroscopy (in MeCN): labs: 502 nm; eabs: 9.9·103 L cm mol–1; lem(exc 510): 726 
nm; Stokes shift: 224 nm; E0,0: 2.13 eV; Cyclic voltammetry (vs SCE): E1/2(P*/P–): +1.37 V, 
E1/2(P/P–): –0.76 V. 
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6-(Diphenylamino)-9-mesityl-1-methoxy-10-phenylacridin-10-ium bromide salt (197b) 
 
The compound was prepared according to the general procedures E and F, using 4-bromo-
N1,N1,N3-triphenylbenzene-1,3-diamine 194 (730 mg, 1.40 mmol) and methyl 2,4,6-
trimethylbenzoate (178 mg, 1.00 mmol). Purification gave a black red solid; yield: 291 mg 
(51%); decomp. > 350 °C; Rf = 0.54 (CH2Cl2/MeOH 10:1). 
IR (ATR, neat): 3729w, 3629w, 2975w, 2361s, 1386m, 1468m, 1341m, 1241m, 1171w, 1095w, 
1004w, 817s, 739s, 698s, 644s cm–1. 
1H NMR (500 MHz, CDCl3): d = 7.86 (1H, dd, 3J 8.6, 8.3, C3H), 7.70–7.63 (3H, m, C3”H, C4”H, 
C5”H), 7.49 (2H, m, C2”H, C6”H), 7.43–7.39. (5H, m, C8H, C3”’H x 2, C5”’H x 2), 7.31 (2H, t, 3J 
7.5, C4”’H x 2), 7.24 (1H, t, 3J 7.5, C4’H), 7.17 (1H, dd, 3J 9.3, 4J 2.0, C7H), 7.09 (2H, s, C3’H, 
C5’H), 7.07 (1H, d, 3J 8.6, C2H), 6.86 (1H, d, 3J 8.3, C4H), 6.10 (1H, d, 4J 2.0, C5H), 3.57 (3H, s, 
OCH3), 2.42 (3H, s, CH3), 1.92 (6H, s, 2 x CH3). 
13C NMR (125 MHz, CDCl3): d = 161.1 (C1), 159.7 (C6), 157.4 (C9), 146.1 (C10a), 144.8 (C1”’), 
144.0 (C4a), 139.4 (C1”), 139.3 (C4’), 139.0 (C3), 135.9 (C1”), 135.1 (C2’, C6’), 132.4 (C3”, C4”, 
C5”), 131.4 (C8, C3”’, C5”’), 129.2 (C2”, C6”), 129.1 (C3’, C5’), 129.0 (C4”’), 128.2 (C2”’, C6”’), 
122.8 (C8a), 122.0 (C7), 117.4 (C9a), 111.7 (C4), 106.8 (C2), 101.1 (C5), 57.3 (OCH3), 21.2 (CH3), 
20.2 (2 x CH3). 
HRMS (ESI): m/z [M+] calcd. for C41H35N2O+: 571.2744; found: 571.2748. 
Absorption spectroscopy (in MeCN): labs: 504 nm; eabs: 1.4·104 L cm mol–1; lem(exc 510): 698 
nm; Stokes shift: 194 nm; E0,0: 2.34 eV; Cyclic voltammetry (vs SCE): E1/2(P*/P–): +1.57 V, 
E1/2(P/P–): –0.77 V. 
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6-(Diphenylamino)-1-methoxy-9-(naphthalen-1-yl)-10-phenylacridin-10-ium bromide salt 
(197c) 
 
The compound was prepared according to the general procedures E and F, using 4-bromo-
N1,N1,N3-triphenylbenzene-1,3-diamine 194 (730 mg, 1.40 mmol) and methyl 1-
naphtoate (186 mg, 1.00 mmol). Purification gave a black red solid; yield: 291 mg (51%); 
decomp. > 350 °C; Rf = 0.55 (CH2Cl2/MeOH 10:1). 
IR (ATR, neat): 3728w, 2978w, 2361s, 1586m, 1649m, 1340w, 1243m, 1170w, 1098w, 967w, 
807w, 755s, 697m, 643m, 620s cm–1. 
1H NMR (500 MHz, CDCl3): d = 8.10 (1H, d, 3J 7.8, C4’H), 8.05 (1H, d, 3J 7.8, C5’H), 7.86 (1H, dd, 
3J 8.6, 8.3, C3H), 7.73–7.6 (5H, m, C3’H, C3”H, C4”H, C5”H), 7.59 (1H, m, C6”H), 7.55 (1H, m, 
C6’H), 7.50 (1H, m, C2”H), 7.42 (1H, m, C2’H), 7.39–7.33 (7H, m, C8H, C7’H, C8’H, C3”’H x 2, 
C5”’H x 2), 7.28 (2H, t, 3J 7.5, C4”’H x 2), 7.22 (4H, m, C2”’H x 2, C6”’H x 2), 7.05 (1H, dd, 3J 9.3, 
4J 2.0, C7H), 6.95 (1H, d, 3J 8.6, C2H), 6.88 (1H, d, 3J 8.3, C4H), 6.13 (1H, d, 4J 2.0, C5H), 3.15 
(3H, s, OCH3). 
13C NMR (125 MHz, CDCl3): d = 160.6 (C1), 158.2 (C6), 157.3 (C9), 146.3 (C10a), 144.8 (C1”’), 
144.0 (C4a), 139.5 (C1”), 138.9 (C3), 137.2 (C1’), 134.5 (C4’a), 133.1 (C8’a), 132.4 (C3”, C4”, 
C5”), 131.4 (C8, C3”’, C5”’), 129.8 (C4’), 129.5 (C5’), 129.2 (C8’), 129.1 (C2”, C6”), 128.9 (C4”’), 
128.1 (C2”’, C6”’), 127.9 (C7’), 127.5 (C6’), 126.5 (C2’), 126.1 (C3’), 124.1 (C8a), 121.7 (C7), 
117.2 (C9a), 111.6 (C4), 107.1 (C2), 101.1 (C5), 56.9 (OCH3). 
HRMS (ESI): m/z [M+] calcd. for C42H31N2O+: 579.2431; found: 579.2433. 
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6-(Diphenylamino)-1-methoxy-9,10-diphenylacridin-10-ium bromide salt (197d) 
 
The compound was prepared according to the general procedures E and F, using 4-bromo-
N1,N1,N3-triphenylbenzene-1,3-diamine 194 (730 mg, 1.40 mmol) and methyl 
benzoate (136 mg, 1.00 mmol). Purification gave a black red solid; yield: 291 mg (51%); 
decomp. > 350 °C; Rf = 0.47 (CH2Cl2/MeOH 10:1). 
IR (ATR, neat): 3729w, 2978w, 2361s, 1585m, 1470m, 1340w, 1243m, 1171w, 1096w, 1002w, 
813m, 754s, 697m cm–1. 
1H NMR (500 MHz, CDCl3): d = 7.86 (1H, dd, 3J 8.6, 8.3, C3H), 7.70–7.64 (3H, m, C3”H, C4”H, 
C5”H), 7.60–7.57 (3H, m, C3’H, C4’H, C5’H), 7.53 (1H, d, 3J 10.0, C8H), 7.45 (2H, m, C2”H, 
C6”H), , 7.42–7.39 (6H, m, C2’H, C6’H, C3”’H x 2, C5”’H x 2), 7.30 (2H, t, 3J 7.5, C4”’H x 2), 7.22 
(4H, m, C2”’H x 2, C6”’H x 2), 7.15 (1H, dd, 3J 9.3, 4J 2.0, C7H), 7.05 (1H, d, 3J 8.6, C2H), 6.83 
(1H, d, 3J 8.3, C4H), 6.10 (1H, d, 4J 2.0, C5H), 3.56 (3H, s, OCH3). 
13C NMR (125 MHz, CDCl3): d = 160.8 (C1), 159.2 (C6), 157.1 (C9), 146.2 (C10a), 144.8 (C1”’), 
144.0 (C4a), 139.5 (C1’), 139.4 (C1”), 139.0 (C3), 135.2 (C1”), 132.7 (C8), 132.4 (C3”, C4”, C5”), 
131.4 (C3”’, C5”’), 129.1 (C2”, C6”), 129.0 (C3’, C4’, C5’), 128.9 (C4”’), 128.7 (C2’, C6’), 128.1 
(C2”’, C6”’), 123.5 (C8a), 121.4 (C7), 117.2 (C9a), 111.4 (C4), 107.1 (C2), 101.0 (C5), 56.9 
(OCH3). 
HRMS (ESI): m/z [M+] calcd. for C38H29N2O+:529.2274; found: 529.2281. 
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 Photoredox catalysis 
 
Photocatalyzed deuteration  
 
General procedure G: 
According to a modified literature procedure.[200] To a mixture of triisopropylsilanethiol (5.71 
mg, 30 μmol), lithium carbonate (35.5 mg, 480 μmol), photocatalyst (2.5 mol%, see table 
below) and deuterium oxide (90.0 μL, 5.00 mmol) in N-methylpyrrolidone (1.6 mL) was added 
clomipramine hydrochloride (33.7 mg, 100 μmol) and was degassed by a stream of argon for 
20 min. The reaction was performed under argon atmosphere for 24 h with the light on. The 
reaction mixture was diluted in EtOAc (15 mL), washed with brine (20 mL) and extracted with 
EtOAc (3 x 15 mL). The combined organic layer was concentrated in vacuo and column 
chromatographed on silica gel with n-hexane:acetone:Et3N, 96:2:2 to afford clomipramine 
free base. Rf 0.34 (n-hexane:acetone:Et3N, 8:1:1); clomipramine free base (deuterated using  
144b as photocatalyst). 
1H NMR (500 MHz, MeOD): d = 7.12–7.17 (m, 3H), 7.09–7.10 (m, 1H), 7.02–7.03 (m, 1H), 6.95–
6.98 (m, 1H), 6.85–6.87 (m, 1H), 3.73–3.76 (m, 1.75H, 12% 2H, C1’H), 3.07–3.15 (m, 4H, C5H, 
C6H), 2.33–2.40 (m, 1.03H, 49% 2H, C3’H), 2.11–2.15 (m, 4.16H, 30% 2H, N(CH3)2), 1.70–1.74 
(m, 2H, C2’H). 
In agreement with literature.[200]  
To afford the clomipramine HCl salt, the free base was dissolved in EtOAc, treated with HCl in 
dioxane (4 molL–1, 250 μL), concentrated in vacuo, triturated from Et2O and filtered. 
  
N
N
Cl
5
6
1' 3'
N
H
N CH3
H3C
Cl
Cl–
Photocatalyst (2.5 mol%)
i Pr3SiSH (30 mol%)
Li2CO3, D2O, NMP, 24 h
40 W blue LED
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Photocat.a Yieldb 
(%) 
Average 
2H/molecule 
2H Incorporationc (%) 
C5 C6 C1’ C3’ NMe2 
4CzIPN 80 7.1 13 13 47 71 70 
Fukuzumi 95 <1.0 - - - 11 4 
128ad 86 1.0 - - - 25 9 
128bd 88 <1.0 - - - 10 - 
129a  92 4.0 - - 20 64 39 
129ad 92 4.0 - - 20 64 39 
129bd 98 4.0 - - 15 70 39 
144a 96 <1.0 - - 3 19 5 
144b 88 3.0 - - 12 49 30 
144e 76 1.3 - - 6 22 13 
144f 98 <1.0 - - 3 15 7 
144i 97 1.0 - - - 25 8 
200 97 2.2 - - 4 43 21 
[a] Reaction performed with clomipramine HCl (100 µmol), Li2CO3 (480 µmol), triisopropylsilanethiol (30 mol%), photocat. (2.5 mol%), unless 
stated otherwise, D2O (5.00 mmol) in NMP (1.6 mL) at RT, 24 h irradiation with Kessil A160WE tuna blue; [b] Yield of isolated products;  
[c] Determined by 1H NMR of the free base; [d] Using 1 mol% of photocatalyst. 
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Photoisomerization of trans-stilbene 
 
General procedure H: 
A solution of trans-stilbene (10 mM) and Photocatalyst  (0.1 mM) in 3.0 mL CD3CN was 
deoxygenated with argon for five minutes in a cuvette equipped with septum cap. The 
reaction mixture was irradiated with light at room temperature under air cooling for 2 h. 
Conversion of trans- to cis-stilbene was monitored by 1H NMR spectroscopy. Cis-stilbene, 
whose NMR data are in agreement with those presented in ref.[225], is the only detectable 
product produced upon illumination. 
 
Dye cis-stilbene Dye cis-stilbene Dye cis-stilbene 
129a 78% 144e 70% 144j 41% 
144a 16% 144f 36% 144k 45% 
144b 72% 144g 37% 144l 47% 
144c 54% 144h 17% 
Fukuzumi 
catalyst 
18% 
144d 77% 144i 84% 
Dimethyl-
acridinium[188] 
28% 
 
 
Photocatalyst* (1mol%)
CD3CN, 2h
40 W blue LED
cis-stilbene
 
 
183	
 REFERENCES 
 
[1] G. Scheffler, H. Seike, E. J. Sorensen, Angew. Chem. Int. Ed. 2000, 39, 4593–4596. 
[2] S. P. Chavan, M. Thakkar, G. F. Jogdand, U. R. Kalkote, J. Org. Chem. 2006, 71, 8986–
8988. 
[3] R. E. Gawley, J. S. Siegel, Stereochemical Aspects of Organolithium Compounds, Wiley-
VCH., 2010. 
[4] V. Alezra, T. Kawabata, Synthesis 2016, 48, 2997–3016. 
[5] D. Seebach, D. Wasmuth, Angew. Chem. Int. Ed. 1981, 20, 971. 
[6] D. Seebach, A. R. Sting, M. Hoffmann, Angew. Chem. Int. Ed. 1996, 35, 2708–2748. 
[7] D. Seebach, M. Boes, R. Naef, W. B. Schweizer, J. Am. Chem. Soc. 1983, 105, 5390–
5398. 
[8] R. M. Williams, T. Glinka, E. Kwast, J. Am. Chem. Soc. 1988, 110, 5927–5929. 
[9] T. Kawabata, K. Yahiro, K. Fuji, J. Am. Chem. Soc. 1991, 113, 9694–9696. 
[10] T. Kawabata, H. Suzuki, Y. Nagae, K. Fuji, Angew. Chem. Int. Ed. 2000, 39, 2155–2157. 
[11] T. Kawabata, O. Öztürk, J. Chen, K. Fuji, Chem. Commun. 2003, 9, 162–163. 
[12] T. Yoshimura, K. Tomohara, T. Kawabata, J. Am. Chem. Soc. 2013, 135, 7102–7105. 
[13] V. Lupi, M. Penso, F. Foschi, F. Gassa, V. Mihali, A. Tagliabue, Chem. Commun. 2009, 
5012–5014. 
[14] D. C. Hsu, P. C. H. Lam, C. Slebodnick, P. R. Carlier, J. Am. Chem. Soc. 2009, 131, 
18168–18176. 
[15] G. H. Christie, J. Kenner, J. Chem. Soc. 1922, 121, 614–620. 
[16] R. Kuhn, “Molekulare Asymmetrie”. Stereochemie, Freudenberg, K. Ed., 1933. 
[17] Y. Chen, S. Yekta, A. K. Yudin, Chem. Rev. 2003, 103, 3155–3211. 
[18] M. Berthod, G. Mignani, G. Woodward, M. Lemaire, Chem. Rev. 2005, 105, 1801–
1836. 
[19] J. Clayden, W. J. Moran, P. J. Edwards, S. R. Laplante, Angew. Chem. Int. Ed. 2009, 48, 
6398–6401. 
[20] J. E. Smyth, N. M. Butler, P. A. Keller, Nat. Prod. Rep. 2015, 32, 1562–1583. 
[21] A. Zask, J. Murphy, G. A. Ellestad, Chirality 2013, 25, 265–274. 
[22] G. Bringmann, A. J. P. Mortimer, P. A. Keller, M. J. Gresser, J. Garner, M. Breuning, 
Angew. Chem. Int. Ed. 2005, 44, 5384–5427. 
[23] E. Kumarasamy, R. Raghunathan, M. P. Sibi, J. Sivaguru, Chem. Rev. 2015, 115, 11239–
11300. 
[24] T. W. Wallace, Org. Biomol. Chem. 2006, 4, 3197–3210. 
[25] D. Zhang, Q. Wang, Coord. Chem. Rev. 2015, 286, 1–16. 
[26] J. Wencel-Delord, A. Panossian, F. R. Leroux, F. Colobert, Chem. Soc. Rev. 2015, 44, 
3418–3430. 
[27] O. Baudoin, European J. Org. Chem. 2005, 4223–4229. 
[28] Y. M. Li, F. Y. Kwong, W. Y. Yu, A. S. C. Chan, Coord. Chem. Rev. 2007, 251, 2119–2144. 
[29] P. Renzi, Org. Biomol. Chem. 2017, 15, 4506–4516. 
[30] P. Loxq, E. Manoury, R. Poli, E. Deydier, A. Labande, Coord. Chem. Rev. 2016, 308, 
131–190. 
[31] B. Zilate, A. Castrogiovanni, C. Sparr, ACS Catal. 2018, 8, 2981–2988. 
[32] G. Bringmann, D. Menche, Acc. Chem. Res. 2001, 34, 615–624.
 
 
184	
[33] G. Bringmann, T. Hartung, L. Göbel, O. Schupp, C. L. J. Ewers, B. Schöner, R. Zagst, K. 
Peters, H. G. von Schnering, C. Burschka, Liebigs Ann. der Chemie 1992, 225–232. 
[34] L. S. Mazzaferro, W. Hüttel, A. Fries, M. Müller, J. Am. Chem. Soc. 2015, 137, 12289–
12295. 
[35] M. Sridhar, S. K. Vadivel, U. T. Bhalerao, Tetrahedron Lett. 1997, 38, 5695–5696. 
[36] J. Liu, R. D. Stipanovic, A. A. Bell, L. S. Puckhaber, C. W. Magill, Phytochemistry 2008, 
69, 3038–3042. 
[37] H. Kang, Y. E. Lee, P. V. G. Reddy, S. Dey, S. E. Allen, K. A. Niederer, P. Sung, K. Hewitt, 
C. Torruellas, M. R. Herling, et al., Org. Lett. 2017, 19, 5505–5508. 
[38] E. E. Podlesny, M. C. Kozlowski, Org. Lett. 2012, 14, 1408–1411. 
[39] C. I. Grove, J. C. Fettinger, J. T. Shaw, Synthesis  2012, 44, 362–371. 
[40] S. S. Zhang, Z. Q. Wang, M. H. Xu, G. Q. Lin, Org. Lett. 2010, 12, 5546–5549. 
[41] G. Xu, W. Fu, G. Liu, C. H. Senanayake, W. Tang, J. Am. Chem. Soc. 2014, 136, 570–
573. 
[42] B. Yalcouye, S. Choppin, A. Panossian, F. R. Leroux, F. Colobert, European J. Org. 
Chem. 2014, 2014, 6285–6294. 
[43] J. Yin, S. L. Buchwald, J. Am. Chem. Soc. 2000, 122, 12051–12052. 
[44] C. Pan, Z. Zhu, M. Zhang, Z. Gu, Angew. Chem. Int. Ed. 2017, 56, 4777–4781. 
[45] T. Yamamoto, Y. Akai, Y. Nagata, M. Suginome, Angew. Chem. Int. Ed. 2011, 50, 8844–
8847. 
[46] O. Quinonero, M. Jean, N. Vanthuyne, C. Roussel, D. Bonne, T. Constantieux, C. 
Bressy, X. Bugaut, J. Rodriguez, Angew. Chem. Int. Ed. 2016, 55, 1401–1405. 
[47] F. Eudier, P. Righi, A. Mazzanti, A. Ciogli, G. Bencivenni, Org. Lett. 2015, 17, 1728–
1731. 
[48] N. Sakiyama, D. Hojo, K. Noguchi, K. Tanaka, Chem. Eur. J. 2011, 17, 1428–1432. 
[49] R. Guo, K. N. Li, B. Liu, H. J. Zhu, Y. M. Fan, L. Z. Gong, Chem. Commun. 2014, 50, 
5451–5454. 
[50] L. Zhang, J. Zhang, J. Ma, D. J. Cheng, B. Tan, J. Am. Chem. Soc. 2017, 139, 1714–1717. 
[51] A. Link, C. Sparr, Angew. Chem. Int. Ed. 2014, 53, 5458–5461. 
[52] V. C. Fäseke, C. Sparr, Angew. Chem. Int. Ed. 2016, 55, 7261–7264. 
[53] D. Lotter, M. Neuburger, M. Rickhaus, D. Häussinger, C. Sparr, Angew. Chem. Int. Ed. 
2016, 55, 2920–2923. 
[54] D. Lotter, A. Castrogiovanni, M. Neuburger, C. Sparr, ACS Cent. Sci. 2018, 4, 656–660. 
[55] D. Sue, K. Takaishi, T. Harada, R. Kuroda, T. Kawabata, K. Tsubaki, J. Org. Chem. 2009, 
74, 3940–3943. 
[56] L. Chabaud, J. Clayden, M. Helliwell, A. Page, J. Raftery, L. Vallverdú, Tetrahedron 
2010, 66, 6936–6957. 
[57] K. T. Barrett, A. J. Metrano, P. R. Rablen, S. J. Miller, Nature 2014, 508, 71–75. 
[58] A. Lüttringhaus, H. Gralheer, Ann. 1942, 550, 67–98. 
[59] C. J. Brown, A. C. Farthing, Nature 1949, 164, 915–916. 
[60] D. J. Cram, H. Steinberg, J. Am. Chem. Soc. 1951, 73, 5691–5704. 
[61] J. Kleinschroth, H. Hopf, Angew. Chem. Int. Ed. 1982, 21, 469–480. 
[62] E. L. Eliel, H. W. Samuel, Stereochemistry of Organic Compounds, John Wiley & Sons, 
New York, 1994. 
[63] S. Bestgen, C. Seidl, T. Wiesner, A. Zimmer, M. Falk, B. Köberle, M. Austeri, J. Paradies, 
S. Bräse, U. Schepers, et al., Chem. Eur. J. 2017, 23, 6315–6322. 
[64] P. J. Pye, K. Rossen, R. A. Reamer, R. P. Volante, P. J. Reider, Tetrahedron Lett. 1998, 
 
 
185	
39, 4441–4444. 
[65] N. Zhang, W. Y. Lo, Z. Cai, L. Li, L. Yu, Nano Lett. 2017, 17, 308–312. 
[66] S. Bhattacharyya, M. B. Roy, S. Ghosh, Chem. Phys. 2004, 300, 295–304. 
[67] Q. Ding, Q. Wang, H. He, Q. Cai, Org. Lett. 2017, 19, 1804–1807. 
[68] T. Gulder, P. S. Baran, Nat. Prod. Rep. 2012, 29, 899–934. 
[69] S. Kotha, M. E. Shirbhate, G. T. Waghule, Beilstein J. Org. Chem. 2015, 11, 1274–1331. 
[70] D. V. Jarikote, P. V. Murphy, European J. Org. Chem. 2010, 4959–4970. 
[71] S. Kotha, M. E. Shirbhate, Synlett 2012, 23, 2183–2188. 
[72] A. B. Smith, C. M. Adams, S. A. Kozmin, D. V. Paone, J. Am. Chem. Soc. 2001, 123, 
5925–5937. 
[73] M. J. Cloninger, H. W. Whitlock, J. Org. Chem. 1998, 63, 6153–6159. 
[74] D. B. Werz, A. Schuster, R. Gleiter, F. Rominger, Org. Lett. 2005, 7, 917–920. 
[75] T. Ichino, H. Arimoto, D. Uemura, Chem. Commun. 2006, 1742–1744. 
[76] H. Wang, J. Huang, W. D. Wulff, A. L. Rheingold, J. Am. Chem. Soc. 2003, 125, 8980–
8981. 
[77] J. P. Krieger, G. Ricci, D. Lesuisse, C. Meyer, J. Cossy, Angew. Chem. Int. Ed. 2014, 53, 
8705–8708. 
[78] T. Araki, D. Hojo, K. Noguchi, K. Tanaka, Synlett 2011, 539–542. 
[79] T. Shibata, T. Uchiyama, K. Endo, Org. Lett. 2009, 11, 3906–3908. 
[80] H. Kondo, A. Miyake, No Title, 1974, JP 49110837. 
[81] P. Liptau, S. Knüppel, G. Kehr, O. Kataeva, R. Fröhlich, G. Erker, J. Organomet. Chem. 
2001, 637–639, 621–630. 
[82] A. Ullmann, M. Gruner, H. U. Reißig, Chem. Eur. J. 1999, 5, 187–197. 
[83] Y. Sakamoto, N. Miyoshi, M. Hirakida, S. Kusumoto, H. Kawase, J. M. Rudzinski, T. 
Shinmyozu, J. Am. Chem. Soc. 1996, 118, 12267–12275. 
[84] M. M. Haley, B. L. Langsdorf, Chem. Commun. 1997, 2, 1121–1122. 
[85] R. R. Bukownik, C. S. Wilcox, J. Org. Chem. 1988, 53, 463–471. 
[86] P. Bolduc, A. Jacques, S. K. Collins, J. Am. Chem. Soc. 2010, 132, 12790–12791. 
[87] S. Kotha, G. T. Waghule, Heterocycles 2015, 90, 1289–1298. 
[88] A. V. Kalinin, B. A. Chauder, S. Rakhit, V. Snieckus, Org. Lett. 2003, 5, 3519–3521. 
[89] H. Weber, J. P. H. Wunderlich, H. Weber, J. Panta, Chem. Ber. 1985, 118, 4259–4270. 
[90] S. Kuroda, Y. Obata, N. C. Thanh, R. Miyatake, Y. Horino, M. Oda, Tetrahedron Lett. 
2008, 49, 552–556. 
[91] E. Huxol, J. M. Basler, M. Neuburger, J. Adjizian, C. P. Ewels, H. A. Wegner, Org. Lett. 
2014, 16, 1594–1597. 
[92] G. J. Bodwell, J. Li, Org. Lett. 2002, 4, 127–129. 
[93] D. Meidlinger, L. Marx, C. Bordeianu, S. Choppin, F. Colobert, A. Speicher, Angew. 
Chem. Int. Ed. 2018, 57, 9160–9164. 
[94] B. Li, X. Li, B. Han, Z. Chen, X. Zhang, G. He, G. Chen, J. Am. Chem. Soc. 2019, 141, 
9401–9407. 
[95] W. M. Schubert, W. A. Sweeney, H. K. Latourette, J. Am. Chem. Soc. 1954, 76, 5462–
5466. 
[96] U. K. Georgi, J. Rétey, J. Chem. Soc. 1971, 32–33. 
[97] J. C. Rohanna, J. D. Rainier, Org. Lett. 2009, 11, 493–495. 
[98] K. C. Nicolaou, Y. P. Sun, H. Korman, D. Sarlah, Angew. Chem. Int. Ed. 2010, 49, 5875–
5878. 
[99] N. Han, X. Lei, N. J. Turro, J. Org. Chem. 1991, 56, 2927–2930.
 
 
186	
 
[100] R. B. Bates, C. A. Ogle, J. Org. Chem. 1982, 47, 3949–3952. 
[101] S. H. Küsefoglu, D. T. Longone, Tetrahedron Lett. 1978, 19, 2391–2394. 
[102] C. K. Prier, D. A. Rankic, D. W. C. MacMillan, Chem. Rev. 2013, 113, 5322–5363. 
[103] C. S. Wang, P. H. Dixneuf, J. F. Soulé, Chem. Rev. 2018, 118, 7532–7585. 
[104] K. N. Lee, M. Y. Ngai, Chem. Commun. 2017, 53, 13093–13112. 
[105] J. Twilton, C. C. Le, P. Zhang, M. H. Shaw, R. W. Evans, D. W. C. MacMillan, Nat. Rev. 
Chem. 2017, 1, DOI 10.1038/s41570-017-0052. 
[106] N. A. Romero, D. A. Nicewicz, Chem. Rev. 2016, 116, 10075–10166. 
[107] S. Fukuzumi, K. Ohkubo, Org. Biomol. Chem. 2014, 12, 6059–6071. 
[108] D. P. Hari, B. König, Chem. Commun. 2014, 50, 6688–6699. 
[109] S. Fukuzumi, H. Kotani, K. Ohkubo, S. Ogo, N. V. Tkachenko, H. Lemmetyinen, J. Am. 
Chem. Soc. 2004, 126, 1600–1601. 
[110] K. Ohkubo, K. Mizushima, R. Iwata, K. Souma, N. Suzuki, S. Fukuzumi, Chem. Commun. 
2010, 46, 601–603. 
[111] M. Brasholz, in Photocatal. Org. Synth., 2018. 
[112] S. Fukuzumi, K. Ohkubo, T. Suenobu, Acc. Chem. Res. 2014, 47, 1455–1464. 
[113] T. Tsudaka, H. Kotani, K. Ohkubo, T. Nakagawa, N. V. Tkachenko, H. Lemmetyinen, S. 
Fukuzumi, Chem. Eur. J. 2017, 23, 1306–1317. 
[114] S. Fukuzumi, K. Doi, A. Itoh, T. Suenobu, K. Ohkubo, Y. Yamada, K. D. Karlin, Proc. Natl. 
Acad. Sci. U. S. A. 2012, 109, 15572–15577. 
[115] M. Hoshino, H. Uekusa, A. Tomita, S. Y. Koshihara, T. Sato, S. Nozawa, S. I. Adachi, K. 
Ohkubo, H. Kotani, S. Fukuzumi, J. Am. Chem. Soc. 2012, 134, 4569–4572. 
[116] A. Joshi-Pangu, F. Lévesque, H. G. Roth, S. F. Oliver, L. C. Campeau, D. Nicewicz, D. A. 
DiRocco, J. Org. Chem. 2016, 81, 7244–7249. 
[117] A. R. White, L. Wang, D. A. Nicewicz, Synlett 2019, 30, 827–832. 
[118] A. Gini, M. Uygur, T. Rigotti, J. Alemán, O. García Mancheño, Chem. Eur. J. 2018, 24, 
12509–12514. 
[119] A. Gini, T. Rigotti, R. Pérez-Ruiz, M. Uygur, R. Mas-Ballesté, I. Corral, L. Martínez-
Fernández, V. A. De La Penã O’Shea, O. G. Manchenõ, J. Alemán, ChemPhotoChem 
2020, 3, 609–612. 
[120] C. Fischer, C. Sparr, Angew. Chem. Int. Ed. 2018, 57, 2436–2440. 
[121] C. Fischer, C. Sparr, Tetrahedron 2018, 74, 5486–5493. 
[122] C. Fischer, C. Sparr, Synlett 2018, 29, 2176–2180. 
[123] F. Wu, L. Wang, J. Chen, D. A. Nicewicz, Y. Huang, Angew. Chem. Int. Ed. 2018, 57, 
2174–2178. 
[124] L. Wang, F. Wu, J. Chen, D. A. Nicewicz, Y. Huang, Angew. Chem. Int. Ed. 2017, 56, 
6896–6900. 
[125] J. B. McManus, N. P. R. Onuska, D. A. Nicewicz, J. Am. Chem. Soc. 2018, 140, 9056–
9060. 
[126] K. A. Margrey, W. L. Czaplyski, D. A. Nicewicz, E. J. Alexanian, J. Am. Chem. Soc. 2018, 
140, 4213–4217. 
[127] N. E. S. Tay, D. A. Nicewicz, J. Am. Chem. Soc. 2017, 139, 16100–16104. 
[128] J. B. McManus, D. A. Nicewicz, J. Am. Chem. Soc. 2017, 139, 2880–2883. 
[129] J. D. Griffin, C. L. Cavanaugh, D. A. Nicewicz, Angew. Chem. Int. Ed. 2017, 56, 2097–
2100. 
[130] H. Liu, L. Ma, R. Zhou, X. Chen, W. Fang, J. Wu, ACS Catal. 2018, 8, 6224–6229.
 
 
187	
 
[131] K. C. Cartwright, J. A. Tunge, ACS Catal. 2018, 8, 11801–11806. 
[132] H. Cao, H. Jiang, H. Feng, J. M. C. Kwan, X. Liu, J. Wu, J. Am. Chem. Soc. 2018, 140, 
16360–16367. 
[133] J. Davies, N. S. Sheikh, D. Leonori, Angew. Chem. Int. Ed. 2017, 56, 13361–13365. 
[134] L. Capaldo, R. Riccardi, D. Ravelli, M. Fagnoni, ACS Catal. 2018, 8, 304–309. 
[135] L. Pitzer, F. Sandfort, F. Strieth-Kalthoff, F. Glorius, Angew. Chem. Int. Ed. 2018, 57, 
16219–16223. 
[136] E. M. Dauncey, S. P. Morcillo, J. J. Douglas, N. S. Sheikh, D. Leonori, Angew. Chem. Int. 
Ed. 2018, 57, 744–748. 
[137] J. Sim, M. W. Campbell, G. A. Molander, ACS Catal. 2019, 9, 1558–1563. 
[138] W. Chen, Z. Huang, N. E. S. Tay, B. Giglio, M. Wang, H. Wang, Z. Wu, D. A. Nicewicz, Z. 
Li, Science  2019, 364, 1170–1174. 
[139] G. Zhang, X. Hu, C. W. Chiang, H. Yi, P. Pei, A. K. Singh, A. Lei, J. Am. Chem. Soc. 2016, 
138, 12037–12040. 
[140] G. Zhang, C. Liu, H. Yi, Q. Meng, C. Bian, H. Chen, J. X. Jian, L. Z. Wu, A. Lei, J. Am. 
Chem. Soc. 2015, 137, 9273–9280. 
[141] L. Niu, J. Liu, H. Yi, S. Wang, X. A. Liang, A. K. Singh, C. W. Chiang, A. Lei, ACS Catal. 
2017, 7, 7412–7416. 
[142] X. Hu, G. Zhang, F. Bu, A. Lei, Angew. Chem. Int. Ed. 2018, 57, 1286–1290. 
[143] G. Zhang, Y. Lin, X. Luo, X. Hu, C. Chen, A. Lei, Nat. Commun. 2018, 9, 1–7. 
[144] S. Kato, Y. Saga, M. Kojima, H. Fuse, S. Matsunaga, A. Fukatsu, M. Kondo, S. Masaoka, 
M. Kanai, J. Am. Chem. Soc. 2017, 139, 2204–2207. 
[145] L. Huang, M. Rueping, Angew. Chem. Int. Ed. 2018, 57, 10333–10337. 
[146] D. Uraguchi, M. Torii, T. Ooi, ACS Catal. 2017, 7, 2765–2769. 
[147] D. Seebach, D. Wasmuth, Angew. Chem. Int. Ed. 1981, 20, 971–971. 
[148] K. Fuji, T. Kawabata, Chem. Eur. J. 1998, 4, 373–376. 
[149] T. Kawabata, S. Matsuda, S. Kawakami, D. Monguchi, K. Moriyama, J. Am. Chem. Soc. 
2006, 128, 15394–15395. 
[150] T. Kawabata, S. Majumdar, K. Tsubaki, D. Monguchi, Org. Biomol. Chem. 2005, 3, 
1609–1611. 
[151] T. Kawabata, S. Kawakami, S. Majumdar, J. Am. Chem. Soc. 2003, 125, 13012–13013. 
[152] T. Kawabata, K. Moriyama, S. Kawakami, K. Tsubaki, J. Am. Chem. Soc. 2008, 130, 
4153–4157. 
[153] A. Erkkilä, P. M. Pihko, M. R. Clarke, Adv. Synth. Catal. 2007, 349, 802–806. 
[154] M. Marigo, D. Fielenbach, A. Braunton, A. Kjærsgaard, K. A. Jørgensen, Angew. Chem. 
Int. Ed. 2005, 44, 3703–3706. 
[155] D. E. Lizos, J. A. Murphy, Org. Biomol. Chem. 2003, 1, 117–122. 
[156] S. Miyano, M. Tobita, H. Hashimoto, Bull. Chem. Soc. Jpn. 1981, 54, 3522–3526. 
[157] A. Richieu, P. A. Peixoto, L. Pouységu, D. Deffieux, S. Quideau, Angew. Chem. Int. Ed. 
2017, 56, 13833–13837. 
[158] A. Ahmed, R. A. Bragg, J. Clayden, L. W. Lai, C. McCarthy, J. H. Pink, N. Westlund, S. A. 
Yasin, Tetrahedron 1998, 54, 13277–13294. 
[159] J. L. Jesuraj, J. Sivaguru, Chem. Commun. 2010, 46, 4791–4793. 
[160] D. P. Curran, W. Liu, C. H. T. Chen, J. Am. Chem. Soc. 1999, 121, 11012–11013. 
[161] K. T. Barrett, S. J. Miller, J. Am. Chem. Soc. 2013, 135, 2963–2966. 
[162] G. Vidari, S. Ferriño, P. A. Grieco, J. Am. Chem. Soc. 1984, 106, 3539–3548.
 
 
188	
 
[163] A. J. L. Ayitou, J. L. Jesuraj, N. Barooah, A. Ugrinov, J. Sivaguru, J. Am. Chem. Soc. 
2009, 131, 11314–11315. 
[164] D. P. Curran, G. R. Hale, S. J. Geib, A. Balog, Q. B. Cass, A. L. G. Degani, M. Z. 
Hernandes, L. C. G. Freitas, Tetrahedron Asymmetry 1997, 8, 3955–3975. 
[165] T. Harrisson, F. Burkamp, L. Jordan, M. Bell, WO2012069852A1, 2012. 
[166] D. H. Hochmuth, H. Dittmann, Chirality 2001, 13, 679–690. 
[167] S. Saito, N. Tsuboya, Y. Yamamoto, J. Org. Chem. 1997, 62, 5042–5047. 
[168] E. Defranq, T. Zesiger, R. Tabacchi, Helv. Chim. Acta 1993, 76, 425–430. 
[169] S. Xu, D. Unabara, D. Uemura, H. Arimoto, Chem. Asian J. 2014, 9, 367–375. 
[170] H. Hart, C.-Y. Lai, G. Nwokogu, S. Shamouilian, Tetrahedron 1987, 43, 5203–5224. 
[171] Y. Wang, S. R. Parkin, J. Gierschner, M. D. Watson, Org. Lett. 2008, 10, 3307–3310. 
[172] C. G. Keck, J. L. Kendall, K. C. Caster, Adv. Synth. Catal. 2007, 349, 165–174. 
[173] A. Link, C. Fischer, C. Sparr, Angew. Chem. Int. Ed. 2015, 54, 12163–12166. 
[174] M. Rickhaus, L. Jundt, M. Mayor, Chimia (Aarau). 2016, 70, 192–202. 
[175] H. Finkelstein, Ber. Dtsch. Chem. Ges. 1910, 43, 1528–1532. 
[176] M. K. Bogdos, E. Pinard, J. A. Murphy, Beilstein J. Org. Chem. 2018, 14, 2035–2064. 
[177] S. Fukuzumi, K. Ohkubo, T. Suenobu, K. Kato, M. Fujitsuka, O. Ito, J. Am. Chem. Soc. 
2001, 123, 8459–8467. 
[178] B. Zilate, C. Fischer, L. Schneider, C. Sparr, Synthesis 2019, 51, 4359–4365. 
[179] A. C. Benniston, K. J. Elliott, R. W. Harrington, W. Clegg, European J. Org. Chem. 2009, 
253–258. 
[180] L. Marzo, S. K. Pagire, O. Reiser, B. König, Angew. Chem. Int. Ed. 2018, 57, 10034–
10072. 
[181] B. G. McCarthy, R. M. Pearson, C. H. Lim, S. M. Sartor, N. H. Damrauer, G. M. Miyake, 
J. Am. Chem. Soc. 2018, 140, 5088–5101. 
[182] E. Speckmeier, T. G. Fischer, K. Zeitler, J. Am. Chem. Soc. 2018, 140, 15353–15365. 
[183] Z. Zuo, D. T. Ahneman, L. Chu, J. A. Terrett, A. G. Doyle, D. W. C. MacMillan, Science  
2014, 345, 437–440. 
[184] E. R. Welin, C. Le, D. M. Arias-Rotondo, J. K. McCusker, D. W. C. MacMillan, Science  
2017, 355, 380–385. 
[185] M. Reckenthäler, A. G. Griesbeck, Adv. Synth. Catal. 2013, 355, 2727–2744. 
[186] C. Kerzig, O. S. Wenger, Chem. Sci. 2018, 9, 6670–6678. 
[187] A. Penzkofer, A. Beidoun, M. Daiber, J. Lumin. 1992, 51, 297–314. 
[188] N. A. Romero, D. A. Nicewicz, J. Am. Chem. Soc. 2014, 136, 17024–17035. 
[189] C. K. Prier, D. A. Rankic, D. W. C. MacMillan, Chem. Rev. 2013, 113, 5322–5363. 
[190] J. Twilton, C. Le, P. Zhang, M. H. Shaw, R. W. Evans, D. W. C. MacMillan, Nat. Rev. 
Chem. 2017, 1, 0052. 
[191] C. Fischer, C. Kerzig, B. Zilate, O. S. Wenger, C. Sparr, ACS Catal. 2020, 10, 210–215. 
[192] M. Rueda-Becerril, O. Mahé, M. Drouin, M. B. Majewski, J. G. West, M. O. Wolf, G. M. 
Sammis, J. F. Paquin, J. Am. Chem. Soc. 2014, 136, 2637–2641. 
[193] S. Ventre, F. R. Petronijevic, D. W. C. Macmillan, J. Am. Chem. Soc. 2015, 137, 5654–
5657. 
[194] T. R. Blum, Y. Zhu, S. A. Nordeen, T. P. Yoon, Angew. Chem. Int. Ed. 2014, 53, 11056–
11059. 
[195] H. Uoyama, K. Goushi, K. Shizu, H. Nomura, C. Adachi, Nature 2012, 492, 234–238. 
[196] J. Luo, J. Zhang, ACS Catal. 2016, 6, 873–877.
 
 
189	
 
[197] Y. Ohtsuka, T. Yamamoto, T. Miyazaki, T. Yamakawa, Adv. Synth. Catal. 2018, 360, 
1007–1018. 
[198] D. Zhu, Q. Liu, B. Luo, M. Chen, R. Pi, P. Huang, S. Wen, Adv. Synth. Catal. 2013, 355, 
2172–2178. 
[199] S. Rousseaux, B. Liégault, K. Fagnou, Modern Tools in TheSynthesis of Complex 
Bioactive Molecules, John Wiley & Sons, 2012. 
[200] Y. Y. Loh, K. Nagao, A. J. Hoover, D. Hesk, N. R. Rivera, S. L. Colletti, I. W. Davies, D. W. 
C. Macmillan, Science  2017, 1187, 1182–1187. 
[201] V. Derdau, J. Atzrodt, J. Zimmermann, C. Kroll, F. Brückner, Chem. Eur. J. 2009, 15, 
10397–10404. 
[202] E. M. Isin, C. S. Elmore, G. N. Nilsson, R. A. Thompson, L. Weidolf, Chem. Res. Toxicol. 
2012, 25, 532–542. 
[203] C. S. Elmore, R. A. Bragg, Bioorganic Med. Chem. Lett. 2015, 25, 167–171. 
[204] J. R. Heys, J. Label. Compd. Radiopharm. 2007, 50, 770–778. 
[205] E. L. Cropper, A. J. P. White, A. Ford, K. K. Hii, J. Org. Chem. 2006, 71, 1732–1735. 
[206] E. S. Lazer, C. K. Miao, H. C. Wong, R. Sorcek, D. M. Spero, A. Gilman, K. Pal, M. 
Behnke, A. G. Graham, J. M. Watrous, et al., J. Med. Chem. 1994, 37, 913–923. 
[207] T. J. Reddy, M. Leclair, M. Proulx, Synlett 2005, 583–586. 
[208] M. Uchiyama, Y. Matsumoto, S. Nakamura, T. Ohwada, N. Kobayashi, N. Yamashita, A. 
Matsumiya, T. Sakamoto, J. Am. Chem. Soc. 2004, 126, 8755–8759. 
[209] R. Hemelaere, F. Carreaux, B. Carboni, European J. Org. Chem. 2015, 2015, 2470–
2481. 
[210] W. Liu, J. Li, P. Querard, C. J. Li, J. Am. Chem. Soc. 2019, 141, 6755–6764. 
[211] S. C. Watson, J. F. Eastham, J. Organomet. Chem. 1967, 9, 165–168. 
[212] Y. Zhao, B. Huang, C. Yang, Q. Chen, W. Xia, Org. Lett. 2016, 18, 5572–5575. 
[213] M. Marigo, T. C. Wabnitz, D. Fielenbach, K. A. Jørgensen, Angew. Chem. Int. Ed. 2005, 
44, 794–797. 
[214] S. Xu, F. Haeffner, B. Li, L. N. Zakharov, S. Y. Liu, Angew. Chem. Int. Ed. 2014, 53, 
6795–6799. 
[215] P. Zhang, M. Cedilote, T. P. Cleary, M. E. Pierce, Tetrahedron Lett. 2007, 48, 8659–
8664. 
[216] C. Fischer, C. Sparr, Angew. Chem. Int. Ed. 2018, 57, 2436–2440. 
[217] S. Hameed P, V. Patil, S. Solapure, U. Sharma, P. Madhavapeddi, A. Raichurkar, M. 
Chinnapattu, P. Manjrekar, G. Shanbhag, J. Puttur, et al., J. Med. Chem. 2014, 57, 
4889–4905. 
[218] A. Klapars, S. L. Buchwald, J. Am. Chem. Soc. 2002, 124, 14844–14845. 
[219] T. Kowada, S. Yamaguchi, H. Fujinaga, K. Ohe, Tetrahedron 2011, 67, 3105–3110. 
[220] S. H. Lee, B. Bin Jang, Z. H. Kafafi, J. Am. Chem. Soc. 2005, 127, 9071–9078. 
[221] L. Wang, E. Ji, N. Liu, B. Dai, Synthesis  2016, 48, 737–750. 
[222] M. Muehlebach, C. J. Mathews, J. N. Scutt, M. Govenkar, WO2008/071405, 2008. 
[223] Y. Kanazawa, T. Yokota, H. Ogasa, H. Watanabe, T. Hanakawa, S. Soga, M. Kawatsura, 
Tetrahedron 2015, 71, 1395–1402. 
[224] Z. Rong, Q. Li, W. Lin, Y. Jia, Tetrahedron Lett. 2013, 54, 4432–4434. 
[225] F. Pape, N. O. Thiel, J. F. Teichert, Chem. Eur. J. 2015, 21, 15934–15938. 
 
 
190	
 APPENDIX 
 
6.1 HPLC data 
(rac) Methyl (R)-2-chloro-2-fluoro-3-phenylpropanoate (25) 
 
No.  Ret.Time  Height  Area  Rel.Area  Amount  Type  
 min mAU mAU*min % n.a.  
1   11,95       1184,486  315,331  49,82     n.a. BMB* 
2   23,62       603,651  317,602  50,18     n.a. BMB* 
Total:  1788,137  632,933  100,00     0,000   
Analyzed on a Chiralpak® OJ-H column using a 1.0 mL/min flow of n-heptane/i PrOH 90:10. 
 
Methyl (R)-2-chloro-2-fluoro-3-phenylpropanoate (25)  
 
No.  Ret.Time  Height  Area  Rel.Area  Amount  Type  
 min mAU mAU*min % n.a.  
1   12,00       610,742  149,182  54,32     n.a. BMB* 
2   23,72       256,027  125,465  45,68     n.a. BMB* 
Total:  866,769  274,647  100,00     0,000  
 
Analyzed on a Chiralpak® OJ-H column using a 1.0 mL/min flow of n-heptane/i PrOH 90:10. 
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(rac)-N-(2-(tert-butyl)phenyl)-3-(hydroxymethyl)-N-methylphenanthrene-4-carboxamide 
(96) 
 
No.  Ret.Time  Height  Area  Rel.Area  Amount  Type  
 min mAU mAU*min % n.a.  
1   10,35       91,675  30,727  40,67     n.a. BMB* 
2   12,03       85,680  36,937  48,89     n.a. BMB* 
3   16,07       5,394  3,251  4,30     n.a. BM * 
4   17,20       5,901  4,642  6,14     n.a.  MB* 
Total:  188,650  75,557  100,00     0,000  
 
Analyzed on a Chiralpak® IC-3 column using a 1.0 mL/min flow of n-heptane/i PrOH 70:30. 
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N-(2-(tert-butyl)phenyl)-3-(hydroxymethyl)-N-methylphenanthrene-4-carboxamide (96) 
 
No.  Ret.Time  Height  Area  Rel.Area  Amount  Type  
 min mAU mAU*min % n.a.  
1   10,75       82,933  31,565  82,40     n.a. BMB* 
2   12,58       7,598  3,633  9,48     n.a. BMB* 
3   17,18       3,585  2,291  5,98     n.a. BMB* 
4   20,05       0,754  0,820  2,14     n.a. BMB* 
Total:  94,871  38,308  100,00     0,000  
 
Analyzed on a Chiralpak® IC-3 column using a 1.0 mL/min flow of n-heptane/i PrOH 70:30. 
 
N-(2-(tert-butyl)phenyl)-2-(hydroxymethyl)-N-methyl-1-naphthamide (101) 
 
 
Analyzed on a Chiralpak® OD-H column using a 1.0 mL/min flow of n-heptane/i PrOH 90:10 with the enantiopure 
proline tetrazole catalyst (right) and the racemic (left). 
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Rotational profile of 1(1,4)-naphthalenacyclohexadecaphane-12-carbaldehyde (116) 
 
No.  Ret.Time  Height  Area  Rel.Area  Amount  Type  
 min mAU mAU*min % n.a.  
1   7,18       1287,837  385,556  50,40     n.a. BMB* 
2   8,18       953,812  379,443  49,60     n.a. BMB* 
Total:  2241,650  764,999  100,00     0,000   
Analyzed on a Chiralpak® OD-H column using a 1.0 mL/min flow of n-heptane/i PrOH 99:1 at 0°C. 
 
 
 
 
No.  Ret.Time  Height  Area  Rel.Area  Amount  Type  
 min mAU mAU*min % n.a.  
1   6,67       1003,774  345,486  50,15     n.a. BM * 
2   8,52       987,313  343,358  49,85     n.a.  MB* 
Total:  1991,087  688,844  100,00     0,000   
Analyzed on a Chiralpak® OD-H column using a 1.0 mL/min flow of n-heptane/i PrOH 99:1 at 20°C. 
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No.  Ret.Time  Height  Area  Rel.Area  Amount  Type  
 min mAU mAU*min % n.a.  
1   6,50       1240,772  435,751  50,38     n.a. BM * 
2   8,17       1226,097  429,096  49,62     n.a.  MB* 
Total:  2466,869  864,848  100,00     0,000   
Analyzed on a Chiralpak® OD-H column using a 1.0 mL/min flow of n-heptane/i PrOH 99:1 at 40°C. 
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6.2 NMR data 
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6.3 UV/VIS & Fluorescence spectra 
9-(4-fluorophenyl)-10-methylacridin-10-ium bromide salt (128a) 
UV/Vis Spectroscopy: 
Fluorescence Spectroscopy: 
 
Excitation Wavelength: 410 nm 
Excitation Slit Width: 2 nm 
Emission Slit Width: 2 nm 
Integration Time: 0.2 s 
Solvent: MeCN  
λem:  512 nm 
FWHM: 100 nm  
UV/VIS	&	Fluorescence	spectra	
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9-(4-methoxyphenyl)-10-methylacridin-10-ium bromide salt (128b) 
UV/Vis Spectroscopy: 
 
 
 
Fluorescence Spectroscopy: 
 
Excitation Wavelength: 360 nm 
Excitation Slit Width: 3 nm 
Emission Slit Width: 2 nm 
Integration Time: 0.2 s 
Solvent: MeCN  
λem:  499 nm 
FWHM: 120 nm 
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3,6-Bis(dimethylamino)-9-(2,6-Dimethylphenyl)-10-methylacridinium bromide salt (129b) 
UV/Vis Spectroscopy: 
 
 
 
Fluorescence Spectroscopy: 
 
Excitation Wavelength: 450 nm 
Excitation Slit Width: 2 nm 
Emission Slit Width: 2 nm 
Integration Time: 0.2 s 
Solvent: MeCN  
λem:  533 nm 
FWHM: 75 nm 
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9-(2,6-Dimethylphenyl)-1-methoxy-10-phenylacridinium bromide salt (144a) 
UV/Vis Spectroscopy: 
 
 
 
Fluorescence Spectroscopy: 
 
Excitation Wavelength: 490 nm 
Excitation Slit Width: 5 nm 
Emission Slit Width: 2 nm 
Integration Time: 0.2 s 
Solvent: MeCN  
λem: 634 nm 
FWHM: 139 nm 
 
  
Spectrum Peak Pick Report 04.05.2018 13:35:16
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Data Set: Storage 133438 - RawData - D:\Sparr 
Group\Fischer\Acridiniums\Patent\CF1219P_0_MeCN.spc
Measurement Properties
Wavelength Range (nm.): 190.00 to 800.00
Scan Speed: Medium
Sampling Interval: 1.0
Auto Sampling Interval: Disabled
Scan Mode: Single
Sample Preparation Properties
Weight: 0.709 mg
Volume: 100 mL
Dilution: -
Path Length: 1.00 cm
Additional Information: CF1219P in Acetonitrile
Instrument Properties
Instrument Type: UV-1600 Series
Measuring Mode: Absorbance
Slit Width: 2.0 nm
Light Source Change Wavelength: 340.8 nm
S/R Exchange: Normal
Attachment Properties
Attachment: None
nm.
190.00 400.00 600.00 800.00
Ab
s.
1.065
1.000
0.500
0.000
-0.097
5
4
3
2
1
No. P/V Wavelength Abs. Description
1 480.00 0.062
2 360.00 0.146
3 283.00 0.665
4 240.00 0.281
5 196.00 0.968
6 589.00 0.001
7 391.00 0.017
8 309.00 0.021
9 256.00 0.180
10 232.00 0.232
FWHM: 98.0 nm 
UV/VIS	&	Fluorescence	spectra	
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6-(Dimethylamino)-9-mesityl-1-methoxy-10-phenylacridinium bromide salt (144b) 
UV/Vis Spectroscopy: 
 
 
 
Fluorescence Spectroscopy: 
 
Excitation Wavelength: 500 nm 
Excitation Slit Width: 4 nm 
Emission Slit Width: 2 nm 
Integration Time: 0.2 s 
Solvent: MeCN  
λem: 573 nm 
FWHM: 95 nm 
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Data Set: Storage 130420 - RawData - D:\Sparr 
Group\Fischer\Acridiniums\Patent\CF1163P_0_MeCN.spc
Measurement Properties
Wavelength Range (nm.): 190.00 to 800.00
Scan Speed: Medium
Sampling Interval: 1.0
Auto Sampling Interval: Disabled
Scan Mode: Single
Sample Preparation Properties
Weight: 0.792 mg
Volume: 100 mL
Dilution: -
Path Length: 1.00 cm
Additional Information: CF1163P in Acetonitrile
Instrument Properties
Instrument Type: UV-1600 Series
Measuring Mode: Absorbance
Slit Width: 2.0 nm
Light Source Change Wavelength: 340.8 nm
S/R Exchange: Normal
Attachment Properties
Attachment: None
nm.
190.00 400.00 600.00 800.00
Ab
s.
1.201
1.000
0.500
0.000
-0.109
7
6
5
4
3
2 1
No. P/V Wavelength Abs. Description
1 513.00 0.153
2 488.00 0.154
3 433.00 0.233
4 293.00 0.505
5 261.00 0.276
6 222.00 0.510
7 200.00 1.092
8 592.00 0.002
9 501.00 0.149
10 464.00 0.126
11 338.00 0.022
12 269.00 0.248
13 250.00 0.244
14 217.00 0.499
FWHM: 75.0 nm 
UV/VIS	&	Fluorescence	spectra	
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(±)-6-(Dimethylamino)-1-methoxy-9-(naphthalen-1-yl)-10-phenylacridinium bromide salt 
(144c) 
UV/Vis Spectroscopy: 
 
 
 
Fluorescence Spectroscopy: 
 
Excitation Wavelength: 500 nm 
Excitation Slit Width: 5 nm 
Emission Slit Width: 2 nm 
Integration Time: 0.2 s 
Solvent: MeCN  
λem: 578 nm 
FWHM: 98 nm 
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Data Set: Storage 183835 - RawData - D:\Sparr 
Group\Fischer\Acridiniums\Patent\CF1252P_rac_4_MeCN.spc
Measurement Properties
Wavelength Range (nm.): 190.00 to 800.00
Scan Speed: Medium
Sampling Interval: 1.0
Auto Sampling Interval: Disabled
Scan Mode: Single
Sample Preparation Properties
Weight: 0.338 mg
Volume: 10 mL
Dilution: 4 fold
Path Length: 1.00 cm
Additional Information: CF1252P rac in Acetonitrile
Instrument Properties
Instrument Type: UV-1600 Series
Measuring Mode: Absorbance
Slit Width: 2.0 nm
Light Source Change Wavelength: 340.8 nm
S/R Exchange: Normal
Attachment Properties
Attachment: None
nm.
190.00 400.00 600.00 800.00
Ab
s.
1.438
1.000
0.500
0.000
-0.126
5
4
3
2 1
No. P/V Wavelength Abs. Description
1 516.00 0.172
2 491.00 0.173
3 433.00 0.252
4 294.00 0.631
5 222.00 1.308
6 590.00 0.006
7 504.00 0.168
8 465.00 0.137
9 347.00 0.027
10 248.00 0.328
11 206.00 0.933
FWHM: 85.1 nm 
UV/VIS	&	Fluorescence	spectra	
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(±)-7-(Dimethylamino)-1-methoxy-9-(naphthalen-1-yl)-10-phenylacridinium bromide salt 
(144d) 
UV/Vis Spectroscopy: 
 
 
 
Fluorescence Spectroscopy: 
 
Excitation Wavelength: 580 nm 
Excitation Slit Width: 10 nm 
Emission Slit Width: 3 nm 
Integration Time: 0.4 s 
Solvent: MeCN  
λem: 755 nm 
FWHM: » 122 nm 
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Data Set: Storage 172851 - RawData - D:\Sparr 
Group\Fischer\Acridiniums\Patent\CF1253P_rac_3_MeCN.spc
Measurement Properties
Wavelength Range (nm.): 190.00 to 800.00
Scan Speed: Medium
Sampling Interval: 1.0
Auto Sampling Interval: Disabled
Scan Mode: Single
Sample Preparation Properties
Weight: 0.334 mg
Volume: 10 mL
Dilution: 3 fold
Path Length: 1.00 cm
Additional Information: CF1253P rac in Acetonitrile
Instrument Properties
Instrument Type: UV-1600 Series
Measuring Mode: Absorbance
Slit Width: 2.0 nm
Light Source Change Wavelength: 340.8 nm
S/R Exchange: Normal
Attachment Properties
Attachment: None
nm.
190.00 400.00 600.00 800.00
Ab
s.
1.378
1.000
0.500
0.000
-0.124
5
4
3
2
1
No. P/V Wavelength Abs. Description
1 590.00 0.086
2 419.00 0.042
3 317.00 0.500
4 295.00 0.443
5 222.00 1.161
6 725.00 0.001
7 472.00 0.014
8 381.00 0.024
9 299.00 0.440
10 249.00 0.269
11 206.00 0.966
FWHM: 112 nm 
UV/VIS	&	Fluorescence	spectra	
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6-(Dimethylamino)-9-(2,6-dimethylphenyl)-1-methoxy-10-phenylacridinium bromide salt 
(144e) 
UV/Vis Spectroscopy: 
 
 
 
Fluorescence Spectroscopy: 
 
Excitation Wavelength: 500 nm 
Excitation Slit Width: 5 nm 
Emission Slit Width: 2 nm 
Integration Time: 0.2 s 
Solvent: MeCN  
λem: 574 nm 
FWHM: 98 nm 
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Data Set: Storage 125048 - RawData - D:\Sparr 
Group\Fischer\Acridiniums\Patent\CF1220P_0_MeCN.spc
Measurement Properties
Wavelength Range (nm.): 190.00 to 800.00
Scan Speed: Medium
Sampling Interval: 1.0
Auto Sampling Interval: Disabled
Scan Mode: Single
Sample Preparation Properties
Weight: 0.773 mg
Volume: 100 mL
Dilution: -
Path Length: 1.00 cm
Additional Information: CF1220P in Acetonitrile
Instrument Properties
Instrument Type: UV-1600 Series
Measuring Mode: Absorbance
Slit Width: 2.0 nm
Light Source Change Wavelength: 340.8 nm
S/R Exchange: Normal
Attachment Properties
Attachment: None
nm.
190.00 400.00 600.00 800.00
Ab
s.
1.242
1.000
0.500
0.000
-0.112
6
5
4
3
2 1
No. P/V Wavelength Abs. Description
1 514.00 0.160
2 489.00 0.161
3 433.00 0.243
4 293.00 0.526
5 261.00 0.284
6 197.00 1.129
7 602.00 0.002
8 501.00 0.155
9 464.00 0.129
10 339.00 0.023
11 270.00 0.251
12 250.00 0.246
FWHM: 79.1 nm 
UV/VIS	&	Fluorescence	spectra	
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9-Mesityl-1-methoxy-10-phenylacridinium bromide salt (144f) 
UV/Vis Spectroscopy: 
 
 
 
Fluorescence Spectroscopy: 
 
Excitation Wavelength: 490 nm 
Excitation Slit Width: 5 nm 
Emission Slit Width: 2 nm 
Integration Time: 0.2 s 
Solvent: MeCN  
λem: 632 nm 
FWHM: 138 nm 
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Data Set: Storage 131349 - RawData - D:\Sparr 
Group\Fischer\Acridiniums\Patent\CF1200P_0_MeCN.spc
Measurement Properties
Wavelength Range (nm.): 190.00 to 800.00
Scan Speed: Medium
Sampling Interval: 1.0
Auto Sampling Interval: Disabled
Scan Mode: Single
Sample Preparation Properties
Weight: 0.728 mg
Volume: 100 mL
Dilution: -
Path Length: 1.00 cm
Additional Information: CF1200P in Acetonitrile
Instrument Properties
Instrument Type: UV-1600 Series
Measuring Mode: Absorbance
Slit Width: 2.0 nm
Light Source Change Wavelength: 340.8 nm
S/R Exchange: Normal
Attachment Properties
Attachment: None
nm.
190.00 400.00 600.00 800.00
Ab
s.
1.462
1.000
0.500
0.000
-0.129
5
4
3
2
1
No. P/V Wavelength Abs. Description
1 479.00 0.089
2 360.00 0.200
3 283.00 0.831
4 240.00 0.378
5 200.00 1.329
6 601.00 0.006
7 387.00 0.028
8 309.00 0.038
9 256.00 0.247
10 233.00 0.337
FWHM: 107 nm 
UV/VIS	&	Fluorescence	spectra	
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1-Methoxy-9,10-diphenylacridinium bromide salt (144g) 
UV/Vis Spectroscopy: 
 
 
 
Fluorescence Spectroscopy: 
 
Excitation Wavelength: 490 nm 
Excitation Slit Width: 5 nm 
Emission Slit Width: 2 nm 
Integration Time: 0.2 s 
Solvent: MeCN  
λem: 637 nm 
FWHM: 142 nm 
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Data Set: Storage 140017 - RawData - D:\Sparr 
Group\Fischer\Acridiniums\Patent\CF1201P_0_MeCN.spc
Measurement Properties
Wavelength Range (nm.): 190.00 to 800.00
Scan Speed: Medium
Sampling Interval: 1.0
Auto Sampling Interval: Disabled
Scan Mode: Single
Sample Preparation Properties
Weight: 0.671 mg
Volume: 100 mL
Dilution: -
Path Length: 1.00 cm
Additional Information: CF1201P in Acetonitrile
Instrument Properties
Instrument Type: UV-1600 Series
Measuring Mode: Absorbance
Slit Width: 2.0 nm
Light Source Change Wavelength: 340.8 nm
S/R Exchange: Normal
Attachment Properties
Attachment: None
nm.
190.00 400.00 600.00 800.00
Ab
s.
1.010
0.500
0.000
-0.086
4
3
2
1
No. P/V Wavelength Abs. Description
1 479.00 0.078
2 362.00 0.169
3 282.00 0.740
4 240.00 0.309
5 626.00 0.007
6 402.00 0.030
7 312.00 0.041
8 254.00 0.188
9 233.00 0.277
FWHM: 106 nm 
UV/VIS	&	Fluorescence	spectra	
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1-Methoxy-10-methyl-9-phenylacridinium bromide salt (144h) 
UV/Vis Spectroscopy: 
 
 
 
Fluorescence Spectroscopy: 
 
Excitation Wavelength: 490 nm 
Excitation Slit Width: 5 nm 
Emission Slit Width: 2 nm 
Integration Time: 0.2 s 
Solvent: MeCN  
λem: 635 nm 
FWHM: 143 nm 
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Data Set: Storage 175251 - RawData - D:\Sparr Group\Fischer\Acridiniums\CF931P_0_ACN.spc
Measurement Properties
Wavelength Range (nm.): 190.00 to 800.00
Scan Speed: Medium
Sampling Interval: 1.0
Auto Sampling Interval: Disabled
Scan Mode: Single
Sample Preparation Properties
Weight: 0.563 mg
Volume: 100 mL
Dilution: -
Path Length: 1.00 cm
Additional Information: CF931P in Acetonitrile
Instrument Properties
Instrument Type: UV-1600 Series
Measuring Mode: Absorbance
Slit Width: 2.0 nm
Light Source Change Wavelength: 340.8 nm
S/R Exchange: Normal
Attachment Properties
Attachment: None
nm.
190.00 400.00 600.00 800.00
Ab
s.
0.922
0.500
0.000
-0.083
4
3
2
1
No. P/V Wavelength Abs. Description
1 473.00 0.070
2 362.00 0.170
3 281.00 0.839
4 238.00 0.329
5 609.00 0.001
6 397.00 0.020
7 304.00 0.021
8 253.00 0.187
9 231.00 0.293
FWHM: 90.3 nm 
Cyclic	voltammetry	(CV)	
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6.4 Cyclic voltammetry (CV)  
9-(4-fluorophenyl)-10-methylacridin-10-ium bromide salt (128a) 
Cyclic voltammogram of acridinium dye 128a shows a ground state reduction potential E1/2(P/P–) of –0.51 V 
against SCE. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The excitation energy (E0,0) of acridinium dye 128a is 436 nm or 2.83 eV. Resulting in an excited state reduction 
potential E1/2(P*/P–) of +2.32 V. 
 
 
9-(4-Methoxyphenyl)-10-methylacridinium bromide salt (128b) 
Cyclic voltammogram of acridinium dye 128b shows a ground state reduction potential E1/2(P/P–) of –0.56 V 
against SCE. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The excitation energy (E0,0) of acridinium dye 128a is 447 nm or 2.77 eV. Resulting in an excited state reduction 
potential E1/2(P*/P–) of +2.21 V. 
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3,6-Bis(dimethylamino)-9-(2,6-Dimethylphenyl)-10-methylacridinium bromide salt (129b) 
Cyclic voltammogram of acridinium dye 129b shows a ground state reduction potential E1/2(P/P–) of –1.15 V 
against SCE. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The excitation energy (E0,0) of acridinium dye 129b is 516 nm or 2.4 eV. Resulting in an excited state reduction 
potential E1/2(P*/P–) of +1.25 V. 
 
 
9-(2,6-Dimethylphenyl)-1-methoxy-10-phenylacridinium bromide salt (144a) 
Cyclic voltammogram of acridinium dye 144a shows a ground state reduction potential E1/2(P/P–) of –0.56 V 
against SCE. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The excitation energy (E0,0) of acridinium dye 144a is 550 nm or 2.25 eV. Resulting in an excited state reduction 
potential E1/2(P*/P–) of +1.69 V. 
  
Wavelength (nm) 
Wavelength (nm) 
Cyclic	voltammetry	(CV)	
	 250	
6-(Dimethylamino)-9-mesityl-1-methoxy-10-phenylacridinium bromide salt (144b) 
Cyclic voltammogram of acridinium dye 144b shows a ground state reduction potential E1/2(P/P–) of –0.89 V 
against SCE. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The excitation energy (E0,0) of acridinium dye 144b is 541 nm or 2.29 eV. Resulting in an excited state reduction 
potential E1/2(P*/P–) of +1.40 V. 
 
 
(±)-6-(Dimethylamino)-1-methoxy-9-(naphthalen-1-yl)-10-phenylacridinium bromide salt 
(144c) 
Cyclic voltammogram of acridinium dye 144c shows a ground state reduction potential E1/2(P/P–) of –0.87 V 
against SCE. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The excitation energy (E0,0) of acridinium dye 144c is 545 nm or 2.27 eV. Resulting in an excited state reduction 
potential E1/2(P*/P–) of +1.40 V. 
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(±)-7-(Dimethylamino)-1-methoxy-9-(naphthalen-1-yl)-10-phenylacridinium bromide salt 
(144d) 
Cyclic voltammogram of acridinium dye 144d shows a ground state reduction potential E1/2(P/P–) of –0.68 V 
against SCE. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The excitation energy (E0,0) of acridinium dye 144d is 663 nm or 1.87 eV. Resulting in an excited state reduction 
potential E1/2(P*/P–) of +1.19 V. 
 
 
6-(Dimethylamino)-9-(2,6-dimethylphenyl)-1-methoxy-10-phenylacridinium bromide salt 
(144e) 
Cyclic voltammogram of acridinium dye 144e shows a ground state reduction potential E1/2(P/P–) of –0.90 V 
against SCE. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The excitation energy (E0,0) of acridinium dye 144e is 541 nm or 2.29 eV. Resulting in an excited state reduction 
potential E1/2(P*/P–) of +1.39 V. 
  
Wavelength (nm) 
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9-Mesityl-1-methoxy-10-phenylacridinium bromide salt (144f) 
Cyclic voltammogram of acridinium dye 144f shows a ground state reduction potential E1/2(P/P–) of –0.57 V 
against SCE. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The excitation energy (E0,0) of acridinium dye 144f is 552 nm or 2.25 eV. Resulting in an excited state reduction 
potential E1/2(P*/P–) of +1.68 V. 
 
 
1-Methoxy-9,10-diphenylacridinium bromide salt (144g) 
Cyclic voltammogram of acridinium dye 144g shows a ground state reduction potential E1/2(P/P–) of –0.54 V 
against SCE. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The excitation energy (E0,0) of acridinium dye 144g is 555 nm or 2.23 eV. Resulting in an excited state reduction 
potential E1/2(P*/P–) of +1.69 V. 
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1-Methoxy-10-methyl-9-phenylacridinium bromide salt (144h) 
Cyclic voltammogram of acridinium dye 144h shows a ground state reduction potential E1/2(P/P–) of –0.48 V 
against SCE. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The excitation energy (E0,0) of acridinium dye 144h is 541 nm or 2.29 eV. Resulting in an excited state reduction 
potential E1/2(P*/P–) of +1.81 V. 
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6.5 Photostability studies  
 
 
Comparative stability of six acridinium dyes and [Ru(bpy)3]2+ (Rubpy) upon illumination with a blue LED in argon-
saturated acetonitrile. Main plots, UV/Vis absorption spectra measured after the illumination times given in the 
corresponding insets. The illuminations were stopped for 2 minutes while the absorption spectra were detected. 
  
129a 144l 
144h 144g 
144f 144a 
Rubpy 
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Abbreviations 
 
Ac acetyl  IR infrared 
Acr acridinium salt  labs absorption maximum 
Al aliphatic  LED light-emitting diode 
Ar aromatic  lem Emission maximum 
Aq aqueous  LUMO lowest unoccupied molecular 
orbital 
BINAP 2,2’-bis(diphenylphosphino)- 
1,1’-binaphthyl 
 Me  methyl 
Boc tert-butyloxycarbonyl  MeCN acetonitrile 
bpy 2,2'-bipyridyl  MeOH methanol 
Bu butyl  Mes mesityl 
Bn benzyl  MS mass spectrometry 
°C degrees centigrade  N.C no conversion 
cat. catalytic  n.d. not determined 
Cbz carbazole  NMR nuclear magnetic resonance 
dba dibenzylideneacetone  NOE nuclear Overhauser effect 
DMF dimethylformamide  Ph phenyl 
DMSO dimethylsulfoxide  Rac racemic 
dppf 1,1’-bis(diphenylphosphino) 
ferrocene 
 RT room temperature 
d. r. Diastereomeric ratio  Ruphos 2-dicyclohexylphosphino-
2’,6’- 
diisopropoxybiphenyl 
 
ee enantiomeric excess  SCE saturated calomel electrode 
 
lmax molar absorption coefficient  SET single electron transfer 
 
e.r. enantiomeric ratio  T temperature 
eV Electronvolt  TBAI tetrabutylammonium iodide 
E1/2 half-wave potential  DFT density functional theory 
FWHM full witdth at half maximum  THF tetrahydrofuran 
h hours  TLC thin layer chromatography 
HOMO highest occupied molecular 
orbital 
 TTET driplet-triplet energy transfer 
HPLC high performance liquid 
chromatography 
 UV ultra-violet light 
HRMS high resolution mass 
spectrometry 
 V volt 
hu photon energy, light  Xyl xylyl 
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